Barclays (NYSE: BCS) lifts 2025 profit, boosts buybacks and sets 2028 RoTE targets
Barclays PLC reported stronger 2025 results with higher returns and larger shareholder payouts. Group income rose to £29.1bn, up 9% year-on-year, while profit before tax increased 13% to £9.1bn. Return on tangible equity improved to 11.3% and earnings per share reached 43.8p, up 22%.
The bank announced total 2025 capital distributions of £3.7bn, including dividends of 8.6p per share and £2.5bn of share buybacks, with a new £1.0bn buyback announced. Tangible net asset value per share grew to 409p and the common equity tier 1 ratio strengthened to 14.3%.
All major divisions delivered double‑digit returns on tangible equity, with particularly strong contributions from the Investment Bank and UK businesses. Barclays set new medium‑term goals, targeting Group RoTE of greater than 12% in 2026 and greater than 14% in 2028, alongside plans to return at least £10bn of capital between 2024‑2026 and more than £15bn between 2026‑2028.
Positive
- Strong 2025 profitability and returns: Income rose 9% to £29.1bn, profit before tax increased 13% to £9.1bn, RoTE improved to 11.3%, and EPS grew 22% to 43.8p, with all divisions delivering double‑digit RoTE.
- Robust capital and sizable shareholder payouts: CET1 ratio increased to 14.3% and Barclays announced £3.7bn of 2025 capital distributions, alongside multi‑year plans to return at least £10bn (2024‑2026) and more than £15bn (2026‑2028).
Negative
- Higher credit costs and conduct provisions: Credit impairment charges rose to £2.3bn, lifting the loan loss rate to 52bps from 46bps, and the Group booked a £325m provision for potential UK motor finance redress, weighing on reported earnings.
Insights
Barclays delivered solid 2025 profit and capital returns, while absorbing higher credit costs and setting ambitious 2028 targets.
Barclays generated profit before tax of
Capital strength remained a key feature. The common equity tier 1 ratio improved to
Risks are visible but contained in the figures. Credit impairment charges rose to
|
|
BARCLAYS
PLC
|
|
|
(Registrant)
|
|
|
By: /s/
Garth Wright
--------------------------------
|
|
|
Garth
Wright
|
|
|
Assistant
Secretary
|
|
|
|
Results Announcement
|
Page
|
|
|
|
|
Notes
|
1
|
|
|
|
|
Performance Highlights
|
2
|
|
|
|
|
Group Finance Director’s Review
|
6
|
|
|
|
|
Results by Business
|
|
|
|
|
|
● Barclays UK
|
9
|
|
|
|
|
● Barclays UK Corporate Bank
|
11
|
|
|
|
|
● Barclays Private Bank and Wealth Management
|
12
|
|
|
|
|
● Barclays Investment Bank
|
13
|
|
|
|
|
● Barclays US Consumer Bank
|
15
|
|
|
|
|
● Head Office
|
17
|
|
|
|
|
Quarterly Results Summary
|
18
|
|
|
|
|
Quarterly Results by Business
|
19
|
|
|
|
|
Performance Management
|
|
|
|
|
|
● Margins and Balances
|
26
|
|
|
|
|
● Remuneration
|
28
|
|
|
|
|
Risk Management
|
|
|
|
|
|
●
Risk Management and Principal Risks
|
30
|
|
|
|
|
●
Credit Risk
|
31
|
|
|
|
|
●
Market Risk
|
52
|
|
|
|
|
●
Treasury and Capital Risk
|
53
|
|
|
|
|
Condensed Consolidated Financial Statements
|
62
|
|
|
|
|
Financial Statement Notes
|
67
|
|
|
|
|
Appendix: Non-IFRS Performance Measures
|
71
|
|
|
|
|
Shareholder Information
|
80
|
|
●
|
Announced 2028 financial targets
|
|
|
●
|
FY25 Group RoTE of 11.3% (FY24: 10.5%) with earnings per share
(EPS) of 43.8p (FY24: 36.0p)
|
|
|
●
|
Total capital distributions of £3.7bn announced in relation to
2025 23% higher than 2024
|
|
|
|
-
|
Reflecting
a total dividend of 8.6p (£1.2bn) and total share buybacks of
£2.5bn for 2025. This includes a 5.6p (£0.8bn) full year
dividend, and the intention to initiate a further share buyback of
up to £1.0bn
|
|
●
|
FY25 Group net interest income (NII) excluding Barclays Investment
Bank (IB) and Head office of £12.8bn, of which Barclays UK was
£7.7bn, meeting 2025 guidance of greater than £12.6bn and
£7.6bn respectively
|
|
|
●
|
Continued cost discipline with FY25 Group cost: income ratio
improving to 61% (FY24: 62%) driven by positive operating leverage
for the third consecutive year
|
|
|
●
|
Achieved £0.7bn of cost efficiency savings in FY25, exceeding
the c.£0.5bn guidance, with a total of £1.7bn across FY24
and FY25
|
|
|
●
|
Robust risk management with FY25 Group loan loss rate (LLR) of
52bps (FY24: 46bps), within the through the cycle range of
50-60bps
|
|
|
●
|
Strong
balance sheet with CET1 ratio of 14.3%
|
|
|
|
-
|
Taking
into account the impact of the £1.0bn share buyback announced
today, the CET1 ratio as of 31 December 2025 would be reduced to
14.0% (at the top end of the 13-14% target range)
|
|
●
|
TNAV
per share of 409p (December 2024: 357p)
|
|
|
|
Income
|
Profit before tax
|
Attributable profit
|
Cost: income ratio
|
LLR
|
RoTE
|
EPS
|
TNAV per share
|
CET1 ratio
|
Total capital return
|
|
FY25
|
£29.1bn
|
£9.1bn
|
£6.2bn
|
61%
|
52bps
|
11.3%
|
43.8p
|
409p
|
14.3%
|
£3.7bn
|
|
Q425
|
£7.1bn
|
£1.9bn
|
£1.2bn
|
66%
|
48bps
|
8.5%
|
8.6p
|
|
●
|
Group RoTE was 11.3% (FY24: 10.5%) with profit before tax of
£9.1bn (FY24: £8.1bn). All divisions delivered double-digit RoTE in
FY25
|
|
|
●
|
Group income of £29.1bn increased 9%
year-on-year.
Group NII excluding IB and Head Office was £12.8bn, up
13% year-on-year
|
|
|
|
-
|
Barclays UK income increased 5%, reflecting higher structural hedge
income and Tesco Bank NII, partially offset by the non-repeat of
the £0.6bn day 1 gain from the acquisition of Tesco Bank in
the prior year
|
|
|
-
|
Barclays UK Corporate Bank (UKCB) income increased 16%, reflecting
higher average deposit and lending balances, and higher structural
hedge income
|
|
|
-
|
Barclays Private Bank and Wealth Management (PBWM) income increased
5%, driven by growth in deposit, invested asset and loan balances
from net new inflows and market movements
|
|
|
-
|
Barclays Investment Bank (IB) income increased 11%, with growth
across Global Markets and Investment Banking, supported by
continued growth in more stable income streams (Financing and
International Corporate Bank)
|
|
|
-
|
Barclays US Consumer Bank (USCB) income increased 11%, reflecting
the impact of repricing initiatives, business growth and the
acquisition of General Motors co-branded cards portfolio (GM
portfolio) in Q325, partially offset by the strengthening of GBP
against USD
|
|
●
|
Group total operating expenses were £17.7bn, up 6%
year-on-year
|
||||
|
|
-
|
Group operating costs increased 5% to £17.0bn, reflecting
Tesco Bank run rate and integration costs, further investment
spend, business growth and inflation, partially offset by
£0.7bn of cost efficiency savings
|
|||
|
|
|
-
|
FY25 total structural cost actions of £0.3bn (FY24:
£0.3bn)
|
|
|
|
|
-
|
Litigation and conduct charges of £0.4bn (FY24: £0.2bn),
included a £235m charge for motor finance redress in
Q325
|
|||
|
●
|
Credit impairment charges were £2.3bn (FY24:
£2.0bn) with an LLR of
52bps (FY24: 46bps)
|
||||
|
●
|
CET1 ratio of 14.3% (December 2024: 13.6%), with RWAs of £356.8bn (December 2024:
£358.1bn) and TNAV per share of 409p (December 2024:
357p)
|
||||
|
●
|
Group RoTE was 8.5% (Q424:
7.5%1)
with profit before tax of £1.9bn (Q424:
£1.7bn1)
|
|
|
●
|
Group income of £7.1bn increased 2% year-on-year.
Q424 included the
£0.6bn day 1 gain from the acquisition of Tesco
Bank
|
|
|
|
-
|
Group NII excluding IB and Head Office was £3.4bn, up 12%
year-on-year
|
|
●
|
Group total operating expenses were £4.7bn, up 1%
year-on-year, with a cost:
income ratio of 66% (Q424: 66%)
|
|
|
|
-
|
Group
operating costs increased 3% to £4.4bn, reflecting business
growth, inflation and one-off costs, including a VAT expense in
Barclays UK, partially offset by c.£0.2bn of cost efficiency
savings
|
|
●
|
Credit impairment charges were
£0.5bn (Q424: £0.7bn) with an LLR of 48bps (Q424: 66bps). Q424 included
a £0.2bn day 1 impact from the acquisition of Tesco
Bank
|
|
|
1
|
Q424 included the day 1 impacts from the acquisition of Tesco Bank:
total income gain of £556m, credit impairment charges of
£209m, and profit before tax benefit of
£347m.
|
|
●
|
Returns: Group RoTE of greater
than 12%
|
||||
|
●
|
Capital returns2: plan to return at least £10bn of capital to
shareholders between 2024 and 2026, through dividends and share
buybacks, with a continued preference for
buybacks
|
||||
|
|
-
|
Progressive increase in total capital returns versus
2025
|
|||
|
|
-
|
Share buybacks announced quarterly
|
|||
|
|
-
|
Dividends to be paid semi-annually, including planned £2bn
dividend for 2026
|
|||
|
●
|
Income: Group total income of
c.£31bn
|
||||
|
|
-
|
Group NII excluding IB and Head Office greater than £13.5bn
and Barclays UK NII of £8.1bn - £8.3bn
|
|||
|
●
|
Costs: Group cost: income ratio
of high 50s in percentage terms
|
||||
|
●
|
Impairment: expect Group LLR of
50-60bps through the cycle
|
||||
|
●
|
Capital: CET1 ratio target
range of 13-14%
|
||||
|
|
-
|
IB RWAs mid 50s% of Group RWAs
|
|||
|
|
-
|
Impact of regulatory change on RWAs in line with our prior guidance
of c.£19-26bn
|
|||
|
|
|
-
|
c.£3-10bn RWAs from Basel 3.1, with implementation expected from 1 January
20273
|
||
|
|
|
-
|
c.£16bn
RWAs from USCB moving to an Internal Ratings Based (IRB) model,
subject to portfolio changes and regulatory approval, c.£5bn
expected on 1 January 2027 with remainder anticipated later in
2027
|
|
|
|
|
-
|
Expect Pillar 2A capital to reduce upon implementation of Basel 3.1
and USCB IRB
|
|||
|
●
|
Returns: Group RoTE of greater
than 14%
|
|
|
●
|
Capital returns2: plan to return greater than £15bn of capital
to shareholders between 2026 and 2028, through dividends and share
buybacks. This provides capacity for additional investment and
growth, exceeding the level of investment in the current
plan
|
|
|
●
|
Income: greater than 5%
compound annual growth rate (CAGR) 2025-2028
|
|
|
●
|
Costs: Group cost: income ratio
of low 50s in percentage terms. Cost target includes total gross
efficiency savings of c.£2bn in 2026-2028
|
|
|
●
|
Impairment: expect Group LLR of
50-60bps through the cycle
|
|
|
●
|
Capital: CET1 ratio target
range of 13-14%
|
|
|
|
-
|
IB RWAs of c.50% of Group RWAs
|
|
1
|
Our targets and guidance are based on management's current
expectations as to the macroeconomic environment and the business
and may be subject to change.
|
|
2
|
This multi-year plan is subject to supervisory and Board approvals,
anticipated financial performance and our published CET1 ratio
target range of 13-14%.
|
|
3
|
Fundamental review of the trading book (FRTB) impact mostly
expected in 2027.
|
|
Barclays Group results
|
Year ended
|
|
Three months ended
|
||||
|
|
31.12.25
|
31.12.24
|
|
|
31.12.25
|
31.12.24
|
|
|
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Barclays UK1
|
8,708
|
8,274
|
5
|
|
2,262
|
2,615
|
(13)
|
|
Barclays
UK Corporate Bank
|
2,064
|
1,780
|
16
|
|
539
|
458
|
18
|
|
Barclays
Private Bank and Wealth Management
|
1,380
|
1,309
|
5
|
|
348
|
351
|
(1)
|
|
Barclays
Investment Bank
|
13,055
|
11,805
|
11
|
|
2,792
|
2,607
|
7
|
|
Barclays
US Consumer Bank
|
3,681
|
3,326
|
11
|
|
1,053
|
857
|
23
|
|
Head
Office
|
252
|
294
|
(14)
|
|
83
|
76
|
9
|
|
Total income
|
29,140
|
26,788
|
9
|
|
7,077
|
6,964
|
2
|
|
Operating costs
|
(17,040)
|
(16,195)
|
(5)
|
|
(4,379)
|
(4,244)
|
(3)
|
|
UK regulatory levies
|
(313)
|
(320)
|
2
|
|
(229)
|
(227)
|
(1)
|
|
Litigation and conduct
|
(392)
|
(220)
|
(78)
|
|
(50)
|
(121)
|
59
|
|
Total operating expenses
|
(17,745)
|
(16,735)
|
(6)
|
|
(4,658)
|
(4,592)
|
(1)
|
|
Other net income/(expenses)
|
23
|
37
|
(38)
|
|
(25)
|
—
|
|
|
Profit before impairment
|
11,418
|
10,090
|
13
|
|
2,394
|
2,372
|
1
|
|
Credit impairment charges
|
(2,279)
|
(1,982)
|
(15)
|
|
(535)
|
(711)
|
25
|
|
Profit before tax
|
9,139
|
8,108
|
13
|
|
1,859
|
1,661
|
12
|
|
Tax charge
|
(1,926)
|
(1,752)
|
(10)
|
|
(388)
|
(448)
|
13
|
|
Profit after tax
|
7,213
|
6,356
|
13
|
|
1,471
|
1,213
|
21
|
|
Non-controlling interests
|
(41)
|
(49)
|
16
|
|
(18)
|
(20)
|
10
|
|
Other equity instrument holders
|
(997)
|
(991)
|
(1)
|
|
(258)
|
(228)
|
(13)
|
|
Attributable profit
|
6,175
|
5,316
|
16
|
|
1,195
|
965
|
24
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
11.3%
|
10.5%
|
|
|
8.5%
|
7.5%
|
|
|
Average tangible shareholders' equity (£bn)
|
54.6
|
50.7
|
|
|
56.5
|
51.5
|
|
|
Cost: income ratio
|
61%
|
62%
|
|
|
66%
|
66%
|
|
|
Loan loss rate (bps)
|
52
|
46
|
|
|
48
|
66
|
|
|
Basic earnings per ordinary share
|
43.8p
|
36.0p
|
22
|
|
8.6p
|
6.7p
|
29
|
|
Dividend per ordinary share
|
8.6p
|
8.4p
|
2
|
|
|
|
|
|
Share buybacks announced (£m)
|
2,500
|
1,750
|
43
|
|
|
|
|
|
Total payout equivalent per share
|
c.26.4p
|
c.20.4p
|
30
|
|
|
|
|
|
Basic weighted average number of shares (m)
|
14,112
|
14,755
|
(4)
|
|
13,883
|
14,432
|
(4)
|
|
Period end number of shares (m)
|
13,867
|
14,420
|
(4)
|
|
|
|
|
|
Period end tangible shareholders' equity (£bn)
|
56.8
|
51.5
|
|
|
|
|
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
Balance sheet and capital management2
|
£bn
|
£bn
|
|
|
Loans and advances at amortised cost
|
430.0
|
414.5
|
|
|
Loans and advances at amortised cost impairment coverage
ratio
|
1.2%
|
1.2%
|
|
|
Total assets
|
1,544.2
|
1,518.2
|
|
|
Deposits at amortised cost
|
585.6
|
560.7
|
|
|
Tangible net asset value per share
|
409p
|
357p
|
|
|
Common equity tier 1 ratio
|
14.3%
|
13.6%
|
|
|
Common equity tier 1 capital
|
51.1
|
48.6
|
|
|
Risk weighted assets
|
356.8
|
358.1
|
|
|
UK leverage ratio
|
5.1%
|
5.0%
|
|
|
UK leverage exposure
|
1,247.3
|
1,206.5
|
|
|
|
|
|
|
|
Funding and liquidity
|
|
|
|
|
Group liquidity pool (£bn)
|
337.8
|
296.9
|
|
|
Liquidity
coverage ratio3
|
170.0%
|
172.4%
|
|
|
Net
stable funding ratio4
|
135.2%
|
134.9%
|
|
|
Loan: deposit ratio
|
73%
|
74%
|
|
|
1
|
Q424 and FY24 included the £556m day 1 gain from the
acquisition of Tesco Bank.
|
|
2
|
Refer to pages 57 to 61 for further information on how capital,
RWAs and leverage are calculated.
|
|
3
|
Represents average of the last 12 spot month end ratios. In June
2025, Barclays implemented a new methodology for calculating net
stress outflows related to secured financing transactions in the
liquidity coverage ratio (LCR).
|
|
4
|
Represents average of the last four spot quarter end
positions.
|
|
●
|
Barclays delivered a profit before tax of £9,139m (FY24:
£8,108m), RoTE of 11.3% (FY24: 10.5%) and EPS of 43.8p (FY24:
36.0p)
|
||||
|
●
|
The Group has a diverse income
profile across businesses and geographies. The year-on-year appreciation of average GBP
against USD negatively impacted income and profits, and positively
impacted credit impairment charges and total operating
expenses
|
||||
|
●
|
Group income increased 9% to
£29,140m driven by higher
structural hedge income, higher income in Global Markets across
FICC and Equities, Tesco Bank NII and lending growth, partially
offset by the non-repeat of the £556m day 1 gain from the
acquisition of Tesco Bank in the prior year
|
||||
|
●
|
Group total operating expenses increased to £17,745m (FY24:
£16,735m)
|
||||
|
|
-
|
Group
operating costs increased 5% to £17,040m, reflecting Tesco
Bank run rate and integration costs, further investment spend,
business growth and inflation, partially offset by c.£700m of
cost efficiency savings
|
|||
|
|
|
-
FY25 total structural cost actions of £285m (FY24:
£273m) with Q425 structural cost actions of £90m (Q424:
£110m)
|
|||
|
|
-
|
Litigation
and conduct charges of £392m (FY24: £220m), included a
£235m charge for motor finance redress in Q325
|
|||
|
●
|
Credit impairment charges
increased to £2,279m (FY24: £1,982m), primarily driven by the impact of the GM portfolio
acquisition, an IB single name charge and elevated US macroeconomic
uncertainty. Total coverage ratio remained stable at 1.2% (December
2024: 1.2%)
|
||||
|
●
|
The effective tax rate (ETR)
was 21.1% (FY24: 21.6%). The
2025 ETR included tax relief on payments made under Additional Tier
1 (AT1) instruments and on holdings of inflation-linked government
bonds
|
||||
|
●
|
Attributable profit was £6,175m (FY24: £5,316m)
|
||||
|
●
|
Total assets increased to
£1,544.2bn (December 2024: £1,518.2bn)
driven by higher trading activity in
IB, growth in the liquidity pool and higher lending in Barclays UK
and UKCB. This was partially offset by a reduction in derivative
assets and the strengthening of spot GBP against USD
|
||||
|
●
|
TNAV per share increased to
409p (December 2024: 357p) as
EPS of 43.8p and a 16p benefit from the cash flow hedging reserve
were partially offset by an 8p reduction from dividends paid during
FY25. The impact of the share buybacks executed throughout 2025 was
broadly neutral to TNAV per share
|
||||
|
●
|
The CET1 ratio increased to 14.3% (December 2024: 13.6%). Taking
into account the impact of the £1.0bn share buyback announced
today, the CET1 ratio as of 31 December 2025 would be reduced to
14.0% (at the top end of the 13-14% target range)
|
|
|
●
|
The c.80bps increase in 2025 was driven by a CET1 capital increase
of £2.5bn to £51.1bn and an RWA decrease of £1.4bn
to £356.8bn:
|
|
|
|
-
|
c.170bps increase from attributable profit
|
|
|
-
|
c.100bps decrease driven by shareholder distributions including the
interim dividend payment of 3.0p per share paid in September 2025,
the completed £2.0bn share buybacks announced with FY24 and
H125 Results, and the ongoing £0.5bn share buyback announced
with Q325 Results, as well as the accrual for the FY25
dividend
|
|
|
-
|
c.30bps increase from other CET1 capital movements, including an
increase in the fair value through other comprehensive income
reserve
|
|
|
-
|
c.20bps decrease as a result of a £5.2bn increase in RWAs,
excluding the impact of foreign exchange movements. This was
primarily driven by lending growth in the UK businesses and an
increase in USCB, including the acquisition of the GM portfolio,
partially offset by the disposal of the German consumer finance
business and of Barclays' joint venture interest in Entercard Group
AB (Entercard)
|
|
|
-
|
A £1.1bn decrease in CET1 capital due to a decrease in the
currency translation reserve was partially offset by a £6.5bn
decrease in RWAs as a result of foreign exchange
movements
|
|
●
|
The
UK leverage ratio increased to 5.1% (December 2024: 5.0%), as Tier
1 capital increased by £3.2bn, partially offset by a
£40.8bn increase in leverage exposure to £1,247.3bn. The
increase in leverage exposure was largely driven by an increase in
trading activity in IB and higher lending in Barclays UK and UKCB,
partially offset by the strengthening of spot GBP against
USD
|
|
|
●
|
The liquidity metrics remain above regulatory requirements,
underpinned by well-diversified sources of funding, a stable global
deposit franchise and a highly liquid balance sheet
|
|
●
|
The liquidity pool was £337.8bn, an increase of £40.9bn
from December 2024. The increase in the liquidity pool was
primarily driven by increased wholesale funding and deposit growth
across businesses
|
|
●
|
The average1
LCR was 170.0% (December 2024:
172.4%), equivalent to a surplus of £131.2bn (December 2024:
£127.5bn)
|
|
●
|
Total deposits increased to £585.6bn (December 2024:
£560.7bn), primarily driven by customer deposit growth in
International Corporate Bank, UKCB and deposits from commercial and
non-commercial banks
|
|
●
|
The average2
Net Stable Funding Ratio (NSFR) was
135.2% (December 2024: 134.9%), which represents a £166.3bn
surplus (December 2024: £162.9bn) above the 100% regulatory
requirement
|
|
●
|
Wholesale funding outstanding, excluding repurchase agreements, was
£220.1bn (December 2024: £186.0bn)
|
|
●
|
The Group issued £16.1bn equivalent of minimum requirement for
own funds and eligible liabilities (MREL) instruments from Barclays
PLC (the Parent company) as of Q425. The Group has a strong MREL
position with a ratio of 35.8%, which is in excess of the
regulatory requirement of 30.5% plus a confidential, institution
specific, Prudential Regulation Authority (PRA) buffer
|
|
1
|
Represents average of the last 12 spot month end ratios. In June
2025, Barclays implemented a new methodology for calculating net
stress outflows related to secured financing transactions in the
liquidity coverage ratio.
|
|
2
|
Represents average of the last four spot quarter end
ratios.
|
|
●
|
Motor finance: On 7 October
2025, the UK Financial Conduct Authority (FCA) began consulting on
an industry-wide compensation scheme for eligible motor finance
customers. Barclays considers it more likely than not that a
redress scheme will be implemented by the FCA. As a result,
Barclays and Clydesdale Financial Services Ltd (a subsidiary of
Barclays PLC) have recognised a provision of £325m in respect
of this matter as at 31 December 2025 (as at 31 December 2024:
£90m). Barclays has engaged with the FCA as part of its
consultation process and the FCA’s Policy Statement and final
redress scheme rules are currently expected to be published in
February or March 2026. The ultimate financial impact on Barclays
could differ from the recognised provision, which represents
Barclays’ best estimate of the cost of redress based on the
information currently available to Barclays
|
|
●
|
FCA investigations concerning financial crime systems and controls
and compliance with the Money Laundering Regulations:
In July 2025, the FCA concluded civil
enforcement investigations into Barclays Bank PLC and Barclays Bank
UK PLC regarding compliance with anti-money laundering regulations
and financial crime controls. Barclays Bank PLC paid £39m to
resolve its investigation, and Barclays Bank UK PLC settled a
separate matter for £9m (including a £6m voluntary
payment to investors). These amounts were fully provided for in
Barclays H125 interim Results. The FCA acknowledged Barclays’
cooperation in both cases, which are now closed
|
|
●
|
Disposal of German consumer finance business: In Q125, Barclays Bank Ireland PLC announced the
completion of the sale of its German consumer finance business to
BAWAG P.S.K., a wholly owned subsidiary of BAWAG Group AG. The sale
released c.£3.3bn of RWAs, increasing Barclays’ CET1
ratio by c.10bps in Q125
|
|
●
|
Long-term strategic partnership for Payment Acceptance
business: On 17 April 2025,
Barclays announced it had entered into a long-term strategic
partnership with Brookfield Asset Management Ltd to grow and
transform Barclays' Payment Acceptance business, previously
referred to as the Merchant Acquiring business
|
|
●
|
GM portfolio acquisition: On 22
August 2025, Barclays completed the acquisition of a US credit card
portfolio of $1.6bn receivables, in partnership with General Motors
Company. The partnership will serve to further scale
Barclays’ credit card portfolio in the US and build on its
growth strategy
|
|
●
|
Disposal of Barclays' entire shareholding in Entercard:
On 28 August 2025, Barclays announced
the sale of its entire shareholding in its joint venture Entercard
to its joint venture partner, Swedbank AB (publ). The sale
completed in Q425 and released c.£0.9bn of RWAs, increasing
Barclays’ CET1 ratio by c.4bps
|
|
●
|
Best Egg, Inc. (Best Egg)
acquisition: On 28 October
2025, Barclays announced an agreement for Barclays Bank Delaware to
acquire Best Egg for $800m, subject to regulatory approvals and
other conditions. Best Egg is a leading US
direct‑to‑consumer
personal loan origination platform focused on prime borrowers.
Completion is expected in Q226, after completion of the previously
announced sale of Barclays’ American Airlines
co‑branded
credit card receivables. The net estimated impact of both
transactions is expected to increase Barclays’ CET1 ratio by
c.6bps in Q226
|
|
Barclays UK
|
Year ended
|
|
Three months ended
|
||||
|
|
31.12.25
|
31.12.241
|
|
|
31.12.25
|
31.12.241
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
7,653
|
6,627
|
15
|
|
2,015
|
1,815
|
11
|
|
Net fee, commission and other income
|
1,055
|
1,647
|
(36)
|
|
247
|
800
|
(69)
|
|
Total income
|
8,708
|
8,274
|
5
|
|
2,262
|
2,615
|
(13)
|
|
Operating costs
|
(4,746)
|
(4,235)
|
(12)
|
|
(1,274)
|
(1,170)
|
(9)
|
|
UK regulatory levies
|
(85)
|
(78)
|
(9)
|
|
(41)
|
(36)
|
(14)
|
|
Litigation and conduct
|
(51)
|
(16)
|
|
|
(14)
|
(9)
|
(56)
|
|
Total operating expenses
|
(4,882)
|
(4,329)
|
(13)
|
|
(1,329)
|
(1,215)
|
(9)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
3,826
|
3,945
|
(3)
|
|
933
|
1,400
|
(33)
|
|
Credit impairment charges
|
(413)
|
(365)
|
(13)
|
|
(74)
|
(283)
|
74
|
|
Profit before tax
|
3,413
|
3,580
|
(5)
|
|
859
|
1,117
|
(23)
|
|
Attributable profit
|
2,443
|
2,465
|
(1)
|
|
706
|
781
|
(10)
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
20.7%
|
23.1%
|
|
|
23.8%
|
28.0%
|
|
|
Average allocated tangible equity (£bn)
|
11.8
|
10.7
|
|
|
11.9
|
11.2
|
|
|
Cost: income ratio
|
56%
|
52%
|
|
|
59%
|
46%
|
|
|
Loan loss rate (bps)
|
18
|
16
|
|
|
13
|
49
|
|
|
Net interest margin
|
3.63%
|
3.29%
|
|
|
3.72%
|
3.53%
|
|
|
|
|
|
|
|
|
|
|
|
Key facts
|
As at 31.12.25
|
As at 31.12.24
|
|
|
|
|
|
|
UK mortgage balances (£bn)
|
172.4
|
163.1
|
|
|
|
|
|
|
Mortgage gross lending flow (£bn)
|
34.3
|
23.9
|
|
|
|
|
|
|
Average
LTV of mortgage portfolio2
|
55%
|
53%
|
|
|
|
|
|
|
Average
LTV of new mortgage lending2
|
70%
|
66%
|
|
|
|
|
|
|
Number of branches
|
206
|
221
|
|
|
|
|
|
|
Digitally
active customers (m)3
|
13.9
|
13.4
|
|
|
|
|
|
|
30 day arrears rate - total UK cards
|
0.8%
|
0.7%
|
|
|
|
|
|
|
90 day arrears rate - total UK cards
|
0.2%
|
0.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
216.5
|
207.7
|
|
|
|
|
|
|
Total assets
|
299.6
|
299.8
|
|
|
|
|
|
|
Customer deposits at amortised cost
|
244.6
|
244.2
|
|
|
|
|
|
|
Loan: deposit ratio
|
94%
|
92%
|
|
|
|
|
|
|
Risk weighted assets
|
85.8
|
84.5
|
|
|
|
|
|
|
Period end allocated tangible equity
|
11.8
|
11.6
|
|
|
|
|
|
|
1
|
Q424 and FY24 included the day 1 impacts from the acquisition of
Tesco Bank: total income gain of £556m, credit impairment
charges of £209m, and profit before tax benefit of
£347m.
|
|
2
|
Average loan to value (LTV) of mortgages is balance weighted and
reflects both residential and buy-to-let (BTL) mortgage portfolios
within the Home Loans portfolio.
|
|
3
|
Excludes Tesco Bank.
|
|
Analysis of Barclays UK
|
Year ended
|
|
Three months ended
|
||||
|
31.12.25
|
31.12.241
|
|
|
31.12.25
|
31.12.241
|
|
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Retail Banking
|
6,582
|
6,270
|
5
|
|
1,702
|
2,078
|
(18)
|
|
Business Banking
|
2,126
|
2,004
|
6
|
|
560
|
537
|
4
|
|
Total income
|
8,708
|
8,274
|
5
|
|
2,262
|
2,615
|
(13)
|
|
|
|
|
|
|
|
|
|
|
Analysis of credit impairment (charges)/releases
|
|
|
|
|
|
|
|
|
Retail Banking
|
(374)
|
(394)
|
5
|
|
(72)
|
(279)
|
74
|
|
Business Banking
|
(39)
|
29
|
|
|
(2)
|
(4)
|
50
|
|
Total credit impairment charges
|
(413)
|
(365)
|
(13)
|
|
(74)
|
(283)
|
74
|
|
|
|
|
|
|
|
|
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
|
|
|
|
Analysis of loans and advances to customers at amortised
cost
|
£bn
|
£bn
|
|
|
|
|
|
|
Retail Banking
|
198.6
|
188.0
|
|
|
|
|
|
|
Business Banking
|
17.9
|
19.7
|
|
|
|
|
|
|
Total loans and advances to customers at amortised
cost
|
216.5
|
207.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised cost
|
|
|
|
|
|
|
|
|
Retail Banking
|
192.7
|
191.4
|
|
|
|
|
|
|
Business Banking
|
51.9
|
52.8
|
|
|
|
|
|
|
Total customer deposits at amortised cost
|
244.6
|
244.2
|
|
|
|
|
|
|
●
|
Profit before tax decreased 5% to £3,413m
|
|
●
|
Total income increased 5% to £8,708m. NII increased 15% to £7,653m, as higher
structural hedge income and the impact from Tesco Bank were
partially offset by retail deposit dynamics. Net fee, commission
and other income decreased 36% to £1,055m primarily driven by
the non-repeat of the day 1 gain from the acquisition of Tesco
Bank
|
|
●
|
Total operating expenses increased 13% to
£4,882m, driven by Tesco Bank run and
integration costs, and inflation. Ongoing efficiency savings
continue to be reinvested, to drive sustainable improvement to the
cost: income ratio
|
|
●
|
Credit impairment charges were £413m (FY24:
£365m), underpinned by
balance growth and stable credit performance. The UK cards 30 and
90 day arrears rates were 0.8% (Q424: 0.7%) and 0.2% (Q424: 0.2%)
respectively. The UK cards total coverage ratio decreased to 4.3%
(December 2024: 4.8%) driven by resilient customer
behaviour
|
|
●
|
Loans and advances to customers at amortised cost increased
£8.8bn to £216.5bn,
primarily driven by growth in mortgages and cards lending in Retail
Banking, partially offset by continued repayment of government
scheme lending in Business Banking
|
|
●
|
Customer deposits at amortised cost increased by £0.4bn
to £244.6bn, driven by an increase in Retail
Banking deposits, partially offset by a reduction in Business
Banking current accounts. The loan:deposit ratio remained broadly
stable at 94% (December 2024: 92%)
|
|
●
|
RWAs increased to £85.8bn (December 2024: £84.5bn)
primarily due to growth in mortgages
and cards lending in Retail Banking, partially offset by
securitisations
|
|
1
|
FY24 included the day 1 impacts from the acquisition of Tesco Bank:
total income gain of £556m, credit impairment charges of
£209m, and profit before tax benefit of
£347m.
|
|
Barclays UK Corporate Bank
|
Year ended
|
|
Three months ended
|
||||
|
|
31.12.25
|
31.12.24
|
|
|
31.12.25
|
31.12.24
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
1,480
|
1,206
|
23
|
|
396
|
324
|
22
|
|
Net fee, commission and other income
|
584
|
574
|
2
|
|
143
|
134
|
7
|
|
Total income
|
2,064
|
1,780
|
16
|
|
539
|
458
|
18
|
|
Operating costs
|
(989)
|
(935)
|
(6)
|
|
(272)
|
(250)
|
(9)
|
|
UK regulatory levies
|
(29)
|
(37)
|
22
|
|
(14)
|
(14)
|
—
|
|
Litigation and conduct
|
(39)
|
(1)
|
|
|
—
|
(1)
|
|
|
Total operating expenses
|
(1,057)
|
(973)
|
(9)
|
|
(286)
|
(265)
|
(8)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
1,007
|
807
|
25
|
|
253
|
193
|
31
|
|
Credit impairment charges
|
(37)
|
(76)
|
51
|
|
(1)
|
(40)
|
98
|
|
Profit before tax
|
970
|
731
|
33
|
|
252
|
153
|
65
|
|
Attributable profit
|
648
|
490
|
32
|
|
168
|
98
|
71
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
18.9%
|
16.0%
|
|
|
19.1%
|
12.3%
|
|
|
Average allocated tangible equity (£bn)
|
3.4
|
3.1
|
|
|
3.5
|
3.2
|
|
|
Cost: income ratio
|
51%
|
55%
|
|
|
53%
|
58%
|
|
|
Loan loss rate (bps)
|
12
|
29
|
|
|
1
|
62
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
30.0
|
25.4
|
|
|
|
|
|
|
Deposits at amortised cost
|
88.7
|
83.1
|
|
|
|
|
|
|
Risk weighted assets
|
26.5
|
23.9
|
|
|
|
|
|
|
Period end allocated tangible equity
|
3.7
|
3.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
|
|
Three months ended
|
||||
|
|
31.12.25
|
31.12.24
|
|
|
31.12.25
|
31.12.24
|
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Corporate lending
|
357
|
267
|
34
|
|
97
|
71
|
37
|
|
Transaction banking
|
1,707
|
1,513
|
13
|
|
442
|
387
|
14
|
|
Total income
|
2,064
|
1,780
|
16
|
|
539
|
458
|
18
|
|
●
|
Profit before tax increased 33% to £970m
|
|
●
|
Total income increased 16% to £2,064m, NII increased 23% to £1,480m, driven by
higher average deposit and lending balances, and higher structural
hedge income. Net fee, commission, trading and other income was
broadly stable at £584m
|
|
●
|
Total operating expenses increased 9% to
£1,057m, including a litigation and
conduct charge of £39m in Q225. Operating costs increased 6%
to £989m, reflecting higher investment spend to support
business growth ambitions, with ongoing efficiency savings
offsetting inflationary headwinds
|
|
●
|
Credit impairment charges were £37m (FY24:
£76m), reflecting stable
underlying credit performance and limited single name
charges
|
|
●
|
Loans and advances to customers at amortised cost increased to
£30.0bn (December 2024: £25.4bn), reflecting the strategic focus to grow
lending
|
|
●
|
Deposits at amortised cost increased to £88.7bn (December
2024: £83.1bn), driven by
an inflow of balances from new and existing
clients
|
|
●
|
RWAs increased to £26.5bn (December 2024:
£23.9bn), reflecting
higher client lending limits and growth in lending
balances
|
|
Barclays Private Bank and Wealth Management
|
Year ended
|
|
Three months ended
|
||||
|
|
31.12.25
|
31.12.24
|
|
|
31.12.25
|
31.12.24
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
799
|
767
|
4
|
|
202
|
216
|
(6)
|
|
Net fee, commission and other income
|
581
|
542
|
7
|
|
146
|
135
|
8
|
|
Total income
|
1,380
|
1,309
|
5
|
|
348
|
351
|
(1)
|
|
Operating costs
|
(994)
|
(911)
|
(9)
|
|
(279)
|
(255)
|
(9)
|
|
UK regulatory levies
|
(10)
|
(9)
|
(11)
|
|
(7)
|
(7)
|
—
|
|
Litigation and conduct
|
(9)
|
—
|
|
|
(10)
|
(1)
|
|
|
Total operating expenses
|
(1,013)
|
(920)
|
(10)
|
|
(296)
|
(263)
|
(13)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
367
|
389
|
(6)
|
|
52
|
88
|
(41)
|
|
Credit impairment releases/(charges)
|
8
|
(6)
|
|
|
(2)
|
(2)
|
—
|
|
Profit before tax
|
375
|
383
|
(2)
|
|
50
|
86
|
(42)
|
|
Attributable profit
|
291
|
288
|
1
|
|
35
|
63
|
(44)
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
26.3%
|
28.1%
|
|
|
12.6%
|
23.9%
|
|
|
Average allocated tangible equity (£bn)
|
1.1
|
1.0
|
|
|
1.1
|
1.1
|
|
|
Cost: income ratio
|
73%
|
70%
|
|
|
85%
|
75%
|
|
|
Loan loss rate (bps)
|
(5)
|
4
|
|
|
5
|
5
|
|
|
|
|
|
|
|
|
|
|
|
Key facts
|
£bn
|
£bn
|
|
|
£bn
|
£bn
|
|
|
Net new
assets under management1
|
3.3
|
3.7
|
|
|
0.6
|
0.7
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
14.7
|
14.5
|
|
|
|
|
|
|
Deposits at amortised cost
|
72.0
|
69.5
|
|
|
|
|
|
|
Risk weighted assets
|
8.0
|
7.9
|
|
|
|
|
|
|
Period end allocated tangible equity
|
1.1
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Invested
assets2
|
140.6
|
124.6
|
|
|
|
|
|
|
Of which:
|
|
|
|
|
|
|
|
|
Assets under management1
|
52.9
|
47.7
|
|
|
|
|
|
|
Assets under supervision1
|
87.7
|
76.9
|
|
|
|
|
|
|
Clients
assets and liabilities3
|
227.6
|
208.9
|
|
|
|
|
|
|
●
|
Profit before tax decreased 2% to £375m
|
|
●
|
Total income increased 5% to £1,380m, driven by growth in deposit, invested asset and
loan balances from net new inflows and market
movements
|
|
●
|
Total operating expenses increased 10% to £1,013m,
reflecting higher investment spend to
support business growth ambitions, with ongoing efficiency savings
offsetting inflationary headwinds
|
|
●
|
Client assets and liabilities increased £18.7bn to
£227.6bn, driven by net
new inflows of invested assets, deposits and loan balances and
market movements, partially offset by FX impact
|
|
●
|
RWAs were broadly stable at £8.0bn (December 2024:
£7.9bn)
|
|
1
|
Refer to page 71 for further information on net new assets under
management, assets under management and assets under
supervision.
|
|
2
|
Invested assets (held off-balance sheet) represent assets under
management and supervision. Uninvested cash held under an
investment mandate and reported within deposits is excluded from
invested assets.
|
|
3
|
Client assets and liabilities refers to deposits, lending and
invested assets.
|
|
Barclays Investment Bank
|
Year ended
|
|
Three months ended
|
||||
|
|
31.12.25
|
31.12.24
|
|
|
31.12.25
|
31.12.24
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
1,334
|
1,031
|
29
|
|
356
|
284
|
25
|
|
Net trading income
|
7,197
|
6,241
|
15
|
|
1,294
|
1,262
|
3
|
|
Net fee, commission and other income
|
4,524
|
4,533
|
—
|
|
1,142
|
1,061
|
8
|
|
Total income
|
13,055
|
11,805
|
11
|
|
2,792
|
2,607
|
7
|
|
Operating costs
|
(7,927)
|
(7,666)
|
(3)
|
|
(1,924)
|
(1,903)
|
(1)
|
|
UK regulatory levies
|
(181)
|
(187)
|
3
|
|
(159)
|
(161)
|
1
|
|
Litigation and conduct
|
(28)
|
(55)
|
49
|
|
(8)
|
(26)
|
69
|
|
Total operating expenses
|
(8,136)
|
(7,908)
|
(3)
|
|
(2,091)
|
(2,090)
|
—
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
4,919
|
3,897
|
26
|
|
701
|
517
|
36
|
|
Credit impairment charges
|
(305)
|
(123)
|
|
|
(22)
|
(46)
|
52
|
|
Profit before tax
|
4,614
|
3,774
|
22
|
|
679
|
471
|
44
|
|
Attributable profit
|
3,092
|
2,513
|
23
|
|
294
|
247
|
19
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
10.6%
|
8.5%
|
|
|
4.0%
|
3.4%
|
|
|
Average allocated tangible equity (£bn)
|
29.1
|
29.7
|
|
|
29.6
|
29.3
|
|
|
Income over average risk weighted assets
|
6.6%
|
5.8%
|
|
|
5.5%
|
5.2%
|
|
|
Cost: income ratio
|
62%
|
67%
|
|
|
75%
|
80%
|
|
|
Loan loss rate (bps)
|
23
|
10
|
|
|
7
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
70.0
|
69.7
|
|
|
|
|
|
|
Loans and advances to banks at amortised cost
|
7.4
|
6.8
|
|
|
|
|
|
|
Debt securities at amortised cost
|
52.9
|
47.9
|
|
|
|
|
|
|
Loans and advances at amortised cost
|
130.3
|
124.4
|
|
|
|
|
|
|
Trading portfolio assets
|
189.5
|
166.1
|
|
|
|
|
|
|
Derivative financial instrument assets
|
251.5
|
291.6
|
|
|
|
|
|
|
Financial assets at fair value through the income
statement
|
183.6
|
190.4
|
|
|
|
|
|
|
Cash collateral and settlement balances
|
121.6
|
111.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits at amortised cost
|
156.1
|
140.5
|
|
|
|
|
|
|
Derivative financial instrument liabilities
|
240.6
|
279.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk weighted assets
|
196.7
|
198.8
|
|
|
|
|
|
|
Period end allocated tangible equity
|
28.9
|
29.3
|
|
|
|
|
|
|
Year ended
|
|
Three months ended
|
|||||
|
|
31.12.25
|
31.12.24
|
|
|
31.12.25
|
31.12.24
|
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
FICC
|
5,429
|
4,667
|
16
|
|
1,024
|
934
|
10
|
|
Equities
|
3,225
|
2,875
|
12
|
|
703
|
604
|
16
|
|
Global Markets
|
8,654
|
7,542
|
15
|
|
1,727
|
1,538
|
12
|
|
Advisory
|
676
|
661
|
2
|
|
214
|
189
|
13
|
|
Equity
capital markets
|
278
|
351
|
(21)
|
|
56
|
98
|
(43)
|
|
Debt
capital markets
|
1,510
|
1,492
|
1
|
|
336
|
327
|
3
|
|
Banking
fees and underwriting
|
2,464
|
2,504
|
(2)
|
|
606
|
614
|
(1)
|
|
Corporate
lending
|
247
|
153
|
61
|
|
27
|
45
|
(40)
|
|
Transaction
banking
|
1,690
|
1,606
|
5
|
|
432
|
410
|
5
|
|
International
Corporate Bank
|
1,937
|
1,759
|
10
|
|
459
|
455
|
1
|
|
Investment Banking
|
4,401
|
4,263
|
3
|
|
1,065
|
1,069
|
—
|
|
Total income
|
13,055
|
11,805
|
11
|
|
2,792
|
2,607
|
7
|
|
●
|
Profit before tax increased to £4,614m (FY24:
£3,774m)
|
||
|
●
|
IB has a diverse income profile across businesses and
geographies. The 3%
appreciation of average GBP against USD adversely impacted income
and profits, and positively impacted credit impairment charges and
total operating expenses
|
||
|
●
|
Total income increased 11% to £13,055m, including adverse
average FX impacts
|
||
|
|
-
|
Global Markets income increased 15% to £8,654m across FICC and
Equities
|
|
|
|
|
-
|
FICC income increased 16% to £5,429m, reflecting continued
support provided to clients through a range of environments,
including a strong performance in Macro, Securitised products and
Credit, and sustained strength in Fixed Income
Financing
|
|
|
|
-
|
Equities income increased 12% to £3,225m (up 17% excluding the
prior year £125m fair value gain on Visa B shares in Q124),
reflecting growth in Prime Financing due to increased client
balances and Cash from strong client activity across
products
|
|
|
-
|
Investment Banking income increased 3% to £4,401m
|
|
|
|
|
-
|
Banking fees and underwriting income decreased 2% to £2,464m,
primarily driven by a 21% decline in Equity Capital Markets fees
due to a strong prior year comparator, which included a large UK
rights issue in Q224, partially offset by Debt Capital Markets and
Advisory
|
|
|
|
-
|
International Corporate Bank income increased 10% to £1,937m.
Corporate lending income increased to £247m due to net gains
on fair value lending and cost of hedging
(c.£130m)1.
Transaction banking income increased 5% to £1,690m, as higher
income from growth in deposit balances was partially offset by
margin compression due to change in deposits product
mix
|
|
●
|
Total operating expenses increased 3% to £8,136m,
driven by inflationary headwinds,
higher performance costs and expenses associated with supporting
the business strategy, partially offset by efficiency savings and
FX
|
||
|
●
|
Credit impairment charges were £305m (FY24:
£123m), primarily driven
by a single name charge in Q325 and elevated US macroeconomic
uncertainty booked in Q125
|
||
|
●
|
Loans and advances at amortised costs increased to
£130.3bn (December 2024: £124.4bn) driven by increased investment in
debt securities in treasury
|
|
●
|
Trading portfolio assets increased to £189.5bn (December 2024:
£166.1bn) driven by
increased trading activity to facilitate client demand in Global
Markets, partially offset by the strengthening of spot GBP against
USD
|
|
●
|
Financial assets at fair value through the income statement
decreased to £183.6bn (December 2024: £190.4bn) as
underlying growth in financing
balances were more than offset by increased netting opportunities
and the strengthening of spot GBP against USD
|
|
●
|
Derivative financial instrument assets decreased to £251.5bn
(December 2024: £291.6bn) and liabilities decreased to
£240.6bn (December 2024: £279.0bn) primarily driven by a reduction in mark-to-market
on FX derivatives and strengthening of spot GBP against USD,
partially offset by an increase in equity
derivatives
|
|
●
|
Deposits at amortised cost increased to £156.1bn (December
2024: £140.5bn) driven by
growth in deposits across International Corporate Bank and
treasury, partially offset by the strengthening of spot GBP against
USD
|
|
●
|
RWAs were broadly stable at £196.7bn (December 2024:
£198.8bn) mainly driven by
business activity as we continued to support clients through a
range of environments, offset by the strengthening of spot GBP
against USD
|
|
1
|
FY25 included c.£45m of fair value gains on lending and cost
of hedging. FY24 included c.£85m of fair value losses on
leverage finance lending.
|
|
Barclays US Consumer Bank
|
Year ended
|
|
Three months ended
|
||||
|
|
31.12.25
|
31.12.24
|
|
|
31.12.25
|
31.12.24
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
2,820
|
2,659
|
6
|
|
776
|
678
|
14
|
|
Net fee, commission and other income
|
861
|
667
|
29
|
|
277
|
179
|
55
|
|
Total income
|
3,681
|
3,326
|
11
|
|
1,053
|
857
|
23
|
|
Operating costs
|
(1,637)
|
(1,612)
|
(2)
|
|
(427)
|
(433)
|
1
|
|
UK regulatory levies
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Litigation and conduct
|
(8)
|
(14)
|
43
|
|
(5)
|
—
|
|
|
Total operating expenses
|
(1,645)
|
(1,626)
|
(1)
|
|
(432)
|
(433)
|
—
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
2,036
|
1,700
|
20
|
|
621
|
424
|
46
|
|
Credit impairment charges
|
(1,521)
|
(1,293)
|
(18)
|
|
(431)
|
(298)
|
(45)
|
|
Profit before tax
|
515
|
407
|
27
|
|
190
|
126
|
51
|
|
Attributable profit
|
390
|
302
|
29
|
|
144
|
94
|
53
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
11.0%
|
9.1%
|
|
|
15.8%
|
11.2%
|
|
|
Average allocated tangible equity (£bn)
|
3.5
|
3.3
|
|
|
3.6
|
3.4
|
|
|
Cost: income ratio
|
45%
|
49%
|
|
|
41%
|
51%
|
|
|
Loan loss rate (bps)
|
496
|
431
|
|
|
558
|
395
|
|
|
Net interest margin
|
11.14%
|
10.65%
|
|
|
11.63%
|
10.66%
|
|
|
|
|
|
|
|
|
|
|
|
Key facts
|
|
|
|
|
|
|
|
|
US cards 30 day arrears rate
|
3.0%
|
3.0%
|
|
|
|
|
|
|
US cards 90 days arrears rate
|
1.6%
|
1.6%
|
|
|
|
|
|
|
US cards customer FICO score distribution1
|
|
|
|
|
|
|
|
|
<660
|
13%
|
12%
|
|
|
|
|
|
|
>660
|
87%
|
88%
|
|
|
|
|
|
|
End net receivables (reported) ($bn)
|
36.6
|
33.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
21.1
|
20.0
|
|
|
|
|
|
|
Deposits at amortised cost
|
24.2
|
23.3
|
|
|
|
|
|
|
Risk weighted assets
|
27.4
|
26.8
|
|
|
|
|
|
|
Period end allocated tangible equity
|
3.8
|
3.7
|
|
|
|
|
|
|
1
|
Reflects FICO distribution based on ending net receivables for
customer credit cards.
|
|
●
|
Profit before tax increased to £515m (FY24:
£407m)
|
|
●
|
The 3% appreciation of average GBP against USD adversely impacted
income and profits, and positively impacted credit impairment
charges and total operating expenses
|
|
●
|
Total income increased 11% to £3,681m, driven by organic business growth, the acquisition
of the GM portfolio, increased purchase activity, and a c.£40m
one-off benefit related to partner rewards in Q425. NII increased
6% to £2,820m with a net interest margin (NIM) of 11.14%
(FY24: 10.65%), including business growth and repricing
initiatives. Net fee, commission and other income increased 29% to
£861m driven by purchases, and fee growth
|
|
●
|
Total operating expenses increased 1% to £1,645m,
driven by partner-related expenses and
supporting business growth, with ongoing efficiency savings
offsetting inflationary headwinds
|
|
●
|
Credit impairment charges were £1,521m (FY24:
£1,293m), driven by the
impact from the acquisition of the GM portfolio and elevated US
macroeconomic uncertainty. The lower charge in prior year was
influenced by the impact of credit risk management actions and
methodology enhancements. US cards 30 and 90 day arrears
rates1
were 3.0% (Q424:
3.0%) and 1.6% (Q424:
1.6%) respectively. The USCB total coverage ratio decreased to
11.1% (December 2024: 11.4%) due to the acquisition of the GM
portfolio
|
|
●
|
Loans and advances to customers at amortised cost increased to
£21.1bn (December 2024: £20.0bn), reflecting the acquisition of the GM portfolio and
organic growth, partially offset by strengthening of spot GBP
against USD
|
|
●
|
Deposits at amortised cost increased to £24.2bn (December
2024: £23.3bn), with
growth in retail savings which is in line with USCB's ambition to
grow core deposits, partially offset by the strengthening of spot
GBP against USD
|
|
●
|
RWAs increased to £27.4bn (December 2024:
£26.8bn), reflecting the
acquisition of the GM portfolio and organic growth, partially
offset by the strengthening of spot GBP against
USD
|
|
1
|
Including a co-branded cards portfolio classified as assets held
for sale.
|
|
Head Office
|
Year ended
|
|
Three months ended
|
||||
|
|
31.12.25
|
31.12.24
|
|
|
31.12.25
|
31.12.24
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
415
|
646
|
(36)
|
|
(11)
|
183
|
|
|
Net fee, commission and other income
|
(163)
|
(352)
|
54
|
|
94
|
(107)
|
|
|
Total income
|
252
|
294
|
(14)
|
|
83
|
76
|
9
|
|
Operating costs
|
(747)
|
(836)
|
11
|
|
(203)
|
(233)
|
13
|
|
UK regulatory levies
|
(8)
|
(9)
|
11
|
|
(8)
|
(9)
|
11
|
|
Litigation and conduct
|
(257)
|
(134)
|
(92)
|
|
(13)
|
(84)
|
85
|
|
Total operating expenses
|
(1,012)
|
(979)
|
(3)
|
|
(224)
|
(326)
|
31
|
|
Other net income/(expenses)
|
23
|
37
|
(38)
|
|
(25)
|
—
|
|
|
Loss before impairment
|
(737)
|
(648)
|
(14)
|
|
(166)
|
(250)
|
34
|
|
Credit impairment charges
|
(11)
|
(119)
|
91
|
|
(5)
|
(42)
|
88
|
|
Loss before tax
|
(748)
|
(767)
|
2
|
|
(171)
|
(292)
|
41
|
|
Attributable loss
|
(689)
|
(742)
|
7
|
|
(152)
|
(318)
|
52
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn)
|
5.7
|
2.9
|
|
|
6.7
|
3.4
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
|
|
|
|
|
|
Risk weighted assets
|
12.3
|
16.2
|
|
|
|
|
|
|
Period end allocated tangible equity
|
7.5
|
2.4
|
|
|
|
|
|
|
●
|
Loss before tax was £748m (FY24: £767m)
|
|
●
|
Total income decreased to £252m (FY24: £294m),
primarily from the impact of the
disposal of the German consumer finance business in Q125 and a fair
value write-down of a legacy portfolio, partially offset by the
non-recurrence of the prior year loss on sale of the performing
Italian retail mortgage portfolio
|
|
●
|
Total operating expenses increased to £1,012m (FY24:
£979m), primarily driven
by higher litigation and conduct charges including the £235m
charge for motor finance redress in FY25 (FY24: £90m) and the
expense for the employee share grant announced at FY24 Results,
partially offset by the impact of the disposal of the German
consumer finance business
|
|
●
|
Credit impairment charges decreased to £11m (FY24:
£119m), driven by the
disposal of the German consumer finance business and non-repeat of
the prior year loss on sale of the non-performing Italian retail
mortgage portfolio
|
|
●
|
RWAs decreased to £12.3bn
(December 2024: £16.2bn), driven by the disposal of the German consumer
finance business and the disposal of Barclays' joint venture
interest in Entercard
|
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Income statement information
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Net interest income
|
3,734
|
3,745
|
3,505
|
3,517
|
|
3,500
|
3,308
|
3,056
|
3,072
|
|
Net fee, commission and other income
|
3,343
|
3,422
|
3,682
|
4,192
|
|
3,464
|
3,239
|
3,268
|
3,881
|
|
Total income
|
7,077
|
7,167
|
7,187
|
7,709
|
|
6,964
|
6,547
|
6,324
|
6,953
|
|
Operating costs
|
(4,379)
|
(4,254)
|
(4,149)
|
(4,258)
|
|
(4,244)
|
(3,954)
|
(3,999)
|
(3,998)
|
|
UK regulatory levies
|
(229)
|
12
|
—
|
(96)
|
|
(227)
|
27
|
—
|
(120)
|
|
Litigation and conduct
|
(50)
|
(255)
|
(76)
|
(11)
|
|
(121)
|
(35)
|
(7)
|
(57)
|
|
Total operating expenses
|
(4,658)
|
(4,497)
|
(4,225)
|
(4,365)
|
|
(4,592)
|
(3,962)
|
(4,006)
|
(4,175)
|
|
Other net (expenses)/income
|
(25)
|
39
|
(9)
|
18
|
|
—
|
21
|
4
|
12
|
|
Profit before impairment
|
2,394
|
2,709
|
2,953
|
3,362
|
|
2,372
|
2,606
|
2,322
|
2,790
|
|
Credit impairment charges
|
(535)
|
(632)
|
(469)
|
(643)
|
|
(711)
|
(374)
|
(384)
|
(513)
|
|
Profit before tax
|
1,859
|
2,077
|
2,484
|
2,719
|
|
1,661
|
2,232
|
1,938
|
2,277
|
|
Tax charges
|
(388)
|
(365)
|
(552)
|
(621)
|
|
(448)
|
(412)
|
(427)
|
(465)
|
|
Profit after tax
|
1,471
|
1,712
|
1,932
|
2,098
|
|
1,213
|
1,820
|
1,511
|
1,812
|
|
Non-controlling interests
|
(18)
|
—
|
(21)
|
(2)
|
|
(20)
|
(3)
|
(23)
|
(3)
|
|
Other equity instrument holders
|
(258)
|
(255)
|
(252)
|
(232)
|
|
(228)
|
(253)
|
(251)
|
(259)
|
|
Attributable profit
|
1,195
|
1,457
|
1,659
|
1,864
|
|
965
|
1,564
|
1,237
|
1,550
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
8.5%
|
10.6%
|
12.3%
|
14.0%
|
|
7.5%
|
12.3%
|
9.9%
|
12.3%
|
|
Average tangible shareholders' equity (£bn)
|
56.5
|
55.1
|
53.9
|
53.1
|
|
51.5
|
51.0
|
49.8
|
50.5
|
|
Cost: income ratio
|
66%
|
63%
|
59%
|
57%
|
|
66%
|
61%
|
63%
|
60%
|
|
Loan loss rate (bps)
|
48
|
57
|
44
|
61
|
|
66
|
37
|
38
|
51
|
|
Basic earnings per ordinary share
|
8.6p
|
10.4p
|
11.7p
|
13.0p
|
|
6.7p
|
10.7p
|
8.3p
|
10.3p
|
|
Basic weighted average number of shares (m)
|
13,883
|
14,045
|
14,211
|
14,314
|
|
14,432
|
14,648
|
14,915
|
14,983
|
|
Period end number of shares (m)
|
13,867
|
13,996
|
14,180
|
14,336
|
|
14,420
|
14,571
|
14,826
|
15,091
|
|
Period end tangible shareholders' equity (£bn)
|
56.8
|
54.9
|
54.5
|
53.4
|
|
51.5
|
51.1
|
50.4
|
50.6
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet and capital
management1
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Loans and advances to customers at amortised cost
|
352.8
|
346.4
|
339.2
|
338.6
|
|
337.9
|
326.5
|
329.8
|
332.1
|
|
Loans and advances to banks at amortised cost
|
8.7
|
9.4
|
8.7
|
9.4
|
|
8.3
|
8.1
|
8.0
|
8.5
|
|
Debt securities at amortised cost
|
68.5
|
70.7
|
69.9
|
71.4
|
|
68.2
|
64.6
|
61.7
|
57.4
|
|
Loans and advances at amortised cost
|
430.0
|
426.5
|
417.8
|
419.4
|
|
414.5
|
399.2
|
399.5
|
397.9
|
|
Loans and advances at amortised cost impairment coverage
ratio
|
1.2%
|
1.2%
|
1.2%
|
1.2%
|
|
1.2%
|
1.3%
|
1.4%
|
1.4%
|
|
Total assets
|
1,544.2
|
1,629.2
|
1,598.7
|
1,593.5
|
|
1,518.2
|
1,531.1
|
1,576.6
|
1,577.1
|
|
Deposits at amortised cost
|
585.6
|
575.3
|
564.5
|
574.3
|
|
560.7
|
542.8
|
557.5
|
552.3
|
|
Tangible net asset value per share
|
409p
|
392p
|
384p
|
372p
|
|
357p
|
351p
|
340p
|
335p
|
|
Common equity tier 1 ratio
|
14.3%
|
14.1%
|
14.0%
|
13.9%
|
|
13.6%
|
13.8%
|
13.6%
|
13.5%
|
|
Common equity tier 1 capital
|
51.1
|
50.3
|
49.5
|
48.8
|
|
48.6
|
47.0
|
47.7
|
47.1
|
|
Risk weighted assets
|
356.8
|
357.4
|
353.0
|
351.3
|
|
358.1
|
340.4
|
351.4
|
349.6
|
|
UK leverage ratio
|
5.1%
|
4.9%
|
5.0%
|
5.0%
|
|
5.0%
|
4.9%
|
5.0%
|
4.9%
|
|
UK leverage exposure
|
1,247.3
|
1,285.3
|
1,259.8
|
1,252.8
|
|
1,206.5
|
1,197.4
|
1,222.7
|
1,226.5
|
|
|
|
|
|
|
|
|
|
|
|
|
Funding and liquidity
|
|
|
|
|
|
|
|
|
|
|
Group liquidity pool (£bn)
|
337.8
|
332.9
|
333.7
|
336.3
|
|
296.9
|
311.7
|
328.7
|
323.5
|
|
Liquidity coverage ratio
|
170.0%
|
174.6%
|
177.7%
|
175.3%
|
|
172.4%
|
170.1%
|
167.0%
|
163.2%
|
|
Net stable funding ratio
|
135.2%
|
135.3%
|
135.6%
|
136.2%
|
|
134.9%
|
135.6%
|
136.4%
|
135.7%
|
|
Loan: deposit ratio
|
73%
|
74%
|
74%
|
73%
|
|
74%
|
74%
|
72%
|
72%
|
|
1
|
Refer to pages 57 to 61 for further information on how capital,
RWAs and leverage are calculated.
|
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q4241
|
Q324
|
Q224
|
Q124
|
|
Income statement information
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Net interest income
|
2,015
|
1,961
|
1,855
|
1,822
|
|
1,815
|
1,666
|
1,597
|
1,549
|
|
Net fee, commission and other income
|
247
|
292
|
264
|
252
|
|
800
|
280
|
290
|
277
|
|
Total income
|
2,262
|
2,253
|
2,119
|
2,074
|
|
2,615
|
1,946
|
1,887
|
1,826
|
|
Operating costs
|
(1,274)
|
(1,189)
|
(1,168)
|
(1,115)
|
|
(1,170)
|
(1,017)
|
(1,041)
|
(1,007)
|
|
UK regulatory levies
|
(41)
|
(1)
|
—
|
(43)
|
|
(36)
|
12
|
—
|
(54)
|
|
Litigation and conduct
|
(14)
|
(8)
|
(27)
|
(2)
|
|
(9)
|
(1)
|
(4)
|
(2)
|
|
Total operating expenses
|
(1,329)
|
(1,198)
|
(1,195)
|
(1,160)
|
|
(1,215)
|
(1,006)
|
(1,045)
|
(1,063)
|
|
Other net income
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
Profit before impairment
|
933
|
1,055
|
924
|
914
|
|
1,400
|
940
|
842
|
763
|
|
Credit impairment charges
|
(74)
|
(102)
|
(79)
|
(158)
|
|
(283)
|
(16)
|
(8)
|
(58)
|
|
Profit before tax
|
859
|
953
|
845
|
756
|
|
1,117
|
924
|
834
|
705
|
|
Attributable profit
|
706
|
647
|
580
|
510
|
|
781
|
621
|
584
|
479
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Loans and advances to customers at amortised cost
|
216.5
|
213.4
|
211.2
|
209.6
|
|
207.7
|
199.3
|
198.7
|
200.8
|
|
Customer deposits at amortised cost
|
244.6
|
241.5
|
241.3
|
243.1
|
|
244.2
|
236.3
|
236.8
|
237.2
|
|
Loan: deposit ratio
|
94%
|
95%
|
94%
|
93%
|
|
92%
|
92%
|
91%
|
92%
|
|
Risk weighted assets
|
85.8
|
86.7
|
86.1
|
85.0
|
|
84.5
|
77.5
|
76.5
|
76.5
|
|
Period end allocated tangible equity
|
11.8
|
11.9
|
11.8
|
11.8
|
|
11.6
|
10.7
|
10.6
|
10.7
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
23.8%
|
21.8%
|
19.7%
|
17.4%
|
|
28.0%
|
23.4%
|
22.3%
|
18.5%
|
|
Average allocated tangible equity (£bn)
|
11.9
|
11.9
|
11.8
|
11.7
|
|
11.2
|
10.6
|
10.5
|
10.4
|
|
Cost: income ratio
|
59%
|
53%
|
56%
|
56%
|
|
46%
|
52%
|
55%
|
58%
|
|
Loan loss rate (bps)
|
13
|
18
|
14
|
28
|
|
49
|
3
|
1
|
11
|
|
Net interest margin
|
3.72%
|
3.68%
|
3.55%
|
3.55%
|
|
3.53%
|
3.34%
|
3.22%
|
3.09%
|
|
1
|
Q424 includes the day 1 impacts from the acquisition of Tesco Bank:
total Income includes a £556m gain, and credit impairment
charges includes a £209m charge.
|
|
Analysis of Barclays UK
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q4241
|
Q324
|
Q224
|
Q124
|
|
Analysis of total income
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Retail Banking
|
1,702
|
1,708
|
1,599
|
1,573
|
|
2,078
|
1,433
|
1,402
|
1,357
|
|
Business Banking
|
560
|
545
|
520
|
501
|
|
537
|
513
|
485
|
469
|
|
Total income
|
2,262
|
2,253
|
2,119
|
2,074
|
|
2,615
|
1,946
|
1,887
|
1,826
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of credit impairment (charges)/releases
|
|
|
|
|
|
|
|
|
|
|
Retail Banking
|
(72)
|
(98)
|
(59)
|
(145)
|
|
(279)
|
(12)
|
(51)
|
(52)
|
|
Business Banking
|
(2)
|
(4)
|
(20)
|
(13)
|
|
(4)
|
(4)
|
43
|
(6)
|
|
Total credit impairment charges
|
(74)
|
(102)
|
(79)
|
(158)
|
|
(283)
|
(16)
|
(8)
|
(58)
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of loans and advances to customers at amortised
cost
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Retail Banking
|
198.6
|
195.2
|
192.4
|
190.4
|
|
188.0
|
178.7
|
177.5
|
178.8
|
|
Business Banking
|
17.9
|
18.2
|
18.8
|
19.2
|
|
19.7
|
20.6
|
21.2
|
22.0
|
|
Total loans and advances to customers at amortised
cost
|
216.5
|
213.4
|
211.2
|
209.6
|
|
207.7
|
199.3
|
198.7
|
200.8
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised cost
|
|
|
|
|
|
|
|
|
|
|
Retail Banking
|
192.7
|
189.3
|
189.3
|
190.8
|
|
191.4
|
182.9
|
183.3
|
183.4
|
|
Business Banking
|
51.9
|
52.2
|
52.0
|
52.3
|
|
52.8
|
53.4
|
53.5
|
53.8
|
|
Total customer deposits at amortised cost
|
244.6
|
241.5
|
241.3
|
243.1
|
|
244.2
|
236.3
|
236.8
|
237.2
|
|
1
|
Q424 includes the day 1 impacts from the acquisition of Tesco Bank:
total Income includes a £556m gain, and credit impairment
charges includes a £209m charge.
|
|
Barclays UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Income statement information
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Net interest income
|
396
|
383
|
359
|
342
|
|
324
|
309
|
296
|
277
|
|
Net fee, commission, trading and other income
|
143
|
139
|
160
|
142
|
|
134
|
136
|
147
|
157
|
|
Total income
|
539
|
522
|
519
|
484
|
|
458
|
445
|
443
|
434
|
|
Operating costs
|
(272)
|
(243)
|
(240)
|
(234)
|
|
(250)
|
(229)
|
(235)
|
(221)
|
|
UK regulatory levies
|
(14)
|
9
|
—
|
(24)
|
|
(14)
|
7
|
—
|
(30)
|
|
Litigation and conduct
|
—
|
—
|
(39)
|
—
|
|
(1)
|
—
|
—
|
—
|
|
Total operating expenses
|
(286)
|
(234)
|
(279)
|
(258)
|
|
(265)
|
(222)
|
(235)
|
(251)
|
|
Other net expenses
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
Profit before impairment
|
253
|
288
|
240
|
226
|
|
193
|
223
|
208
|
183
|
|
Credit impairment charges
|
(1)
|
(5)
|
(12)
|
(19)
|
|
(40)
|
(13)
|
(8)
|
(15)
|
|
Profit before tax
|
252
|
283
|
228
|
207
|
|
153
|
210
|
200
|
168
|
|
Attributable profit
|
168
|
196
|
142
|
142
|
|
98
|
144
|
135
|
113
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Loans and advances to customers at amortised cost
|
30.0
|
29.0
|
27.9
|
26.7
|
|
25.4
|
24.8
|
25.7
|
25.7
|
|
Deposits at amortised cost
|
88.7
|
86.7
|
85.3
|
85.3
|
|
83.1
|
82.3
|
84.9
|
81.7
|
|
Risk weighted assets
|
26.5
|
25.2
|
25.3
|
24.2
|
|
23.9
|
22.1
|
21.9
|
21.4
|
|
Period end allocated tangible equity
|
3.7
|
3.4
|
3.5
|
3.4
|
|
3.3
|
3.0
|
3.0
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
19.1%
|
22.8%
|
16.6%
|
17.1%
|
|
12.3%
|
18.8%
|
18.0%
|
15.2%
|
|
Average allocated tangible equity (£bn)
|
3.5
|
3.4
|
3.4
|
3.3
|
|
3.2
|
3.1
|
3.0
|
3.0
|
|
Cost: income ratio
|
53%
|
45%
|
54%
|
53%
|
|
58%
|
50%
|
53%
|
58%
|
|
Loan loss rate (bps)
|
1
|
7
|
17
|
28
|
|
62
|
21
|
12
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Corporate lending
|
97
|
90
|
90
|
80
|
|
71
|
67
|
57
|
72
|
|
Transaction banking
|
442
|
432
|
429
|
404
|
|
387
|
378
|
386
|
362
|
|
Total income
|
539
|
522
|
519
|
484
|
|
458
|
445
|
443
|
434
|
|
Barclays Private Bank and Wealth Management
|
|
|
|
|
|
|
|
|
|
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Income statement information
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Net interest income
|
202
|
190
|
203
|
204
|
|
216
|
189
|
187
|
175
|
|
Net fee, commission and other income
|
146
|
145
|
145
|
145
|
|
135
|
137
|
133
|
137
|
|
Total income
|
348
|
335
|
348
|
349
|
|
351
|
326
|
320
|
312
|
|
Operating costs
|
(279)
|
(243)
|
(238)
|
(234)
|
|
(255)
|
(222)
|
(220)
|
(214)
|
|
UK regulatory levies
|
(7)
|
(1)
|
—
|
(2)
|
|
(7)
|
1
|
—
|
(3)
|
|
Litigation and conduct
|
(10)
|
1
|
—
|
—
|
|
(1)
|
—
|
1
|
—
|
|
Total operating expenses
|
(296)
|
(243)
|
(238)
|
(236)
|
|
(263)
|
(221)
|
(219)
|
(217)
|
|
Other net income
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
Profit before impairment
|
52
|
92
|
110
|
113
|
|
88
|
105
|
101
|
95
|
|
Credit impairment (charges)/releases
|
(2)
|
(1)
|
2
|
9
|
|
(2)
|
(7)
|
3
|
—
|
|
Profit before tax
|
50
|
91
|
112
|
122
|
|
86
|
98
|
104
|
95
|
|
Attributable profit
|
35
|
72
|
88
|
96
|
|
63
|
74
|
77
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Loans and advances to customers at amortised cost
|
14.7
|
14.9
|
14.5
|
14.5
|
|
14.5
|
14.0
|
13.9
|
13.7
|
|
Deposits at amortised cost
|
72.0
|
70.6
|
66.7
|
73.1
|
|
69.5
|
64.8
|
64.6
|
61.9
|
|
Risk weighted assets
|
8.0
|
7.9
|
7.9
|
8.0
|
|
7.9
|
7.3
|
7.0
|
7.2
|
|
Period end allocated tangible equity
|
1.1
|
1.1
|
1.1
|
1.1
|
|
1.1
|
1.0
|
1.0
|
1.0
|
|
Client assets and liabilities1
|
227.6
|
221.5
|
213.4
|
212.4
|
|
208.9
|
201.5
|
198.5
|
189.1
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
12.6%
|
26.4%
|
31.9%
|
34.5%
|
|
23.9%
|
29.0%
|
30.8%
|
28.7%
|
|
Average allocated tangible equity (£bn)
|
1.1
|
1.1
|
1.1
|
1.1
|
|
1.1
|
1.0
|
1.0
|
1.0
|
|
Cost: income ratio
|
85%
|
73%
|
68%
|
68%
|
|
75%
|
68%
|
68%
|
70%
|
|
Loan loss rate (bps)
|
5
|
3
|
(5)
|
(25)
|
|
5
|
19
|
(9)
|
—
|
|
1
|
Client assets and liabilities refers to deposits, lending and
invested assets.
|
|
Barclays Investment Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Income statement information
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Net interest income
|
356
|
347
|
334
|
297
|
|
284
|
282
|
268
|
197
|
|
Net trading income
|
1,294
|
1,581
|
1,906
|
2,416
|
|
1,262
|
1,512
|
1,485
|
1,982
|
|
Net fee, commission and other income
|
1,142
|
1,155
|
1,067
|
1,160
|
|
1,061
|
1,057
|
1,266
|
1,149
|
|
Total income
|
2,792
|
3,083
|
3,307
|
3,873
|
|
2,607
|
2,851
|
3,019
|
3,328
|
|
Operating costs
|
(1,924)
|
(2,010)
|
(1,932)
|
(2,061)
|
|
(1,903)
|
(1,906)
|
(1,900)
|
(1,957)
|
|
UK regulatory levies
|
(159)
|
5
|
—
|
(27)
|
|
(161)
|
7
|
—
|
(33)
|
|
Litigation and conduct
|
(8)
|
(9)
|
(8)
|
(3)
|
|
(26)
|
(17)
|
(3)
|
(9)
|
|
Total operating expenses
|
(2,091)
|
(2,014)
|
(1,940)
|
(2,091)
|
|
(2,090)
|
(1,916)
|
(1,903)
|
(1,999)
|
|
Other net expenses
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
Profit before impairment
|
701
|
1,069
|
1,367
|
1,782
|
|
517
|
935
|
1,116
|
1,329
|
|
Credit impairment (charges)/releases
|
(22)
|
(144)
|
(67)
|
(72)
|
|
(46)
|
(43)
|
(44)
|
10
|
|
Profit before tax
|
679
|
925
|
1,300
|
1,710
|
|
471
|
892
|
1,072
|
1,339
|
|
Attributable profit
|
294
|
723
|
876
|
1,199
|
|
247
|
652
|
715
|
899
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Loans and advances to customers at amortised cost
|
70.0
|
68.6
|
66.8
|
68.6
|
|
69.7
|
64.5
|
66.6
|
64.6
|
|
Loans and advances to banks at amortised cost
|
7.4
|
7.5
|
7.1
|
7.4
|
|
6.8
|
6.7
|
6.6
|
7.6
|
|
Debt securities at amortised cost
|
52.9
|
53.0
|
52.4
|
53.1
|
|
47.9
|
44.8
|
41.7
|
40.4
|
|
Loans and advances at amortised cost
|
130.3
|
129.1
|
126.3
|
129.1
|
|
124.4
|
116.0
|
114.9
|
112.6
|
|
Trading portfolio assets
|
189.5
|
191.3
|
186.1
|
185.5
|
|
166.1
|
185.8
|
197.2
|
195.3
|
|
Derivative financial instrument assets
|
251.5
|
263.8
|
279.0
|
253.6
|
|
291.6
|
256.7
|
251.4
|
248.9
|
|
Financial assets at fair value through the income
statement
|
183.6
|
222.8
|
215.2
|
209.5
|
|
190.4
|
210.8
|
211.7
|
225.1
|
|
Cash collateral and settlement balances
|
121.6
|
152.1
|
145.0
|
148.8
|
|
111.1
|
134.7
|
139.8
|
129.8
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits at amortised cost
|
156.1
|
152.8
|
148.7
|
148.9
|
|
140.5
|
139.8
|
151.3
|
151.1
|
|
Derivative financial instrument liabilities
|
240.6
|
252.0
|
265.1
|
245.1
|
|
279.0
|
249.4
|
241.8
|
241.5
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk weighted assets
|
196.7
|
199.1
|
196.4
|
195.9
|
|
198.8
|
194.2
|
203.3
|
200.4
|
|
Period end allocated tangible equity
|
28.9
|
29.1
|
28.7
|
28.9
|
|
29.3
|
28.4
|
29.7
|
29.6
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
4.0%
|
10.1%
|
12.2%
|
16.2%
|
|
3.4%
|
8.8%
|
9.6%
|
12.0%
|
|
Average allocated tangible equity (£bn)
|
29.6
|
28.6
|
28.7
|
29.6
|
|
29.3
|
29.5
|
29.9
|
30.0
|
|
Income over average risk weighted assets
|
5.5%
|
6.3%
|
6.7%
|
7.7%
|
|
5.2%
|
5.7%
|
5.9%
|
6.5%
|
|
Cost: income ratio
|
75%
|
65%
|
59%
|
54%
|
|
80%
|
67%
|
63%
|
60%
|
|
Loan loss rate (bps)
|
7
|
44
|
21
|
23
|
|
15
|
15
|
15
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
FICC
|
1,024
|
1,256
|
1,450
|
1,699
|
|
934
|
1,180
|
1,149
|
1,404
|
|
Equities
|
703
|
689
|
870
|
963
|
|
604
|
692
|
696
|
883
|
|
Global Markets
|
1,727
|
1,945
|
2,320
|
2,662
|
|
1,538
|
1,872
|
1,845
|
2,287
|
|
Advisory
|
214
|
196
|
123
|
143
|
|
189
|
186
|
138
|
148
|
|
Equity
capital markets
|
56
|
71
|
81
|
70
|
|
98
|
64
|
121
|
68
|
|
Debt
capital markets
|
336
|
379
|
364
|
431
|
|
327
|
344
|
420
|
401
|
|
Banking
Fees and Underwriting
|
606
|
646
|
568
|
644
|
|
614
|
594
|
679
|
617
|
|
Corporate
lending
|
27
|
68
|
(4)
|
156
|
|
45
|
(21)
|
87
|
42
|
|
Transaction
banking
|
432
|
424
|
423
|
411
|
|
410
|
406
|
408
|
382
|
|
International
Corporate Banking
|
459
|
492
|
419
|
567
|
|
455
|
385
|
495
|
424
|
|
Investment Banking
|
1,065
|
1,138
|
987
|
1,211
|
|
1,069
|
979
|
1,174
|
1,041
|
|
Total income
|
2,792
|
3,083
|
3,307
|
3,873
|
|
2,607
|
2,851
|
3,019
|
3,328
|
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
|
|
|
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Income statement information
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Net interest income
|
776
|
726
|
640
|
678
|
|
678
|
647
|
646
|
688
|
|
Net fee, commission, trading and other income
|
277
|
215
|
183
|
186
|
|
179
|
144
|
173
|
171
|
|
Total income
|
1,053
|
941
|
823
|
864
|
|
857
|
791
|
819
|
859
|
|
Operating costs
|
(427)
|
(407)
|
(396)
|
(407)
|
|
(433)
|
(384)
|
(408)
|
(387)
|
|
UK regulatory levies
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
Litigation and conduct
|
(5)
|
—
|
—
|
(3)
|
|
—
|
(9)
|
(2)
|
(3)
|
|
Total operating expenses
|
(432)
|
(407)
|
(396)
|
(410)
|
|
(433)
|
(393)
|
(410)
|
(390)
|
|
Other net income
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
Profit before impairment
|
621
|
534
|
427
|
454
|
|
424
|
398
|
409
|
469
|
|
Credit impairment charges
|
(431)
|
(379)
|
(312)
|
(399)
|
|
(298)
|
(276)
|
(309)
|
(410)
|
|
Profit before tax
|
190
|
155
|
115
|
55
|
|
126
|
122
|
100
|
59
|
|
Attributable profit
|
144
|
118
|
87
|
41
|
|
94
|
89
|
75
|
44
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Loans and advances to customers at amortised cost
|
21.1
|
20.0
|
18.2
|
18.8
|
|
20.0
|
23.2
|
24.3
|
23.6
|
|
Deposits at amortised cost
|
24.2
|
23.7
|
22.5
|
23.8
|
|
23.3
|
19.4
|
20.0
|
20.3
|
|
Risk weighted assets
|
27.4
|
25.8
|
24.7
|
25.6
|
|
26.8
|
23.2
|
24.4
|
23.9
|
|
Period end allocated tangible equity
|
3.8
|
3.5
|
3.4
|
3.5
|
|
3.7
|
3.2
|
3.3
|
3.3
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
15.8%
|
13.5%
|
10.2%
|
4.5%
|
|
11.2%
|
10.9%
|
9.2%
|
5.3%
|
|
Average allocated tangible equity (£bn)
|
3.6
|
3.5
|
3.4
|
3.6
|
|
3.4
|
3.3
|
3.3
|
3.3
|
|
Cost: income ratio
|
41%
|
43%
|
48%
|
47%
|
|
51%
|
50%
|
50%
|
46%
|
|
Loan loss rate (bps)1
|
558
|
505
|
456
|
562
|
|
395
|
411
|
438
|
610
|
|
Net interest margin
|
11.63%
|
11.50%
|
10.83%
|
10.53%
|
|
10.66%
|
10.38%
|
10.43%
|
11.12%
|
|
1
|
LLR includes held for sale portfolios to remain consistent with the
treatment of impairment.
|
|
Head Office
|
|
|
|
|
|
|
|
|
|
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
Income statement information
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Net interest income
|
(11)
|
138
|
114
|
174
|
|
183
|
215
|
62
|
186
|
|
Net fee, commission and other income
|
94
|
(105)
|
(43)
|
(109)
|
|
(107)
|
(27)
|
(226)
|
8
|
|
Total income
|
83
|
33
|
71
|
65
|
|
76
|
188
|
(164)
|
194
|
|
Operating costs
|
(203)
|
(162)
|
(175)
|
(207)
|
|
(233)
|
(197)
|
(195)
|
(211)
|
|
UK regulatory levies
|
(8)
|
—
|
—
|
—
|
|
(9)
|
—
|
—
|
—
|
|
Litigation and conduct
|
(13)
|
(239)
|
(2)
|
(3)
|
|
(84)
|
(7)
|
1
|
(44)
|
|
Total operating expenses
|
(224)
|
(401)
|
(177)
|
(210)
|
|
(326)
|
(204)
|
(194)
|
(255)
|
|
Other net (expenses)/income
|
(25)
|
39
|
(9)
|
18
|
|
—
|
21
|
4
|
12
|
|
(Loss)/profit before impairment
|
(166)
|
(329)
|
(115)
|
(127)
|
|
(250)
|
5
|
(354)
|
(49)
|
|
Credit impairment charges
|
(5)
|
(1)
|
(1)
|
(4)
|
|
(42)
|
(19)
|
(18)
|
(40)
|
|
Loss before tax
|
(171)
|
(330)
|
(116)
|
(131)
|
|
(292)
|
(14)
|
(372)
|
(89)
|
|
Attributable loss
|
(152)
|
(299)
|
(114)
|
(124)
|
|
(318)
|
(16)
|
(349)
|
(59)
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Risk weighted assets
|
12.3
|
12.7
|
12.6
|
12.7
|
|
16.2
|
16.1
|
18.3
|
20.2
|
|
Period end allocated tangible equity
|
7.5
|
5.8
|
5.9
|
4.7
|
|
2.4
|
4.9
|
2.7
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn)
|
6.7
|
6.6
|
5.5
|
3.8
|
|
3.4
|
3.5
|
2.1
|
2.8
|
|
Margins and balances
|
|
|
|
|
|
|
|
|
Year ended 31.12.25
|
Year ended 31.12.24
|
||||
|
|
Net interest income
|
Average customer assets
|
Net interest margin
|
Net interest income
|
Average customer assets
|
Net interest margin
|
|
|
£m
|
£m
|
%
|
£m
|
£m
|
%
|
|
Barclays UK
|
7,653
|
210,925
|
3.63
|
6,627
|
201,152
|
3.29
|
|
Barclays UK Corporate Bank
|
1,480
|
26,142
|
5.66
|
1,206
|
22,776
|
5.30
|
|
Barclays Private Bank and Wealth Management
|
799
|
14,827
|
5.39
|
767
|
13,983
|
5.49
|
|
Barclays US Consumer Bank1
|
2,820
|
25,313
|
11.14
|
2,659
|
24,978
|
10.65
|
|
Group excluding IB and Head
Office1
|
12,752
|
277,207
|
4.60
|
11,259
|
262,889
|
4.28
|
|
Barclays Investment Bank
|
1,334
|
|
|
1,031
|
|
|
|
Head Office
|
415
|
|
|
646
|
|
|
|
Barclays Group Net interest income
|
14,501
|
|
|
12,936
|
|
|
|
Quarterly analysis
|
|
|
|||
|
|
Q425
|
Q325
|
Q225
|
Q125
|
Q424
|
|
Net interest income
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Barclays UK
|
2,015
|
1,961
|
1,855
|
1,822
|
1,815
|
|
Barclays UK Corporate Bank
|
396
|
383
|
359
|
342
|
324
|
|
Barclays Private Bank and Wealth Management
|
202
|
190
|
203
|
204
|
216
|
|
Barclays US Consumer Bank
|
776
|
726
|
640
|
678
|
678
|
|
Group excluding IB and Head Office
|
3,389
|
3,260
|
3,057
|
3,046
|
3,033
|
|
|
|
|
|
|
|
|
Average customer assets
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Barclays UK
|
214,770
|
211,384
|
209,649
|
208,305
|
204,793
|
|
Barclays UK Corporate Bank
|
27,841
|
26,645
|
25,478
|
24,605
|
23,450
|
|
Barclays Private Bank and Wealth Management
|
15,105
|
14,802
|
14,729
|
14,674
|
14,381
|
|
Barclays US Consumer Bank1
|
26,470
|
25,037
|
23,713
|
26,106
|
25,314
|
|
Group excluding IB and Head
Office1
|
284,186
|
277,868
|
273,569
|
273,690
|
267,938
|
|
|
|
|
|
|
|
|
Net interest margin
|
%
|
%
|
%
|
%
|
%
|
|
Barclays UK
|
3.72
|
3.68
|
3.55
|
3.55
|
3.53
|
|
Barclays UK Corporate Bank
|
5.64
|
5.70
|
5.65
|
5.64
|
5.50
|
|
Barclays Private Bank and Wealth Management
|
5.31
|
5.09
|
5.53
|
5.64
|
5.98
|
|
Barclays US Consumer Bank
|
11.63
|
11.50
|
10.83
|
10.53
|
10.66
|
|
Group excluding IB and Head Office
|
4.73
|
4.65
|
4.48
|
4.51
|
4.50
|
|
1
|
Includes average customer asset balances classified as held for
sale.
|
|
|
Year ended 31.12.25
|
Year ended 31.12.24
|
|
|
|
£m
|
£m
|
% Change
|
|
Incentive awards granted:
|
|
|
|
|
Current year bonus
|
1,422
|
1,278
|
(11)
|
|
Deferred bonus
|
786
|
636
|
(24)
|
|
Total incentive awards granted
|
2,208
|
1,914
|
(15)
|
|
|
|
|
|
|
Reconciliation of incentive awards granted to income statement
charge:
|
|
|
|
|
Less: deferred bonuses granted but not charged in current
year
|
(555)
|
(452)
|
(23)
|
|
Add: current year charges for deferred bonuses from previous
years
|
426
|
405
|
(5)
|
|
Other differences between incentive awards granted and income
statement charge
|
3
|
(2)
|
(250)
|
|
Income statement charge for performance costs
|
2,082
|
1,865
|
(12)
|
|
|
|
|
|
|
Other income statement charges:
|
|
|
|
|
Salaries
|
5,099
|
4,994
|
(2)
|
|
Social security costs
|
863
|
754
|
(14)
|
|
Retirement benefits1
|
572
|
558
|
(3)
|
|
Other compensation costs
|
637
|
587
|
(9)
|
|
Total compensation
costs2
|
9,253
|
8,758
|
(6)
|
|
|
|
|
|
|
Other resourcing costs
|
|
|
|
|
Outsourcing
|
929
|
693
|
(34)
|
|
Redundancy and restructuring
|
199
|
235
|
15
|
|
Temporary staff costs
|
70
|
61
|
(15)
|
|
Other
|
156
|
129
|
(21)
|
|
Total other resourcing costs
|
1,354
|
1,118
|
(21)
|
|
|
|
|
|
|
Total staff costs
|
10,607
|
9,876
|
(7)
|
|
|
|
|
|
|
Group compensation costs as a % of total income
|
31.8
|
32.7
|
|
|
Group staff costs as a % of total income
|
36.4
|
36.9
|
|
|
1
|
Retirement benefits charge includes £382m (2024: £377m)
in respect of defined contribution schemes and £190m (2024:
£181m) in respect of defined benefit schemes.
|
|
2
|
£834m (2024: £875m) of Group compensation cost was
capitalised as internally generated software and excluded from the
staff cost disclosed above.
|
|
|
Actual
|
|
Expected1,
2
|
||
|
|
Year ended
|
Year ended
|
|
Year ended
|
2027 and
|
|
|
31.12.24
|
31.12.25
|
|
31.12.26
|
beyond
|
|
|
£m
|
£m
|
|
£m
|
£m
|
|
Deferred bonuses from 2022 and earlier bonus pools
|
186
|
80
|
|
11
|
—
|
|
Deferred bonuses from 2023 bonus pool
|
219
|
132
|
|
66
|
13
|
|
Deferred bonuses from 2024 bonus pool
|
184
|
214
|
|
150
|
105
|
|
Deferred bonuses from 2025 bonus pool
|
—
|
231
|
|
220
|
251
|
|
Income statement charge for deferred bonuses
|
589
|
657
|
|
447
|
369
|
|
1
|
The actual amount charged depends upon whether conditions have been
met and may vary compared with the above expectation.
|
|
2
|
Does not include the impact of grants which will be made in 2026
and beyond.
|
|
Grant date
|
Expected payment date(s)2
and
percentage of
the deferred bonus paid
|
Year
|
Income statement charge %
profile of 2025
onwards3,4
|
|
March 2026
|
|
2025
|
33%
|
|
|
|
2026
|
31%
|
|
|
March 2027 (33.3%)
|
2027
|
21%
|
|
|
March 2028 (33.3%)
|
2028
|
12%
|
|
|
March 2029 (33.3%)
|
2029
|
2%
|
|
1
|
Represents a typical vesting schedule for deferred awards. Certain
awards may be subject to a 3, 4, 5 or 7 year deferral in line with
regulatory requirements.
|
|
2
|
Share awards may be subject to an additional holding
period.
|
|
3
|
The income statement charge is based on the period over which
conditions are met.
|
|
4
|
Income statement charge profile % disclosed as a percentage of the
award excluding lapse.
|
|
|
Gross exposure
|
|
Impairment allowance
|
||||||||
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
As at 31.12.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
159,825
|
13,757
|
1,836
|
—
|
175,418
|
|
15
|
16
|
60
|
—
|
91
|
|
Retail credit cards
|
14,922
|
1,943
|
279
|
24
|
17,168
|
|
171
|
398
|
174
|
—
|
743
|
|
Retail other
|
9,867
|
1,512
|
286
|
15
|
11,680
|
|
98
|
178
|
214
|
—
|
490
|
|
Corporate loans1
|
54,182
|
6,936
|
1,392
|
—
|
62,510
|
|
125
|
180
|
422
|
—
|
727
|
|
Total UK
|
238,796
|
24,148
|
3,793
|
39
|
266,776
|
|
409
|
772
|
870
|
—
|
2,051
|
|
Retail mortgages
|
1,829
|
72
|
131
|
—
|
2,032
|
|
2
|
—
|
24
|
—
|
26
|
|
Retail credit cards
|
18,801
|
2,536
|
1,776
|
—
|
23,113
|
|
395
|
796
|
1,395
|
—
|
2,586
|
|
Retail other
|
2,482
|
206
|
63
|
—
|
2,751
|
|
3
|
5
|
19
|
—
|
27
|
|
Corporate loans
|
66,671
|
3,702
|
1,767
|
—
|
72,140
|
|
82
|
135
|
382
|
—
|
599
|
|
Total Rest of the World
|
89,783
|
6,516
|
3,737
|
—
|
100,036
|
|
482
|
936
|
1,820
|
—
|
3,238
|
|
Total loans and advances at amortised cost
|
328,579
|
30,664
|
7,530
|
39
|
366,812
|
|
891
|
1,708
|
2,690
|
—
|
5,289
|
|
Debt securities at amortised cost
|
68,126
|
371
|
—
|
—
|
68,497
|
|
13
|
9
|
—
|
—
|
22
|
|
Total loans and advances at amortised cost including debt
securities
|
396,705
|
31,035
|
7,530
|
39
|
435,309
|
|
904
|
1,717
|
2,690
|
—
|
5,311
|
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
410,493
|
16,473
|
812
|
5
|
427,783
|
|
144
|
240
|
32
|
—
|
416
|
|
Total3,4
|
807,198
|
47,508
|
8,342
|
44
|
863,092
|
|
1,048
|
1,957
|
2,722
|
—
|
5,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
Coverage ratio
|
||||||||
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
As at 31.12.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
%
|
%
|
%
|
%
|
%
|
|
Retail mortgages
|
159,810
|
13,741
|
1,776
|
—
|
175,327
|
|
—
|
0.1
|
3.3
|
—
|
0.1
|
|
Retail credit cards
|
14,751
|
1,545
|
105
|
24
|
16,425
|
|
1.1
|
20.5
|
62.4
|
—
|
4.3
|
|
Retail other
|
9,769
|
1,334
|
72
|
15
|
11,190
|
|
1.0
|
11.8
|
74.8
|
—
|
4.2
|
|
Corporate loans1
|
54,057
|
6,756
|
970
|
—
|
61,783
|
|
0.2
|
2.6
|
30.3
|
—
|
1.2
|
|
Total UK
|
238,387
|
23,376
|
2,923
|
39
|
264,725
|
|
0.2
|
3.2
|
22.9
|
—
|
0.8
|
|
Retail mortgages
|
1,827
|
72
|
107
|
—
|
2,006
|
|
0.1
|
—
|
18.3
|
—
|
1.3
|
|
Retail credit cards
|
18,406
|
1,740
|
381
|
—
|
20,527
|
|
2.1
|
31.4
|
78.5
|
—
|
11.2
|
|
Retail other
|
2,479
|
201
|
44
|
—
|
2,724
|
|
0.1
|
2.4
|
30.2
|
—
|
1.0
|
|
Corporate loans
|
66,589
|
3,567
|
1,385
|
—
|
71,541
|
|
0.1
|
3.6
|
21.6
|
—
|
0.8
|
|
Total Rest of the World
|
89,301
|
5,580
|
1,917
|
—
|
96,798
|
|
0.5
|
14.4
|
48.7
|
—
|
3.2
|
|
Total loans and advances at amortised cost
|
327,688
|
28,956
|
4,840
|
39
|
361,523
|
|
0.3
|
5.6
|
35.7
|
—
|
1.4
|
|
Debt securities at amortised cost
|
68,113
|
362
|
—
|
—
|
68,475
|
|
—
|
2.4
|
—
|
—
|
—
|
|
Total loans and advances at amortised cost including debt
securities
|
395,801
|
29,318
|
4,840
|
39
|
429,998
|
|
0.2
|
5.5
|
35.7
|
—
|
1.2
|
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
410,349
|
16,233
|
780
|
5
|
427,367
|
|
—
|
1.5
|
3.9
|
—
|
0.1
|
|
Total3,4
|
806,150
|
45,551
|
5,620
|
44
|
857,365
|
|
0.1
|
4.1
|
32.6
|
—
|
0.7
|
|
1
|
Includes Business Banking, which has a gross exposure of
£12.4bn and an impairment allowance of £326m. This
comprises £62m impairment allowance on £9.3bn Stage 1
exposure, £50m on £2.3bn Stage 2 exposure and £214m
on £0.8bn Stage 3 exposure. Excluding this, total coverage for
corporate loans in UK is 0.8%.
|
|
2
|
Excludes loan commitments and financial guarantees of £22.2bn
carried at fair value and includes exposure relating to financial
assets classified as assets held for sale.
|
|
3
|
Other financial assets subject to impairment excluded in the table
above include cash collateral and settlement balances, reverse
repurchase agreements and other similar secured lending, financial
assets at fair value through other comprehensive income and other
assets. These have a total gross exposure of £224.1bn and an
impairment allowance of £150m. This comprises £18m
impairment allowance on £222.4bn Stage 1 exposure, £8m on
£1.6bn Stage 2 exposure and £124m on £127m Stage 3
exposure.
|
|
4
|
The annualised loan loss rate is 52bps after applying the total
impairment charge of £2,279m.
|
|
|
Gross exposure
|
|
Impairment allowance
|
||||||||
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
145,039
|
19,507
|
1,793
|
—
|
166,339
|
|
36
|
61
|
61
|
—
|
158
|
|
Retail credit cards
|
13,497
|
2,064
|
179
|
40
|
15,780
|
|
219
|
440
|
91
|
—
|
750
|
|
Retail other
|
10,606
|
1,218
|
257
|
17
|
12,098
|
|
135
|
110
|
138
|
—
|
383
|
|
Corporate loans1
|
52,284
|
7,266
|
2,171
|
—
|
61,721
|
|
133
|
196
|
420
|
—
|
749
|
|
Total UK
|
221,426
|
30,055
|
4,400
|
57
|
255,938
|
|
523
|
807
|
710
|
—
|
2,040
|
|
Retail mortgages
|
1,651
|
89
|
169
|
—
|
1,909
|
|
2
|
1
|
26
|
—
|
29
|
|
Retail credit cards
|
17,629
|
2,953
|
1,724
|
—
|
22,306
|
|
334
|
807
|
1,416
|
—
|
2,557
|
|
Retail other
|
1,844
|
155
|
121
|
—
|
2,120
|
|
3
|
1
|
23
|
—
|
27
|
|
Corporate loans
|
64,224
|
3,901
|
945
|
—
|
69,070
|
|
76
|
135
|
206
|
—
|
417
|
|
Total Rest of the World
|
85,348
|
7,098
|
2,959
|
—
|
95,405
|
|
415
|
944
|
1,671
|
—
|
3,030
|
|
Total loans and advances at amortised cost
|
306,774
|
37,153
|
7,359
|
57
|
351,343
|
|
938
|
1,751
|
2,381
|
—
|
5,070
|
|
Debt securities at amortised cost
|
64,988
|
3,245
|
—
|
—
|
68,233
|
|
12
|
11
|
—
|
—
|
23
|
|
Total loans and advances at amortised cost including debt
securities
|
371,762
|
40,398
|
7,359
|
57
|
419,576
|
|
950
|
1,762
|
2,381
|
—
|
5,093
|
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
412,255
|
18,728
|
1,168
|
6
|
432,157
|
|
164
|
250
|
25
|
—
|
439
|
|
Total3,4
|
784,017
|
59,126
|
8,527
|
63
|
851,733
|
|
1,114
|
2,012
|
2,406
|
—
|
5,532
|
|
|
Net exposure
|
|
Coverage ratio
|
||||||||
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
%
|
%
|
%
|
%
|
%
|
|
Retail mortgages
|
145,003
|
19,446
|
1,732
|
—
|
166,181
|
|
—
|
0.3
|
3.4
|
—
|
0.1
|
|
Retail credit cards
|
13,278
|
1,624
|
88
|
40
|
15,030
|
|
1.6
|
21.3
|
50.8
|
—
|
4.8
|
|
Retail other
|
10,471
|
1,108
|
119
|
17
|
11,715
|
|
1.3
|
9.0
|
53.7
|
—
|
3.2
|
|
Corporate loans1
|
52,151
|
7,070
|
1,751
|
—
|
60,972
|
|
0.3
|
2.7
|
19.3
|
—
|
1.2
|
|
Total UK
|
220,903
|
29,248
|
3,690
|
57
|
253,898
|
|
0.2
|
2.7
|
16.1
|
—
|
0.8
|
|
Retail mortgages
|
1,649
|
88
|
143
|
—
|
1,880
|
|
0.1
|
1.1
|
15.4
|
—
|
1.5
|
|
Retail credit cards
|
17,295
|
2,146
|
308
|
—
|
19,749
|
|
1.9
|
27.3
|
82.1
|
—
|
11.5
|
|
Retail other
|
1,841
|
154
|
98
|
—
|
2,093
|
|
0.2
|
0.6
|
19.0
|
—
|
1.3
|
|
Corporate loans
|
64,148
|
3,766
|
739
|
—
|
68,653
|
|
0.1
|
3.5
|
21.8
|
—
|
0.6
|
|
Total Rest of the World
|
84,933
|
6,154
|
1,288
|
—
|
92,375
|
|
0.5
|
13.3
|
56.5
|
—
|
3.2
|
|
Total loans and advances at amortised cost
|
305,836
|
35,402
|
4,978
|
57
|
346,273
|
|
0.3
|
4.7
|
32.4
|
—
|
1.4
|
|
Debt securities at amortised cost
|
64,976
|
3,234
|
—
|
—
|
68,210
|
|
—
|
0.3
|
—
|
—
|
—
|
|
Total loans and advances at amortised cost including debt
securities
|
370,812
|
38,636
|
4,978
|
57
|
414,483
|
|
0.3
|
4.4
|
32.4
|
—
|
1.2
|
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
412,091
|
18,478
|
1,143
|
6
|
431,718
|
|
—
|
1.3
|
2.1
|
—
|
0.1
|
|
Total3,4
|
782,903
|
57,114
|
6,121
|
63
|
846,201
|
|
0.1
|
3.4
|
28.2
|
—
|
0.6
|
|
1
|
Includes Business Banking, which has a
gross exposure of £13.1bn and an impairment allowance of
£356m. This comprises £60m impairment allowance on £8.9bn Stage 1 exposure, £60m on £2.8bn
Stage 2 exposure and £236m on £1.5bn Stage 3 exposure.
Excluding this, total coverage for corporate loans in UK is
0.8%.
|
|
2
|
Excludes loan commitments and financial guarantees of £16.3bn
carried at fair value and includes exposure relating to financial
assets classified as assets held for sale.
|
|
3
|
Other financial assets subject to impairment excluded in the table
above include cash collateral and settlement balances, reverse
repurchase agreements and other similar secured lending, financial
assets at fair value through other comprehensive income and other
assets. These have a total gross exposure of £204.2bn and an
impairment allowance of £156m. This comprises £19m
impairment allowance on £202.7bn Stage 1 exposure, £7m on
£1.3bn Stage 2 exposure and £130m on £139m Stage 3
exposure.
|
|
4
|
The annualised loan loss rate is 46bps after applying the total
impairment charge of £1,982m.
|
|
|
|
Stage 2
|
|
|
|
|||
|
As at 31.12.25
|
Stage 1
|
Not past due
|
<=30 days past due
|
>30 days past due
|
Total
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
Gross exposure
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
161,654
|
11,072
|
2,033
|
724
|
13,829
|
1,967
|
—
|
177,450
|
|
Retail credit cards
|
33,723
|
3,832
|
317
|
330
|
4,479
|
2,055
|
24
|
40,281
|
|
Retail other
|
12,349
|
1,398
|
207
|
113
|
1,718
|
349
|
15
|
14,431
|
|
Corporate loans
|
120,853
|
10,409
|
71
|
158
|
10,638
|
3,159
|
—
|
134,650
|
|
Total
|
328,579
|
26,711
|
2,628
|
1,325
|
30,664
|
7,530
|
39
|
366,812
|
|
|
|
|
|
|
|
|
|
|
|
Impairment allowance
|
|
|
|
|
|
|
|
|
|
Retail mortgages
|
17
|
9
|
4
|
3
|
16
|
84
|
—
|
117
|
|
Retail credit cards
|
566
|
840
|
138
|
216
|
1,194
|
1,569
|
—
|
3,329
|
|
Retail other
|
101
|
126
|
28
|
29
|
183
|
233
|
—
|
517
|
|
Corporate loans
|
207
|
298
|
7
|
10
|
315
|
804
|
—
|
1,326
|
|
Total
|
891
|
1,273
|
177
|
258
|
1,708
|
2,690
|
—
|
5,289
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
|
|
|
|
|
|
|
|
Retail mortgages
|
161,637
|
11,063
|
2,029
|
721
|
13,813
|
1,883
|
—
|
177,333
|
|
Retail credit cards
|
33,157
|
2,992
|
179
|
114
|
3,285
|
486
|
24
|
36,952
|
|
Retail other
|
12,248
|
1,272
|
179
|
84
|
1,535
|
116
|
15
|
13,914
|
|
Corporate loans
|
120,646
|
10,111
|
64
|
148
|
10,323
|
2,355
|
—
|
133,324
|
|
Total
|
327,688
|
25,438
|
2,451
|
1,067
|
28,956
|
4,840
|
39
|
361,523
|
|
|
|
|
|
|
|
|
|
|
|
Coverage ratio
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
|
Retail mortgages
|
—
|
0.1
|
0.2
|
0.4
|
0.1
|
4.3
|
—
|
0.1
|
|
Retail credit cards
|
1.7
|
21.9
|
43.5
|
65.5
|
26.7
|
76.4
|
—
|
8.3
|
|
Retail other
|
0.8
|
9.0
|
13.5
|
25.7
|
10.7
|
66.8
|
—
|
3.6
|
|
Corporate loans
|
0.2
|
2.9
|
9.9
|
6.3
|
3.0
|
25.5
|
—
|
1.0
|
|
Total
|
0.3
|
4.8
|
6.7
|
19.5
|
5.6
|
35.7
|
—
|
1.4
|
|
|
As at 31.12.24
|
|
|
|
|
|
|
|
|
|
|
Gross exposure
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
|
Retail mortgages
|
146,690
|
16,790
|
2,034
|
772
|
19,596
|
1,962
|
—
|
168,248
|
|
|
Retail credit cards
|
31,126
|
4,435
|
303
|
279
|
5,017
|
1,903
|
40
|
38,086
|
|
|
Retail other
|
12,450
|
1,056
|
211
|
106
|
1,373
|
378
|
17
|
14,218
|
|
|
Corporate loans
|
116,508
|
10,849
|
144
|
174
|
11,167
|
3,116
|
—
|
130,791
|
|
|
Total
|
306,774
|
33,130
|
2,692
|
1,331
|
37,153
|
7,359
|
57
|
351,343
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment allowance
|
|
|
|
|
|
|
|
|
|
|
Retail mortgages
|
38
|
42
|
13
|
7
|
62
|
87
|
—
|
187
|
|
|
Retail credit cards
|
553
|
959
|
122
|
166
|
1,247
|
1,507
|
—
|
3,307
|
|
|
Retail other
|
138
|
76
|
17
|
18
|
111
|
161
|
—
|
410
|
|
|
Corporate loans
|
209
|
316
|
7
|
8
|
331
|
626
|
—
|
1,166
|
|
|
Total
|
938
|
1,393
|
159
|
199
|
1,751
|
2,381
|
—
|
5,070
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
|
|
|
|
|
|
|
|
|
Retail mortgages
|
146,652
|
16,748
|
2,021
|
765
|
19,534
|
1,875
|
—
|
168,061
|
|
|
Retail credit cards
|
30,573
|
3,476
|
181
|
113
|
3,770
|
396
|
40
|
34,779
|
|
|
Retail other
|
12,312
|
980
|
194
|
88
|
1,262
|
217
|
17
|
13,808
|
|
|
Corporate loans
|
116,299
|
10,533
|
137
|
166
|
10,836
|
2,490
|
—
|
129,625
|
|
|
Total
|
305,836
|
31,737
|
2,533
|
1,132
|
35,402
|
4,978
|
57
|
346,273
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coverage ratio
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
|
|
Retail mortgages
|
—
|
0.3
|
0.6
|
0.9
|
0.3
|
4.4
|
—
|
0.1
|
|
|
Retail credit cards
|
1.8
|
21.6
|
40.3
|
59.5
|
24.9
|
79.2
|
—
|
8.7
|
|
|
Retail other
|
1.1
|
7.2
|
8.1
|
17.0
|
8.1
|
42.6
|
—
|
2.9
|
|
|
Corporate loans
|
0.2
|
2.9
|
4.9
|
4.6
|
3.0
|
20.1
|
—
|
0.9
|
|
|
Total
|
0.3
|
4.2
|
5.9
|
15.0
|
4.7
|
32.4
|
—
|
1.4
|
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|||||
|
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
|
Retail mortgages
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
As at 1 January 2025
|
146,690
|
38
|
19,596
|
62
|
1,962
|
87
|
—
|
—
|
168,248
|
187
|
|
Transfers from Stage 1 to Stage 2
|
(8,750)
|
(3)
|
8,750
|
3
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Transfers from Stage 2 to Stage 1
|
12,686
|
26
|
(12,686)
|
(26)
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Transfers to Stage 3
|
(389)
|
(1)
|
(502)
|
(5)
|
891
|
6
|
—
|
—
|
—
|
—
|
|
Transfers from Stage 3
|
108
|
2
|
119
|
—
|
(227)
|
(2)
|
—
|
—
|
—
|
—
|
|
Business activity in the period
|
32,944
|
4
|
1,186
|
2
|
7
|
—
|
—
|
—
|
34,137
|
6
|
|
Refinements to models used for calculation1
|
—
|
(19)
|
—
|
(36)
|
—
|
6
|
—
|
—
|
—
|
(49)
|
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(7,660)
|
(26)
|
(683)
|
25
|
(113)
|
30
|
—
|
—
|
(8,456)
|
29
|
|
Final repayments
|
(13,634)
|
(3)
|
(1,802)
|
(5)
|
(431)
|
(20)
|
—
|
—
|
(15,867)
|
(28)
|
|
Disposals2
|
(341)
|
(1)
|
(149)
|
(4)
|
(104)
|
(5)
|
—
|
—
|
(594)
|
(10)
|
|
Write-offs
|
—
|
—
|
—
|
—
|
(18)
|
(18)
|
—
|
—
|
(18)
|
(18)
|
|
As at 31 December 2025
|
161,654
|
17
|
13,829
|
16
|
1,967
|
84
|
—
|
—
|
177,450
|
117
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail credit cards
|
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
31,126
|
553
|
5,017
|
1,247
|
1,903
|
1,507
|
40
|
—
|
38,086
|
3,307
|
|
Transfers from Stage 1 to Stage 2
|
(1,716)
|
(51)
|
1,716
|
51
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Transfers from Stage 2 to Stage 1
|
2,220
|
444
|
(2,220)
|
(444)
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Transfers to Stage 3
|
(728)
|
(26)
|
(922)
|
(351)
|
1,650
|
377
|
—
|
—
|
—
|
—
|
|
Transfers from Stage 3
|
30
|
15
|
20
|
8
|
(50)
|
(23)
|
—
|
—
|
—
|
—
|
|
Business activity in the period3
|
4,999
|
111
|
617
|
188
|
75
|
54
|
—
|
—
|
5,691
|
353
|
|
Refinements to models used for calculation1
|
—
|
57
|
—
|
(274)
|
—
|
1
|
—
|
—
|
—
|
(216)
|
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes4
|
(1,906)
|
(526)
|
290
|
782
|
(6)
|
1,074
|
(16)
|
—
|
(1,638)
|
1,330
|
|
Final repayments
|
(302)
|
(11)
|
(39)
|
(13)
|
(35)
|
(28)
|
—
|
—
|
(376)
|
(52)
|
|
Disposals2
|
—
|
—
|
—
|
—
|
(457)
|
(368)
|
—
|
—
|
(457)
|
(368)
|
|
Write-offs
|
—
|
—
|
—
|
—
|
(1,025)
|
(1,025)
|
—
|
—
|
(1,025)
|
(1,025)
|
|
As at 31 December 2025
|
33,723
|
566
|
4,479
|
1,194
|
2,055
|
1,569
|
24
|
—
|
40,281
|
3,329
|
|
1
|
Refinements to models used for calculation reported within Retail
mortgages include a £(49)m movement in the calculated ECL for
the UK Mortgages portfolio. In Retail credit cards, this include a
£(204)m movement in UK Cards and a £(12)m movement in US
Cards portfolio, respectively. These reflect model enhancements
made during the period. Barclays continually reviews the output of
models to determine accuracy of the ECL calculation including
review of model monitoring, external benchmarking and experience of
model operation over an extended period of time. This helps to
ensure that the models used continue to reflect the risks inherent
in the businesses.
|
|
2
|
The £594m of gross disposals reported within Retail mortgages
include £584m transfer of facilities to a non-consolidated SPV
for the purpose of securitisation and £10m relates to sale of
the Italian mortgage loans. The £457m of gross disposals
reported within Retail credit cards relate to debt sales undertaken
during the period.
|
|
3
|
Business activity in the year reported within Retail credit cards
include £1.2bn related to acquisition of the GM co-branded
card portfolio within USCB.
|
|
4
|
'Net drawdowns, repayments, net re-measurement and movements due to
exposure and risk parameter changes' reported within Retail credit
cards include a gain recognised on the reassessment of purchased or
originated credit-impaired (POCI) assets, where the expected credit
loss on POCI assets is lower than anticipated at the time of
purchase. The resulting increase in carrying value is recognised
within gross exposure rather than as a negative impairment
allowance.
|
|
Loans and advances at amortised cost
|
|
|
|
|
|
|||||
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|||||
|
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
Gross exposure
|
ECL
|
|
Retail other
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
As at 1 January 2025
|
12,450
|
138
|
1,373
|
111
|
378
|
161
|
17
|
—
|
14,218
|
410
|
|
Transfers from Stage 1 to Stage 2
|
(733)
|
(12)
|
733
|
12
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Transfers from Stage 2 to Stage 1
|
372
|
24
|
(372)
|
(24)
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Transfers to Stage 3
|
(206)
|
(3)
|
(119)
|
(28)
|
325
|
31
|
—
|
—
|
—
|
—
|
|
Transfers from Stage 3
|
58
|
2
|
4
|
4
|
(62)
|
(6)
|
—
|
—
|
—
|
—
|
|
Business activity in the period
|
4,683
|
37
|
494
|
58
|
37
|
34
|
—
|
—
|
5,214
|
129
|
|
Refinements to models used for calculation
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes1
|
(1,080)
|
(62)
|
(16)
|
55
|
34
|
180
|
(2)
|
—
|
(1,064)
|
173
|
|
Final repayments
|
(3,195)
|
(23)
|
(379)
|
(5)
|
(205)
|
(20)
|
—
|
—
|
(3,779)
|
(48)
|
|
Disposals2
|
—
|
—
|
—
|
—
|
(43)
|
(32)
|
—
|
—
|
(43)
|
(32)
|
|
Write-offs
|
—
|
—
|
—
|
—
|
(115)
|
(115)
|
—
|
—
|
(115)
|
(115)
|
|
As at 31 December 2025
|
12,349
|
101
|
1,718
|
183
|
349
|
233
|
15
|
—
|
14,431
|
517
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate loans
|
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
116,508
|
209
|
11,167
|
331
|
3,116
|
626
|
—
|
—
|
130,791
|
1,166
|
|
Transfers from Stage 1 to Stage 2
|
(3,993)
|
(19)
|
3,993
|
19
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Transfers from Stage 2 to Stage 1
|
3,316
|
70
|
(3,316)
|
(70)
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Transfers to Stage 3
|
(895)
|
(5)
|
(748)
|
(32)
|
1,643
|
37
|
—
|
—
|
—
|
—
|
|
Transfers from Stage 3
|
441
|
18
|
459
|
14
|
(900)
|
(32)
|
—
|
—
|
—
|
—
|
|
Business activity in the period3
|
28,142
|
49
|
1,134
|
40
|
341
|
29
|
—
|
—
|
29,617
|
118
|
|
Refinements to models used for calculation4
|
—
|
(65)
|
—
|
(24)
|
—
|
—
|
—
|
—
|
—
|
(89)
|
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
3,727
|
(21)
|
(41)
|
95
|
(108)
|
476
|
—
|
—
|
3,578
|
550
|
|
Final repayments
|
(26,236)
|
(28)
|
(2,008)
|
(56)
|
(511)
|
(10)
|
—
|
—
|
(28,755)
|
(94)
|
|
Disposals2
|
(157)
|
(1)
|
(2)
|
(2)
|
(121)
|
(21)
|
—
|
—
|
(280)
|
(24)
|
|
Write-offs
|
—
|
—
|
—
|
—
|
(301)
|
(301)
|
—
|
—
|
(301)
|
(301)
|
|
As at 31 December 2025
|
120,853
|
207
|
10,638
|
315
|
3,159
|
804
|
—
|
—
|
134,650
|
1,326
|
|
1
|
'Net drawdowns, repayments, net re-measurement and movements due to
exposure and risk parameter changes' reported within Retail other
include a gain recognised on the reassessment of purchased or
originated credit-impaired (POCI) assets, where the expected credit
loss on POCI assets is lower than anticipated at the time of
purchase. The resulting increase in carrying value is recognised
within gross exposure rather than as a negative impairment
allowance.
|
|
2
|
The £43m of gross disposals reported within Retail other and
£280m of gross disposals reported within Corporate loans
relate to debt sales undertaken during the period.
|
|
3
|
Business activity in the year reported within Corporate loans
include £0.1bn related to acquisition of the GM co-branded
card portfolio within USCB.
|
|
4
|
Refinements to models used for calculation reported within
Corporate loans include a £(89)m movement in the calculated
ECL for the UKCB and IB portfolio. These reflect model enhancements
made during the period. Barclays continually reviews the output of
models to determine accuracy of the ECL calculation including
review of model monitoring, external benchmarking and experience of
model operation over an extended period of time. This helps to
ensure that the models used continue to reflect the risks inherent
in the businesses.
|
|
Reconciliation of ECL movement to impairment charge/(release) for
the period
|
|
|
||||||
|
|
|
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|
|
|
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
(20)
|
(42)
|
20
|
—
|
(42)
|
|||
|
Retail credit cards
|
13
|
(53)
|
1,455
|
—
|
1,415
|
|||
|
Retail other
|
(37)
|
72
|
219
|
—
|
254
|
|||
|
Corporate loans
|
(1)
|
(14)
|
500
|
—
|
485
|
|||
|
ECL movements excluding disposals and
write-offs1
|
(45)
|
(37)
|
2,194
|
—
|
2,112
|
|||
|
ECL movement on
loan commitments and other financial guarantees
|
(20)
|
(10)
|
7
|
—
|
(23)
|
|||
|
ECL movement on other financial assets
|
(1)
|
1
|
(6)
|
—
|
(6)
|
|||
|
ECL movement on debt securities at amortised cost
|
1
|
(2)
|
—
|
—
|
(1)
|
|||
|
Recoveries and reimbursements2
|
9
|
(29)
|
(147)
|
—
|
(167)
|
|||
|
ECL charge on assets held for sale3
|
|
|
|
|
181
|
|||
|
Total exchange and other adjustments
|
|
|
|
|
183
|
|||
|
Total income statement charge for the period
|
|
|
|
|
2,279
|
|||
|
1
|
In 2025, gross write-offs amounted to £1,459m (2024:
£1,547m) and post write-off recoveries amounted to £83m
(2024: £76m). Net write-offs represent gross write-offs less
post write-off recoveries and amounted to £1,376m (2024:
£1,471m).
|
|
2
|
Recoveries and reimbursements include £84m (2024: £15m)
for reimbursements where the Group has entered into financial
guarantee contracts which provide credit protection over certain
assets with third parties and cash recoveries of previously
written-off amounts of £83m (2024: £76m).
|
|
3
|
ECL charge on assets held for sale relate to the charges on a
co-branded card portfolio in USCB and the German consumer finance
business.
|
|
Loan commitments and financial
guarantees1
|
||||||||||
|
|
Stage 1
|
Stage 2
|
Stage 3 excluding POCI
|
Stage 3 POCI
|
Total
|
|||||
|
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
Gross
exposure
|
ECL
|
|
Retail mortgages
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
As at 1 January 2025
|
11,093
|
—
|
340
|
—
|
2
|
—
|
—
|
—
|
11,435
|
—
|
|
Net transfers between stages
|
131
|
—
|
(141)
|
—
|
10
|
—
|
—
|
—
|
—
|
—
|
|
Business activity in the period
|
8,970
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
8,970
|
—
|
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(8,097)
|
—
|
(44)
|
—
|
(10)
|
—
|
—
|
—
|
(8,151)
|
—
|
|
Limit management and final repayments
|
(342)
|
—
|
(30)
|
—
|
(2)
|
—
|
—
|
—
|
(374)
|
—
|
|
As at 31 December 2025
|
11,755
|
—
|
125
|
—
|
—
|
—
|
—
|
—
|
11,880
|
—
|
|
Retail credit cards
|
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
162,471
|
53
|
2,515
|
13
|
122
|
—
|
6
|
—
|
165,114
|
66
|
|
Net transfers between stages
|
(1,837)
|
13
|
1,760
|
(13)
|
77
|
—
|
—
|
—
|
—
|
—
|
|
Business activity in the period
|
28,148
|
18
|
341
|
3
|
1
|
—
|
—
|
—
|
28,490
|
21
|
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(6,183)
|
(24)
|
(1,845)
|
9
|
(72)
|
—
|
(1)
|
—
|
(8,101)
|
(15)
|
|
Limit management and final repayments
|
(13,584)
|
(8)
|
(220)
|
(9)
|
(24)
|
—
|
—
|
—
|
(13,828)
|
(17)
|
|
Disposals2
|
(5,291)
|
—
|
(221)
|
—
|
(10)
|
—
|
—
|
—
|
(5,522)
|
—
|
|
As at 31 December 2025
|
163,724
|
52
|
2,330
|
3
|
94
|
—
|
5
|
—
|
166,153
|
55
|
|
Retail other
|
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
8,416
|
6
|
440
|
—
|
25
|
—
|
—
|
—
|
8,881
|
6
|
|
Net transfers between stages
|
(31)
|
—
|
28
|
—
|
3
|
—
|
—
|
—
|
—
|
—
|
|
Business activity in the period
|
625
|
—
|
1
|
—
|
—
|
—
|
—
|
—
|
626
|
—
|
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
(341)
|
(5)
|
7
|
—
|
12
|
—
|
—
|
—
|
(322)
|
(5)
|
|
Limit management and final repayments
|
(797)
|
—
|
(33)
|
—
|
(20)
|
—
|
—
|
—
|
(850)
|
—
|
|
Disposals2
|
(756)
|
—
|
(30)
|
—
|
(1)
|
—
|
—
|
—
|
(787)
|
—
|
|
As at 31 December 2025
|
7,116
|
1
|
413
|
—
|
19
|
—
|
—
|
—
|
7,548
|
1
|
|
Corporate loans
|
|
|
|
|
|
|
|
|
|
|
|
As at 1 January 2025
|
230,275
|
105
|
15,433
|
237
|
1,019
|
25
|
—
|
—
|
246,727
|
367
|
|
Net transfers between stages
|
(122)
|
41
|
216
|
(41)
|
(94)
|
—
|
—
|
—
|
—
|
—
|
|
Business activity in the period
|
48,961
|
28
|
2,701
|
61
|
405
|
—
|
—
|
—
|
52,067
|
89
|
|
Net drawdowns, repayments, net re-measurement and movement due to
exposure and risk parameter changes
|
9,733
|
(57)
|
(480)
|
36
|
(291)
|
11
|
—
|
—
|
8,962
|
(10)
|
|
Limit management and final repayments
|
(60,949)
|
(26)
|
(4,265)
|
(56)
|
(340)
|
(4)
|
—
|
—
|
(65,554)
|
(86)
|
|
As at 31 December 2025
|
227,898
|
91
|
13,605
|
237
|
699
|
32
|
—
|
—
|
242,202
|
360
|
|
1
|
Loan commitments reported also include exposure relating to
financial assets classified as held for sale.
|
|
2
|
The gross disposals reported within Retail credit cards and Retail
other relate to the German consumer finance business; sale of which
was completed in Q125.
|
|
|
Impairment allowance pre management
adjustments1
|
Economic uncertainty adjustments
|
Other adjustments
|
Management
adjustments2
|
Total impairment
allowance3
|
Proportion of Management adjustments to total impairment
allowance
|
|
|
|
(a)
|
(b)
|
(a+b)
|
|
|
|
As at 31.12.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
|
Retail mortgages
|
76
|
—
|
15
|
15
|
91
|
16.5
|
|
Retail credit cards
|
761
|
—
|
—
|
—
|
761
|
—
|
|
Retail other
|
406
|
—
|
85
|
85
|
491
|
17.3
|
|
Corporate loans
|
714
|
39
|
53
|
92
|
806
|
11.4
|
|
Total UK
|
1,957
|
39
|
153
|
192
|
2,149
|
8.9
|
|
Retail mortgages
|
25
|
—
|
1
|
1
|
26
|
3.8
|
|
Retail credit cards
|
2,505
|
31
|
87
|
118
|
2,623
|
4.5
|
|
Retail other
|
27
|
—
|
—
|
—
|
27
|
—
|
|
Corporate loans
|
823
|
44
|
13
|
57
|
880
|
6.5
|
|
Total Rest of the World
|
3,380
|
75
|
101
|
176
|
3,556
|
4.9
|
|
Total
|
5,337
|
114
|
254
|
368
|
5,705
|
6.5
|
|
Debt securities at amortised cost
|
21
|
1
|
—
|
1
|
22
|
4.5
|
|
Total including debt securities at amortised cost
|
5,358
|
115
|
254
|
369
|
5,727
|
6.4
|
|
|
|
|
|
|
|
|
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
|
Retail mortgages
|
51
|
36
|
71
|
107
|
158
|
67.7
|
|
Retail credit cards
|
787
|
—
|
(22)
|
(22)
|
765
|
(2.9)
|
|
Retail other
|
298
|
—
|
90
|
90
|
388
|
23.2
|
|
Corporate loans
|
759
|
42
|
39
|
81
|
840
|
9.6
|
|
Total UK
|
1,895
|
78
|
178
|
256
|
2,151
|
11.9
|
|
Retail mortgages
|
29
|
—
|
—
|
—
|
29
|
—
|
|
Retail credit cards
|
2,631
|
—
|
(23)
|
(23)
|
2,608
|
(0.9)
|
|
Retail other
|
24
|
—
|
4
|
4
|
28
|
14.3
|
|
Corporate loans
|
695
|
—
|
(2)
|
(2)
|
693
|
(0.3)
|
|
Total Rest of the World
|
3,379
|
—
|
(21)
|
(21)
|
3,358
|
(0.6)
|
|
Total
|
5,274
|
78
|
157
|
235
|
5,509
|
4.3
|
|
Debt securities at amortised cost
|
30
|
—
|
(7)
|
(7)
|
23
|
(30.4)
|
|
Total including debt securities at amortised cost
|
5,304
|
78
|
150
|
228
|
5,532
|
4.1
|
|
1
|
Includes £4.3bn (December 2024: £4.7bn) of modelled ECL,
£0.7bn (December 2024: £0.5bn) of individually assessed
impairments, £(0.2)bn (December 2024: £(0.3)bn) of ECL
from assets held for sale (co-branded card portfolio) and
£0.6bn (December 2024: £0.4bn) of ECL from benchmarked
exposures and debt securities.
|
|
2
|
Management adjustments related to other financial assets subject to
impairment not included in the table above include cash collateral
and settlement balances £1m (December 2024: £(1)m),
reverse repurchase agreements £1m (December 2024: £(2)m)
and financial assets at fair value through other comprehensive
income £nil (December 2024: £(2)m) within the IB
portfolio.
|
|
3
|
Total impairment allowance consists of ECL stock on drawn and
undrawn exposures.
|
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
As at 31.12.25
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
|
Retail credit cards
|
—
|
—
|
—
|
—
|
|
Retail other
|
—
|
—
|
—
|
—
|
|
Corporate loans
|
23
|
10
|
6
|
39
|
|
Total UK
|
23
|
10
|
6
|
39
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
|
Retail credit cards
|
—
|
31
|
—
|
31
|
|
Retail other
|
—
|
—
|
—
|
—
|
|
Corporate loans
|
13
|
31
|
—
|
44
|
|
Total Rest of the World
|
13
|
62
|
—
|
75
|
|
Total
|
36
|
72
|
6
|
114
|
|
Debt securities at amortised cost
|
1
|
—
|
—
|
1
|
|
Total including debt securities at amortised cost
|
37
|
72
|
6
|
115
|
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
7
|
18
|
11
|
36
|
|
Retail credit cards
|
—
|
—
|
—
|
—
|
|
Retail other
|
—
|
—
|
—
|
—
|
|
Corporate loans
|
26
|
10
|
6
|
42
|
|
Total UK
|
33
|
28
|
17
|
78
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
|
Retail credit cards
|
—
|
—
|
—
|
—
|
|
Retail other
|
—
|
—
|
—
|
—
|
|
Corporate loans
|
—
|
—
|
—
|
—
|
|
Total Rest of the World
|
—
|
—
|
—
|
—
|
|
Total
|
33
|
28
|
17
|
78
|
|
Debt securities at amortised cost
|
—
|
—
|
—
|
—
|
|
Total including debt securities at amortised cost
|
33
|
28
|
17
|
78
|
|
●
|
Retail mortgages (UK) £nil
(December 2024: £11m): The
prior refinancing risk adjustment was retired following the rebuild
of the UK Mortgages impairment models, which now better capture
sensitivity to interest rate and inflation
movements
|
|
●
|
Retail credit cards (ROW)
£31m (December 2024: £nil): This adjustment reflects elevated US macroeconomic
uncertainty, with impacts yet to materialise in consumer
behaviour
|
|
●
|
Corporate loans (UK) £39m
(December 2024: £42m): This adjustment reflects potential cross-default
risk on Barclays’ lending in respect of clients who have
taken out Bounce Back Loans
|
|
●
|
Corporate loans (ROW) £44m
(December 2024: £nil): This adjustment reflects elevated US macroeconomic
uncertainty, with impacts yet to materialise in borrower
behaviour
|
|
●
|
Retail mortgages
(UK) £nil (December 2024:
£25m): The prior
adjustment to address model over-sensitivity was retired following
the rebuild of the UK Mortgages impairment models, which now better
capture consumer responses to the macroeconomic
outlook
|
|
●
|
Retail mortgages (UK) £15m (December 2024:
£71m): The reduction is
driven by the retirement of adjustments following the rebuild of
the UK Mortgages impairment models
|
|
●
|
Retail credit cards (UK) £nil (December 2024:
£(22)m): The prior
adjustment to address default over-prediction was retired following
model remediation in the UK Cards portfolio
|
|
●
|
Retail credit cards (ROW) £87m (December 2024:
£(23)m): This adjustment
reflects provisioning for the GM consumer cards portfolio acquired
during the year, while the previously held high-risk account
management (HRAM) adjustment was retired following model
remediation in USCB
|
|
●
|
Retail other (UK) £85m (December 2024: £90m) and
Corporate loans (UK) £53m (December 2024: £39m):
These include adjustments for
definition of default (DOD) criteria under the Capital Requirements
Regulation and model monitoring outcomes, which were re-sized
during the year
|
|
●
|
Corporate loans (ROW) £13m (December 2024: £(2)m):
This adjustment reflects provisioning
for the GM business cards portfolio acquired during the
year
|
|
●
|
Debt securities £nil (December 2024:
£(7)m): The
movement is driven by the retirement of the Exposure at Default
recalibration adjustment following model remediation in the IB
portfolio
|
|
1
|
Significant Risk Transfer (SRT) refers to risk transfer
transactions used to enhance risk management
capabilities.
|
|
Macroeconomic variables used in the calculation of ECL
|
|||||
|
As at 31.12.25
|
2025
|
2026
|
2027
|
2028
|
2029
|
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP1
|
1.5
|
1.1
|
1.4
|
1.4
|
1.4
|
|
UK unemployment2
|
4.7
|
4.9
|
4.8
|
4.8
|
4.7
|
|
UK HPI3
|
1.5
|
2.9
|
2.5
|
4.3
|
3.8
|
|
UK bank rate6
|
4.2
|
3.4
|
3.4
|
3.5
|
3.6
|
|
US GDP1
|
2.1
|
2.0
|
2.0
|
2.0
|
2.0
|
|
US unemployment4
|
4.2
|
4.5
|
4.4
|
4.4
|
4.4
|
|
US HPI5
|
3.2
|
1.7
|
1.9
|
2.6
|
2.6
|
|
US federal funds rate6
|
4.2
|
3.4
|
3.3
|
3.3
|
3.5
|
|
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
(2.5)
|
(1.2)
|
2.8
|
1.1
|
|
UK unemployment2
|
4.7
|
5.8
|
7.7
|
6.9
|
5.7
|
|
UK HPI3
|
1.5
|
(24.9)
|
(5.1)
|
9.6
|
14.2
|
|
UK bank rate6
|
4.2
|
2.3
|
0.5
|
0.4
|
1.1
|
|
US GDP1
|
2.1
|
(2.7)
|
(2.8)
|
1.6
|
2.4
|
|
US unemployment4
|
4.2
|
5.7
|
8.0
|
7.9
|
5.9
|
|
US HPI5
|
3.2
|
(8.2)
|
(1.7)
|
7.2
|
7.7
|
|
US federal funds rate6
|
4.2
|
3.6
|
2.4
|
1.4
|
1.2
|
|
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
(0.7)
|
0.1
|
2.1
|
1.3
|
|
UK unemployment2
|
4.7
|
5.3
|
6.3
|
5.8
|
5.2
|
|
UK HPI3
|
1.5
|
(11.8)
|
(1.3)
|
6.9
|
8.9
|
|
UK bank rate6
|
4.2
|
2.9
|
2.0
|
1.9
|
2.4
|
|
US GDP1
|
2.1
|
(0.3)
|
(0.4)
|
1.8
|
2.2
|
|
US unemployment4
|
4.2
|
5.1
|
6.2
|
6.1
|
5.1
|
|
US HPI5
|
3.2
|
(3.3)
|
0.1
|
4.9
|
5.1
|
|
US federal funds rate6
|
4.2
|
3.6
|
2.8
|
2.4
|
2.4
|
|
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
2.7
|
3.7
|
2.9
|
2.4
|
|
UK unemployment2
|
4.7
|
4.3
|
4.0
|
3.9
|
3.8
|
|
UK HPI3
|
1.5
|
11.9
|
8.4
|
5.1
|
4.1
|
|
UK bank rate6
|
4.2
|
3.1
|
2.3
|
2.3
|
2.6
|
|
US GDP1
|
2.1
|
2.8
|
3.1
|
2.8
|
2.8
|
|
US unemployment4
|
4.2
|
3.9
|
3.7
|
3.7
|
3.7
|
|
US HPI5
|
3.2
|
6.2
|
4.7
|
4.8
|
4.9
|
|
US federal funds rate6
|
4.2
|
3.0
|
2.5
|
2.5
|
2.5
|
|
|
|
|
|
|
|
|
Upside 1
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
1.9
|
2.6
|
2.2
|
1.9
|
|
UK unemployment2
|
4.7
|
4.6
|
4.4
|
4.4
|
4.3
|
|
UK HPI3
|
1.5
|
7.4
|
5.4
|
4.7
|
3.9
|
|
UK bank rate6
|
4.2
|
3.2
|
2.8
|
2.8
|
3.1
|
|
US GDP1
|
2.1
|
2.4
|
2.6
|
2.4
|
2.4
|
|
US unemployment4
|
4.2
|
4.2
|
4.1
|
4.1
|
4.1
|
|
US HPI5
|
3.2
|
4.0
|
3.3
|
3.7
|
3.7
|
|
US federal funds rate6
|
4.2
|
3.3
|
2.8
|
2.8
|
3.0
|
|
1
|
Average Real GDP seasonally adjusted change in year.
|
|
2
|
Average UK unemployment rate 16-year+.
|
|
3
|
Change in year end UK HPI = Halifax HPI Meth2 All Houses, All
Buyers index.
|
|
4
|
Average US civilian unemployment rate 16-year+.
|
|
5
|
Change in year end US HPI = FHFA House Price Index, relative to
prior year end.
|
|
6
|
Average rate.
|
|
As at 31.12.24
|
2024
|
2025
|
2026
|
2027
|
2028
|
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP1
|
1.0
|
1.4
|
1.5
|
1.6
|
1.5
|
|
UK unemployment2
|
4.3
|
4.4
|
4.5
|
4.4
|
4.4
|
|
UK HPI3
|
2.8
|
3.3
|
1.6
|
4.5
|
3.0
|
|
UK bank rate6
|
5.1
|
4.3
|
4.0
|
4.0
|
3.8
|
|
US GDP1
|
2.7
|
2.0
|
2.0
|
2.0
|
2.0
|
|
US unemployment4
|
4.1
|
4.3
|
4.2
|
4.2
|
4.2
|
|
US HPI5
|
6.5
|
2.6
|
2.7
|
3.0
|
3.0
|
|
US federal funds rate6
|
5.1
|
4.1
|
4.0
|
3.8
|
3.8
|
|
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
|
UK GDP1
|
1.0
|
(2.3)
|
(1.3)
|
2.6
|
2.3
|
|
UK unemployment2
|
4.3
|
6.2
|
8.1
|
6.6
|
5.5
|
|
UK HPI3
|
2.8
|
(24.8)
|
(5.2)
|
10.0
|
14.6
|
|
UK bank rate6
|
5.1
|
3.5
|
1.7
|
0.6
|
1.1
|
|
US GDP1
|
2.7
|
(1.3)
|
(1.3)
|
3.3
|
2.9
|
|
US unemployment4
|
4.1
|
5.8
|
7.2
|
6.2
|
5.5
|
|
US HPI5
|
6.5
|
(8.0)
|
(0.7)
|
5.2
|
4.0
|
|
US federal funds rate6
|
5.1
|
2.5
|
0.6
|
0.8
|
1.5
|
|
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
|
UK GDP1
|
1.0
|
(0.5)
|
0.1
|
2.1
|
1.9
|
|
UK unemployment2
|
4.3
|
5.3
|
6.3
|
5.5
|
5.0
|
|
UK HPI3
|
2.8
|
(11.6)
|
(1.8)
|
7.2
|
8.7
|
|
UK bank rate6
|
5.1
|
3.9
|
2.9
|
2.3
|
2.4
|
|
US GDP1
|
2.7
|
0.3
|
0.4
|
2.7
|
2.4
|
|
US unemployment4
|
4.1
|
5.1
|
5.7
|
5.2
|
4.9
|
|
US HPI5
|
6.5
|
(2.7)
|
1.0
|
4.1
|
3.5
|
|
US federal funds rate6
|
5.1
|
3.4
|
2.3
|
2.3
|
2.7
|
|
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
|
UK GDP1
|
1.0
|
3.0
|
3.7
|
2.9
|
2.4
|
|
UK unemployment2
|
4.3
|
3.8
|
3.4
|
3.5
|
3.5
|
|
UK HPI3
|
2.8
|
11.9
|
8.4
|
5.1
|
4.1
|
|
UK bank rate6
|
5.1
|
3.9
|
2.9
|
2.8
|
2.8
|
|
US GDP1
|
2.7
|
2.8
|
3.1
|
2.8
|
2.8
|
|
US unemployment4
|
4.1
|
3.8
|
3.5
|
3.5
|
3.5
|
|
US HPI5
|
6.5
|
6.2
|
4.7
|
4.8
|
4.9
|
|
US federal funds rate6
|
5.1
|
3.7
|
3.3
|
3.1
|
2.8
|
|
|
|
|
|
|
|
|
Upside 1
|
|
|
|
|
|
|
UK GDP1
|
1.0
|
2.2
|
2.6
|
2.2
|
2.0
|
|
UK unemployment2
|
4.3
|
4.1
|
4.0
|
4.0
|
4.0
|
|
UK HPI3
|
2.8
|
7.6
|
4.9
|
4.8
|
3.5
|
|
UK bank rate6
|
5.1
|
4.1
|
3.5
|
3.4
|
3.3
|
|
US GDP1
|
2.7
|
2.4
|
2.6
|
2.4
|
2.4
|
|
US unemployment4
|
4.1
|
4.0
|
3.9
|
3.9
|
3.9
|
|
US HPI5
|
6.5
|
4.4
|
3.7
|
3.9
|
3.9
|
|
US federal funds rate6
|
5.1
|
4.0
|
3.8
|
3.6
|
3.3
|
|
1
|
Average Real GDP seasonally adjusted change in year.
|
|
2
|
Average UK unemployment rate 16-year+.
|
|
3
|
Change in year end UK HPI = Halifax All Houses, All Buyers index,
relative to prior year end.
|
|
4
|
Average US civilian unemployment rate 16-year+.
|
|
5
|
Change in year end US HPI = FHFA House Price Index, relative to
prior year end.
|
|
6
|
Average rate.
|
|
Scenario weighting
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
|
|
%
|
%
|
%
|
%
|
%
|
|
As at 31.12.25
|
|
|
|
|
|
|
Scenario weighting
|
14.4
|
27.4
|
38.5
|
12.7
|
7.0
|
|
As at 31.12.24
|
|
|
|
|
|
|
Scenario weighting
|
17.4
|
26.8
|
32.5
|
14.7
|
8.6
|
|
Macroeconomic variables (specific
bases)1
|
|||||
|
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
|
As at 31.12.25
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP2
|
14.5
|
10.8
|
1.4
|
(0.3)
|
(3.5)
|
|
UK unemployment3
|
3.8
|
4.3
|
4.8
|
6.5
|
8.1
|
|
UK HPI4
|
34.6
|
24.9
|
3.0
|
(12.6)
|
(28.0)
|
|
UK bank rate3
|
2.3
|
2.8
|
3.6
|
4.6
|
4.6
|
|
US GDP2
|
14.6
|
12.4
|
2.0
|
(0.2)
|
(4.6)
|
|
US unemployment3
|
3.7
|
4.1
|
4.4
|
6.6
|
8.8
|
|
US HPI4
|
26.2
|
19.3
|
2.4
|
(1.5)
|
(8.1)
|
|
US federal funds rate3
|
2.5
|
2.8
|
3.5
|
4.3
|
4.3
|
|
As at 31.12.24
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP2
|
15.0
|
11.6
|
1.4
|
0.2
|
(2.9)
|
|
UK unemployment3
|
3.4
|
3.9
|
4.4
|
6.5
|
8.4
|
|
UK HPI4
|
36.3
|
25.9
|
3.0
|
(11.3)
|
(26.8)
|
|
UK bank rate3
|
2.8
|
3.3
|
4.2
|
5.3
|
5.3
|
|
US GDP2
|
14.9
|
12.8
|
2.2
|
0.4
|
(2.1)
|
|
US unemployment3
|
3.5
|
3.8
|
4.2
|
5.9
|
7.5
|
|
US HPI4
|
30.1
|
24.4
|
3.5
|
1.1
|
(4.0)
|
|
US federal funds rate3
|
2.8
|
3.3
|
4.2
|
5.3
|
5.3
|
|
1
|
UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK
unemployment rate 16-year+; UK HPI (31.12.24) = Halifax All Houses,
All Buyers Index; UK HPI (31.12.25) = Halifax HPI Meth2 All Houses,
All Buyers index; US GDP = Real GDP growth seasonally adjusted; US
unemployment = US civilian unemployment rate 16-year+; US HPI =
FHFA House Price Index. 20 quarter period starts from Q125 (2024:
Q124).
|
|
2
|
Maximum growth relative to Q424 (2024: Q423), based on 20 quarter
period in Upside scenarios; 5-year yearly average CAGR in Baseline;
minimum growth relative to Q424 (2024: Q423), based on 20 quarter
period in Downside scenarios.
|
|
3
|
Lowest quarter in 20 quarter period in Upside scenarios; 5-year
average in Baseline; highest quarter 20 quarter period in Downside
scenarios.
|
|
4
|
Maximum growth relative to Q424 (2024: Q423), based on 20 quarter
period in Upside scenarios; 5-year quarter end CAGR in Baseline;
minimum growth relative to Q424 (2024: Q423), based on 20 quarter
period in Downside scenarios.
|
|
Macroeconomic variables (5-year
averages)1
|
|||||
|
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
|
As at 31.12.25
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP2
|
2.7
|
2.0
|
1.4
|
0.9
|
0.3
|
|
UK unemployment3
|
4.1
|
4.5
|
4.8
|
5.5
|
6.2
|
|
UK HPI4
|
6.1
|
4.5
|
3.0
|
0.6
|
(2.0)
|
|
UK bank rate3
|
2.9
|
3.2
|
3.6
|
2.7
|
1.7
|
|
US GDP2
|
2.7
|
2.4
|
2.0
|
1.1
|
0.1
|
|
US unemployment3
|
3.9
|
4.1
|
4.4
|
5.4
|
6.3
|
|
US HPI4
|
4.8
|
3.6
|
2.4
|
1.9
|
1.5
|
|
US federal funds rate3
|
2.9
|
3.2
|
3.5
|
3.1
|
2.5
|
|
As at 31.12.24
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP2
|
2.6
|
2.0
|
1.4
|
0.9
|
0.5
|
|
UK unemployment3
|
3.7
|
4.0
|
4.4
|
5.3
|
6.1
|
|
UK HPI4
|
6.4
|
4.7
|
3.0
|
0.8
|
(1.6)
|
|
UK bank rate3
|
3.5
|
3.9
|
4.2
|
3.3
|
2.4
|
|
US GDP2
|
2.9
|
2.5
|
2.2
|
1.7
|
1.2
|
|
US unemployment3
|
3.7
|
3.9
|
4.2
|
5.0
|
5.8
|
|
US HPI4
|
5.4
|
4.5
|
3.5
|
2.4
|
1.2
|
|
US federal funds rate3
|
3.6
|
4.0
|
4.2
|
3.2
|
2.1
|
|
1
|
UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK
unemployment rate 16-year+; UK HPI (31.12.24) = Halifax All Houses,
All Buyers Index; UK HPI (31.12.25) = Halifax HPI Meth2 All Houses,
All Buyers index; US GDP = Real GDP growth seasonally adjusted; US
unemployment = US civilian unemployment rate 16-year+; US HPI =
FHFA House Price Index. 20 quarter period starts from Q125 (2024:
Q124).
|
|
2
|
5-year yearly average CAGR, starting 2024 (2024:
2023).
|
|
3
|
5-year average. Period based on 20 quarters from Q125 (2024:
Q124).
|
|
4
|
5-year quarter end CAGR, starting Q424 (2024: Q423).
|
|
|
Scenarios
|
|||||
|
As at 31.12.25
|
Weighted1
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
|
Stage 1 Model Exposure (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
149,004
|
151,314
|
150,144
|
148,760
|
146,786
|
144,360
|
|
Retail credit cards2
|
61,320
|
61,096
|
61,204
|
61,325
|
61,569
|
61,724
|
|
Retail other
|
6,260
|
6,378
|
6,326
|
6,268
|
6,106
|
5,927
|
|
Corporate loans2
|
220,292
|
222,057
|
221,337
|
220,646
|
218,634
|
213,827
|
|
Stage 1 Model ECL (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
3
|
1
|
2
|
2
|
6
|
13
|
|
Retail credit cards2
|
561
|
523
|
541
|
561
|
599
|
637
|
|
Retail other
|
32
|
30
|
31
|
31
|
35
|
38
|
|
Corporate loans2
|
231
|
201
|
212
|
221
|
274
|
329
|
|
Stage 1 Coverage (%)
|
|
|
|
|
|
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Retail credit cards
|
0.9
|
0.9
|
0.9
|
0.9
|
1.0
|
1.0
|
|
Retail other
|
0.5
|
0.5
|
0.5
|
0.5
|
0.6
|
0.6
|
|
Corporate loans
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.2
|
|
Stage 2 Model Exposure (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
13,586
|
11,276
|
12,446
|
13,830
|
15,804
|
18,230
|
|
Retail credit cards2
|
5,307
|
5,133
|
5,224
|
5,301
|
5,478
|
5,759
|
|
Retail other
|
1,164
|
1,046
|
1,098
|
1,156
|
1,318
|
1,497
|
|
Corporate loans2
|
18,172
|
16,264
|
17,037
|
17,836
|
19,979
|
24,927
|
|
Stage 2 Model ECL (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
16
|
6
|
8
|
11
|
33
|
79
|
|
Retail credit cards2
|
1,183
|
1,099
|
1,138
|
1,175
|
1,277
|
1,415
|
|
Retail other
|
81
|
67
|
72
|
77
|
102
|
134
|
|
Corporate loans2
|
477
|
383
|
415
|
454
|
604
|
879
|
|
Stage 2 Coverage (%)
|
|
|
|
|
|
|
|
Retail mortgages
|
0.1
|
0.1
|
0.1
|
0.1
|
0.2
|
0.4
|
|
Retail credit cards
|
22.3
|
21.4
|
21.8
|
22.2
|
23.3
|
24.6
|
|
Retail other
|
7.0
|
6.4
|
6.6
|
6.7
|
7.7
|
9.0
|
|
Corporate loans
|
2.6
|
2.4
|
2.4
|
2.5
|
3.0
|
3.5
|
|
Stage 3 Model Exposure
(£m)3
|
|
|
|
|
|
|
|
Retail mortgages
|
1,621
|
1,621
|
1,621
|
1,621
|
1,621
|
1,621
|
|
Retail credit cards2
|
2,158
|
2,158
|
2,158
|
2,158
|
2,158
|
2,158
|
|
Retail other
|
128
|
128
|
128
|
128
|
128
|
128
|
|
Corporate loans2
|
3,650
|
3,650
|
3,650
|
3,650
|
3,650
|
3,650
|
|
Stage 3 Model ECL (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
43
|
32
|
35
|
38
|
59
|
98
|
|
Retail credit cards2
|
1,592
|
1,548
|
1,573
|
1,596
|
1,632
|
1,663
|
|
Retail other
|
79
|
76
|
77
|
77
|
80
|
87
|
|
Corporate loans2,4
|
60
|
57
|
57
|
59
|
64
|
71
|
|
Stage 3 Coverage (%)
|
|
|
|
|
|
|
|
Retail mortgages
|
2.7
|
2.0
|
2.2
|
2.3
|
3.6
|
6.0
|
|
Retail credit cards
|
73.8
|
71.7
|
72.9
|
74.0
|
75.6
|
77.1
|
|
Retail other
|
61.7
|
59.4
|
60.2
|
60.2
|
62.5
|
68.0
|
|
Corporate loans4
|
1.6
|
1.6
|
1.6
|
1.6
|
1.8
|
1.9
|
|
Total Model ECL (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
62
|
39
|
45
|
51
|
98
|
190
|
|
Retail credit cards2
|
3,336
|
3,170
|
3,252
|
3,332
|
3,508
|
3,715
|
|
Retail other
|
192
|
173
|
180
|
185
|
217
|
259
|
|
Corporate loans2,4
|
768
|
641
|
684
|
734
|
942
|
1,279
|
|
Total Model ECL
|
4,358
|
4,023
|
4,161
|
4,302
|
4,765
|
5,443
|
|
Reconciliation to total ECL
|
£m
|
|
Total weighted model ECL
|
4,358
|
|
ECL from individually assessed exposures4
|
672
|
|
ECL from benchmarked exposures and others5
|
542
|
|
ECL from debt securities at amortised cost
|
22
|
|
ECL from held for sale assets (co-branded card
portfolio)
|
(235)
|
|
ECL from post model management adjustments
|
368
|
|
Of which: ECL from economic uncertainty adjustments
|
114
|
|
Total ECL
|
5,727
|
|
1
|
Model exposures are allocated to a stage based on an individual
scenario rather than a probability-weighted approach as required
for Barclays reported impairment allowances. As a result, it is not
possible to back solve the final reported weighted ECL from
individual scenarios given balances may be assigned to a different
stage dependent on the scenario.
|
|
2
|
Model exposure and ECL reported within Retail credit cards and
Corporate loans continue to include a co-branded card portfolio in
USCB, classified as assets held for sale.
|
|
3
|
Model exposures allocated to Stage 3 do not change in any of the
scenarios as the transition criteria relies only on observable
evidence of default as at 31 December 2025 and not on the
macroeconomic scenario.
|
|
4
|
Material corporate loan defaults are individually assessed across
different recovery strategies. As a result, ECL of £672m is
reported as an individually assessed impairment in the
reconciliation table.
|
|
5
|
ECL from benchmarked exposures and others includes ECL on Tesco
Bank of £400m calculated using a benchmarked approach based on
UK cards and UK retail loans. The sensitivity of these exposures
would materially reflect the sensitivity of the benchmarked
model.
|
|
|
Scenarios1
|
|||||
|
As at 31.12.24
|
Weighted2
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
|
Stage 1 Model Exposure (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
139,086
|
140,828
|
140,079
|
139,188
|
136,671
|
134,861
|
|
Retail credit cards
|
63,937
|
63,821
|
63,859
|
63,894
|
63,980
|
63,975
|
|
Retail other
|
7,952
|
8,074
|
8,025
|
7,968
|
7,804
|
7,614
|
|
Corporate loans
|
213,905
|
216,064
|
215,215
|
214,293
|
212,007
|
207,062
|
|
Stage 1 Model ECL (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
1
|
—
|
1
|
1
|
3
|
6
|
|
Retail credit cards
|
535
|
512
|
523
|
534
|
560
|
586
|
|
Retail other
|
34
|
32
|
32
|
33
|
36
|
40
|
|
Corporate loans
|
270
|
235
|
247
|
258
|
311
|
363
|
|
Stage 1 Coverage (%)
|
|
|
|
|
|
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Retail credit cards
|
0.8
|
0.8
|
0.8
|
0.8
|
0.9
|
0.9
|
|
Retail other
|
0.4
|
0.4
|
0.4
|
0.4
|
0.5
|
0.5
|
|
Corporate loans
|
0.1
|
0.1
|
0.1
|
0.1
|
0.1
|
0.2
|
|
Stage 2 Model Exposure (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
20,401
|
18,178
|
19,072
|
20,134
|
23,359
|
26,339
|
|
Retail credit cards
|
6,904
|
6,747
|
6,817
|
6,889
|
7,052
|
7,310
|
|
Retail other
|
1,232
|
1,110
|
1,159
|
1,215
|
1,380
|
1,570
|
|
Corporate loans
|
21,197
|
18,889
|
19,793
|
20,827
|
23,238
|
28,340
|
|
Stage 2 Model ECL (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
4
|
1
|
2
|
3
|
8
|
16
|
|
Retail credit cards
|
1,473
|
1,387
|
1,422
|
1,459
|
1,567
|
1,714
|
|
Retail other
|
81
|
68
|
72
|
77
|
101
|
134
|
|
Corporate loans
|
532
|
424
|
461
|
505
|
655
|
932
|
|
Stage 2 Coverage (%)
|
|
|
|
|
|
|
|
Retail mortgages
|
—
|
—
|
—
|
—
|
—
|
0.1
|
|
Retail credit cards
|
21.3
|
20.6
|
20.9
|
21.2
|
22.2
|
23.4
|
|
Retail other
|
6.6
|
6.1
|
6.2
|
6.3
|
7.3
|
8.5
|
|
Corporate loans
|
2.5
|
2.2
|
2.3
|
2.4
|
2.8
|
3.3
|
|
Stage 3 Model Exposure
(£m)3
|
|
|
|
|
|
|
|
Retail mortgages
|
1,062
|
1,062
|
1,062
|
1,062
|
1,062
|
1,062
|
|
Retail credit cards
|
2,197
|
2,197
|
2,197
|
2,197
|
2,197
|
2,197
|
|
Retail other
|
158
|
158
|
158
|
158
|
158
|
158
|
|
Corporate loans
|
4,051
|
4,051
|
4,051
|
4,051
|
4,051
|
4,051
|
|
Stage 3 Model ECL (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
19
|
12
|
14
|
17
|
29
|
41
|
|
Retail credit cards
|
1,625
|
1,585
|
1,606
|
1,627
|
1,663
|
1,695
|
|
Retail other
|
92
|
90
|
91
|
92
|
95
|
97
|
|
Corporate loans4
|
71
|
66
|
67
|
69
|
79
|
89
|
|
Stage 3 Coverage (%)
|
|
|
|
|
|
|
|
Retail mortgages
|
1.8
|
1.1
|
1.3
|
1.6
|
2.7
|
3.9
|
|
Retail credit cards
|
74.0
|
72.1
|
73.1
|
74.1
|
75.7
|
77.2
|
|
Retail other
|
58.2
|
57.0
|
57.6
|
58.2
|
60.1
|
61.4
|
|
Corporate loans4
|
1.8
|
1.6
|
1.7
|
1.7
|
2.0
|
2.2
|
|
Total Model ECL (£m)
|
|
|
|
|
|
|
|
Retail mortgages
|
24
|
13
|
17
|
21
|
40
|
63
|
|
Retail credit cards
|
3,633
|
3,484
|
3,551
|
3,620
|
3,790
|
3,995
|
|
Retail other
|
207
|
190
|
195
|
202
|
232
|
271
|
|
Corporate loans4
|
873
|
725
|
775
|
832
|
1,045
|
1,384
|
|
Total Model ECL
|
4,737
|
4,412
|
4,538
|
4,675
|
5,107
|
5,713
|
|
Reconciliation to total ECL
|
£m
|
|
Total weighted model ECL
|
4,737
|
|
ECL from individually assessed exposures4
|
461
|
|
ECL from benchmarked exposures and others5
|
358
|
|
ECL from debt securities at amortised cost
|
23
|
|
ECL from held for sale assets (co-branded card
portfolio)
|
(282)
|
|
ECL from post model management adjustments
|
235
|
|
Of which: ECL from economic uncertainty adjustments
|
78
|
|
Total ECL
|
5,532
|
|
1
|
Model exposure and ECL reported within Retail credit cards and
Retail Other excludes the German consumer finance business, sale of
which completed after the balance sheet date. Model exposure and
ECL reported within Retail credit cards and Corporate loans
continue to include a co-branded card portfolio, as its sale is
expected to close in 2026.
|
|
2
|
Model exposures are allocated to a stage based on an individual
scenario rather than a probability-weighted approach as required
for Barclays reported impairment allowances. As a result, it is not
possible to back solve the final reported weighted ECL from
individual scenarios given balances may be assigned to a different
stage dependent on the scenario.
|
|
3
|
Model exposures allocated to Stage 3 do not change in any of the
scenarios as the transition criteria relies only on observable
evidence of default as at 31 December 2024 and not on the
macroeconomic scenario.
|
|
4
|
Material corporate loan defaults are individually assessed across
different recovery strategies. As a result, ECL of £461m is
reported as an individually assessed impairment in the
reconciliation table.
|
|
5
|
ECL from benchmarked exposures and others includes ECL on Tesco
Bank of £209m calculated using a benchmarked approach based on
UK cards and UK retail loans. The sensitivity of these exposures
would materially reflect the sensitivity of the benchmarked
model.
|
|
|
Barclays UK
|
|
|
Home loans principal portfolios
|
As at 31.12.25
|
As at 31.12.24
|
|
Gross loans and advances (£m)
|
172,415
|
163,197
|
|
90 day arrears rate, excluding recovery book (%)
|
0.1
|
0.2
|
|
Annualised gross charge-off rates - 180 days past due
(%)
|
0.5
|
0.5
|
|
Recovery book proportion of outstanding balances (%)
|
0.6
|
0.6
|
|
Recovery book impairment coverage ratio (%)1
|
4.3
|
3.7
|
|
|
|
|
|
Average marked to market LTV
|
|
|
|
Balance weighted %
|
55.2
|
53.0
|
|
Valuation weighted %
|
41.5
|
39.7
|
|
|
|
|
|
New lending
|
Year ended 31.12.25
|
Year ended 31.12.24
|
|
New home loan bookings (£m)
|
34,326
|
23,895
|
|
New home loan proportion > 90% LTV (%)
|
2.8
|
0.9
|
|
Average LTV on new home loans: balance weighted (%)
|
69.6
|
65.5
|
|
Average LTV on new home loans: valuation weighted (%)
|
61.1
|
56.3
|
|
1
|
Recovery Book Impairment Coverage Ratio excludes Kensington
Mortgages Company.
|
|
|
Distribution of balances
|
Distribution of impairment allowance
|
Coverage ratio
|
|||||||||
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
Barclays UK
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
|
As at 31.12.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<=75%
|
73.4
|
6.9
|
0.9
|
81.2
|
3.3
|
14.1
|
49.9
|
67.3
|
—
|
0.1
|
2.5
|
—
|
|
>75% and <=90%
|
16.0
|
1.0
|
0.1
|
17.1
|
4.3
|
6.3
|
11.7
|
22.3
|
—
|
0.3
|
7.3
|
0.1
|
|
>90% and <=100%
|
1.7
|
—
|
—
|
1.7
|
0.8
|
0.5
|
5.4
|
6.7
|
—
|
0.7
|
22.7
|
0.2
|
|
>100%
|
—
|
—
|
—
|
—
|
—
|
0.1
|
3.6
|
3.7
|
—
|
2.9
|
31.3
|
5.9
|
|
As at 31.12.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<=75%
|
74.5
|
10.7
|
0.9
|
86.1
|
8.3
|
15.8
|
18.7
|
42.8
|
—
|
0.1
|
1.8
|
—
|
|
>75% and <=90%
|
11.8
|
1.2
|
0.1
|
13.1
|
10.2
|
24.2
|
9.7
|
44.1
|
0.1
|
1.7
|
13.0
|
0.3
|
|
>90% and <=100%
|
0.8
|
—
|
—
|
0.8
|
1.3
|
2.3
|
4.0
|
7.6
|
0.1
|
4.9
|
35.8
|
0.8
|
|
>100%
|
—
|
—
|
—
|
—
|
0.2
|
1.4
|
3.9
|
5.5
|
1.6
|
45.9
|
68.7
|
24.8
|
|
1
|
Portfolio marked to market based on the most updated valuation
including recovery book balances. Updated valuations reflect the
application of the latest HPI available as at 31 December
2025.
|
|
Principal portfolios
|
Gross exposure
|
30 day arrears
rate, excluding
recovery book
|
90 day arrears
rate, excluding
recovery book
|
Annualised
gross write-off
rate
|
Annualised net
write-off rate
|
|
As at 31.12.25
|
£m
|
%
|
%
|
%
|
%
|
|
Barclays UK
|
|
|
|
|
|
|
UK cards1
|
17,169
|
0.8
|
0.2
|
1.0
|
0.8
|
|
UK personal loans1
|
8,515
|
1.1
|
0.5
|
0.7
|
0.6
|
|
Barclays Partner Finance
|
1,210
|
0.7
|
0.3
|
1.2
|
1.2
|
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
US cards2
|
29,100
|
3.0
|
1.6
|
3.4
|
3.2
|
|
|
|
|
|
|
|
|
As at 31.12.24
|
|
|
|
|
|
|
Barclays UK
|
|
|
|
|
|
|
UK cards1
|
15,781
|
0.7
|
0.2
|
1.1
|
0.9
|
|
UK personal loans1
|
8,051
|
1.0
|
0.4
|
0.7
|
0.5
|
|
Barclays Partner Finance
|
1,609
|
0.6
|
0.3
|
1.0
|
1.0
|
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
US cards2
|
28,548
|
3.0
|
1.6
|
3.8
|
3.7
|
|
1
|
Includes Tesco Bank. Tesco Bank arrears rates are calculated using
POCI balances adjusted to fair value.
|
|
2
|
Includes a co-branded card portfolio in USCB, classified as held
for sale (see table below).
|
|
Retail Credit Cards and Retail Other held for sale
|
Gross exposure
|
30 day arrears rate, excluding recovery book
|
90 day arrears rate, excluding recovery book
|
Annualised gross write-off rate
|
Annualised net write-off rate
|
|
As at 31.12.25
|
£m
|
%
|
%
|
%
|
%
|
|
Barclays US Consumer Bank
|
5,988
|
1.8
|
0.9
|
2.1
|
1.9
|
|
|
|
|
|
|
|
|
As at 31.12.24
|
|
|
|
|
|
|
Barclays US Consumer Bank
|
6,241
|
1.3
|
0.5
|
2.0
|
2.0
|
|
Head Office - German consumer finance business
|
3,733
|
1.8
|
0.9
|
1.3
|
1.2
|
|
Loans and advances to customers classified as assets held for
sale
|
|||||||||||||||
|
|
Stage 1
|
|
Stage 2
|
|
Stage 3
|
|
Total
|
||||||||
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
As at 31.12.25
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
Retail credit cards - US
|
5,468
|
65
|
1.2
|
|
466
|
124
|
26.6
|
|
54
|
44
|
81.5
|
|
5,988
|
233
|
3.9
|
|
Retail credit cards - Germany
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Retail other - Germany
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Corporate loans - US
|
43
|
1
|
2.3
|
|
6
|
2
|
33.3
|
|
—
|
—
|
—
|
|
49
|
3
|
6.1
|
|
Total Rest of the World
|
5,511
|
66
|
1.2
|
|
472
|
126
|
26.7
|
|
54
|
44
|
81.5
|
|
6,037
|
236
|
3.9
|
|
As at 31.12.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail credit cards - US
|
5,495
|
64
|
1.2
|
|
689
|
161
|
23.4
|
|
57
|
46
|
80.7
|
|
6,241
|
271
|
4.3
|
|
Retail credit cards - Germany
|
1,908
|
18
|
0.9
|
|
307
|
29
|
9.4
|
|
93
|
69
|
74.2
|
|
2,308
|
116
|
5.0
|
|
Retail other - Germany
|
1,134
|
16
|
1.4
|
|
220
|
33
|
15.0
|
|
71
|
48
|
67.6
|
|
1,425
|
97
|
6.8
|
|
Corporate loans - US
|
49
|
1
|
2.0
|
|
9
|
3
|
33.3
|
|
1
|
1
|
100.0
|
|
59
|
5
|
8.5
|
|
Total Rest of the World
|
8,586
|
99
|
1.2
|
|
1,225
|
226
|
18.4
|
|
222
|
164
|
73.9
|
|
10,033
|
489
|
4.9
|
|
Management adjustments to models for impairment allowance presented
by product
|
||||||
|
|
Impairment
allowance pre
management adjustments
|
Economic
uncertainty
adjustments1
|
Other
adjustments
|
Management
adjustments
|
Total
impairment
allowance
|
Proportion of
Management
adjustments to
total
impairment
allowance
|
|
|
|
|
|
|
|
|
|
As at 31.12.25
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
|
Retail credit cards - US
|
232
|
5
|
—
|
5
|
237
|
2.1
|
|
Retail credit cards - Germany
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Retail other - Germany
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Corporate loans - US
|
3
|
—
|
—
|
—
|
3
|
—
|
|
Total Rest of the World
|
235
|
5
|
—
|
5
|
240
|
2.1
|
|
|
|
|
|
|
|
|
|
As at 31.12.24
|
£m
|
£m
|
£m
|
£m
|
£m
|
%
|
|
Retail credit cards - US
|
277
|
—
|
—
|
—
|
277
|
—
|
|
Retail credit cards - Germany
|
101
|
—
|
16
|
16
|
117
|
13.7
|
|
Retail other - Germany
|
80
|
—
|
17
|
17
|
97
|
17.5
|
|
Corporate loans - US
|
5
|
—
|
—
|
—
|
5
|
—
|
|
Total Rest of the World
|
463
|
—
|
33
|
33
|
496
|
6.7
|
|
1
|
Reflects a Stage 2 adjustment for elevated US macroeconomic
uncertainty; with impacts yet to materialise in consumer
behaviour.
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended 31.12.25
|
|
Year ended 31.12.24
|
|
||||
|
|
Average
|
High
|
Low
|
|
Average
|
High
|
Low
|
|
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
|
|
Credit risk
|
15
|
21
|
11
|
|
21
|
27
|
17
|
|
|
Interest rate risk
|
15
|
25
|
5
|
|
15
|
25
|
7
|
|
|
Equity risk
|
7
|
14
|
4
|
|
6
|
12
|
2
|
|
|
Basis risk
|
6
|
9
|
4
|
|
5
|
8
|
4
|
|
|
Spread risk
|
5
|
7
|
3
|
|
5
|
7
|
3
|
|
|
Foreign exchange risk
|
5
|
10
|
3
|
|
4
|
9
|
2
|
|
|
Commodity risk
|
—
|
1
|
—
|
|
—
|
1
|
—
|
|
|
Inflation risk
|
5
|
8
|
3
|
|
4
|
5
|
2
|
|
|
Diversification effect1
|
(40)
|
n/a
|
n/a
|
|
(34)
|
n/a
|
n/a
|
|
|
Total management VaR
|
18
|
30
|
8
|
|
26
|
36
|
15
|
|
|
1
|
Diversification effects recognise that forecast losses from
different assets or businesses are unlikely to occur concurrently,
hence the expected aggregate loss is lower than the sum of the
expected losses from each area. Historical correlations between
losses are taken into account in making these assessments. The high
and low VaR figures reported for each category did not necessarily
occur on the same day as the high and low total management VaR.
Consequently, a diversification effect balance for the high and low
VaR figures would not be meaningful and is therefore omitted from
the above table.
|
|
Liquidity coverage
ratio1
|
As at 31.12.25
|
As at 31.12.24
|
|
|
£bn
|
£bn
|
|
LCR Eligible High Quality Liquid Assets (HQLA)
|
321.4
|
304.4
|
|
Net stress outflows
|
(190.2)
|
(176.9)
|
|
Surplus
|
131.2
|
127.5
|
|
|
|
|
|
Liquidity coverage ratio
|
170.0%
|
172.4%
|
|
1
|
Represents the average of the last 12 spot month end ratios. In
June 2025, Barclays implemented a new methodology for calculating
net stress outflows related to secured financing transactions in
the liquidity coverage ratio.
|
|
Net Stable Funding
Ratio2
|
As at 31.12.25
|
As at 31.12.24
|
|
|
£bn
|
£bn
|
|
Total Available Stable Funding
|
639.4
|
629.6
|
|
Total Required Stable Funding
|
473.1
|
466.7
|
|
Surplus
|
166.3
|
162.9
|
|
|
|
|
|
Net Stable Funding Ratio
|
135.2%
|
134.9%
|
|
2
|
Represents average of the last four spot quarter end
ratios.
|
|
Composition of the Group liquidity pool
|
|
|
|
|
|
|
|
|
|
|
LCR eligible1
High Quality Liquid Assets
(HQLA)
|
|
Liquidity pool
|
|||||
|
|
Cash
|
Level 1
|
Level 2A
|
Level 2B
|
Total
|
|
2025
|
2024
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
|
Cash and deposits with central
banks2
|
219
|
|
|
|
219
|
|
237
|
216
|
|
|
|
|
|
|
|
|
|
|
|
Government bonds3
|
|
|
|
|
|
|
|
|
|
AAA to AA-
|
|
55
|
7
|
|
62
|
|
62
|
55
|
|
A+ to A-
|
|
14
|
|
|
14
|
|
14
|
2
|
|
BBB+ to BBB-
|
|
2
|
|
|
2
|
|
2
|
1
|
|
Other LCR Ineligible Government bonds
|
|
|
|
|
|
|
|
|
|
Total government bonds
|
|
71
|
7
|
|
78
|
|
78
|
58
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
|
|
|
Government Guaranteed Issuers, PSEs and GSEs
|
|
4
|
|
|
4
|
|
7
|
9
|
|
International Organisations and MDBs
|
|
7
|
|
|
7
|
|
7
|
7
|
|
Covered bonds
|
|
3
|
4
|
|
7
|
|
8
|
7
|
|
Other
|
|
|
|
5
|
5
|
|
1
|
|
|
Total other
|
|
14
|
4
|
5
|
23
|
|
23
|
23
|
|
|
|
|
|
|
|
|
|
|
|
Total as at 31 December 2025
|
219
|
85
|
11
|
5
|
320
|
|
338
|
|
|
Total as at 31 December 2024
|
196
|
74
|
9
|
2
|
281
|
|
|
297
|
|
1
|
The LCR eligible HQLA is adjusted under the Liquidity Coverage
Ratio (CRR) Part of the PRA Rulebook for operational restrictions
upon consolidation, such as trapped liquidity within Barclays
subsidiaries. It also reflects differences in eligibility of assets
between the LCR and Barclays’ Liquidity Pool.
|
|
2
|
Includes cash held at central banks and surplus cash at central
banks related to payment schemes. Over 99.5% (December 2024: over
98%) was placed with the Bank of England, US Federal Reserve,
European Central Bank, Bank of Japan and Swiss National
Bank.
|
|
3
|
Of which over 85% (December 2024: over 85%) comprised UK, US,
French, German, Japanese, Swiss and Dutch securities.
|
|
|
As at 31.12.25
|
|
As at 31.12.24
|
||
|
|
Loans and
advances, debt
securities at
amortised cost
|
Deposits at
amortised cost
|
Loan: deposit
ratio1
|
|
Loan: deposit
ratio1
|
|
Funding of loans and advances
|
£bn
|
£bn
|
%
|
|
%
|
|
Barclays UK
|
230
|
245
|
94
|
|
92
|
|
Barclays UK Corporate Bank
|
30
|
89
|
34
|
|
31
|
|
Barclays Private Bank and Wealth Management
|
15
|
72
|
21
|
|
21
|
|
Barclays Investment Bank
|
130
|
156
|
83
|
|
88
|
|
Barclays US consumer Bank
|
22
|
24
|
92
|
|
91
|
|
Head Office
|
3
|
—
|
|
|
|
|
Barclays Group
|
430
|
586
|
73
|
|
74
|
|
1
|
The loan: deposit ratio is calculated as loans and advances at
amortised cost and debt securities at amortised cost divided by
deposits at amortised cost.
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
Assets
|
£bn
|
£bn
|
|
Liabilities and equity
|
£bn
|
£bn
|
|
Loans and advances at amortised cost1
|
400
|
392
|
|
Deposits at amortised cost
|
586
|
561
|
|
Group liquidity pool
|
338
|
297
|
|
<1 Year wholesale funding
|
84
|
55
|
|
|
|
|
|
>1 Year wholesale funding
|
136
|
131
|
|
Reverse repurchase agreements, trading portfolio assets, cash
collateral and settlement balances
|
471
|
433
|
|
Repurchase agreements, trading portfolio liabilities, cash
collateral and settlement balances
|
359
|
358
|
|
Derivative financial instruments
|
252
|
294
|
|
Derivative financial instruments
|
241
|
279
|
|
Other assets2
|
83
|
102
|
|
Other liabilities
|
60
|
62
|
|
|
|
|
|
Equity
|
78
|
72
|
|
Total assets
|
1,544
|
1,518
|
|
Total liabilities and equity
|
1,544
|
1,518
|
|
1
|
Adjusted for liquidity pool debt securities reported at amortised
cost of £30bn (December 2024: £22bn).
|
|
2
|
Other assets include fair value assets that are not part of reverse
repurchase agreements or trading portfolio assets, and other asset
categories.
|
|
Maturity profile of wholesale
funding2
|
|
|
|
|
|
|
|
|
|||
|
|
<1 month
|
1-3 months
|
3-6 months
|
6-12 months
|
<1 year
|
1-2 years
|
2-3 years
|
3-4 years
|
4-5 years
|
>5 years
|
Total
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Barclays PLC (the Parent company)
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior unsecured (Public benchmark)
|
1.9
|
—
|
0.6
|
—
|
2.5
|
7.3
|
7.5
|
8.6
|
3.8
|
27.0
|
56.7
|
|
Senior unsecured (Privately placed)
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0.1
|
0.1
|
0.9
|
1.1
|
|
Subordinated liabilities
|
—
|
—
|
1.5
|
—
|
1.5
|
—
|
1.5
|
—
|
1.1
|
7.1
|
11.2
|
|
Barclays Bank Group
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior unsecured (Privately placed)3
|
2.7
|
5.8
|
5.5
|
9.5
|
23.5
|
12.9
|
12.1
|
9.9
|
8.0
|
20.3
|
86.7
|
|
Certificates of deposit and commercial paper
|
0.6
|
2.3
|
22.1
|
14.8
|
39.8
|
—
|
—
|
—
|
—
|
—
|
39.8
|
|
Asset backed commercial paper
|
2.3
|
8.9
|
1.1
|
—
|
12.3
|
—
|
—
|
—
|
—
|
—
|
12.3
|
|
Asset backed securities
|
—
|
—
|
0.4
|
0.1
|
0.5
|
0.2
|
1.3
|
0.1
|
0.1
|
2.7
|
4.9
|
|
Subordinated liabilities
|
—
|
—
|
—
|
0.4
|
0.4
|
0.3
|
0.1
|
—
|
—
|
0.3
|
1.1
|
|
Barclays Bank UK Group
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior unsecured (Privately placed)
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0.1
|
0.1
|
0.2
|
|
Certificates of deposit and commercial paper
|
2.9
|
—
|
—
|
—
|
2.9
|
—
|
—
|
—
|
—
|
—
|
2.9
|
|
Covered bonds
|
—
|
—
|
—
|
—
|
—
|
0.5
|
0.2
|
0.6
|
0.6
|
0.1
|
2.0
|
|
Asset backed securities
|
—
|
—
|
0.3
|
0.2
|
0.5
|
—
|
—
|
—
|
—
|
—
|
0.5
|
|
Subordinated liabilities
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0.7
|
0.7
|
|
Total as at 31 December 2025
|
10.4
|
17.0
|
31.5
|
25.0
|
83.9
|
21.2
|
22.7
|
19.3
|
13.8
|
59.2
|
220.1
|
|
Of which secured
|
2.3
|
8.9
|
1.8
|
0.3
|
13.3
|
0.7
|
1.5
|
0.7
|
0.7
|
3.5
|
20.4
|
|
Of which unsecured
|
8.1
|
8.1
|
29.7
|
24.7
|
70.6
|
20.5
|
21.2
|
18.6
|
13.1
|
55.7
|
199.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total as at 31 December 2024
|
7.9
|
21.3
|
11.9
|
13.9
|
55.0
|
23.0
|
17.5
|
18.6
|
15.1
|
56.8
|
186.0
|
|
Of which secured
|
2.4
|
8.8
|
2.1
|
0.8
|
14.1
|
1.1
|
0.5
|
0.9
|
0.6
|
3.3
|
20.5
|
|
Of which unsecured
|
5.5
|
12.5
|
9.8
|
13.1
|
40.9
|
21.9
|
17.0
|
17.7
|
14.5
|
53.5
|
165.5
|
|
1
|
Term funding comprises public benchmark and privately placed senior
unsecured notes, covered bonds, asset-backed securities and
subordinated debt where the original maturity of the instrument is
more than 1 year.
|
|
2
|
The composition of wholesale funds comprises the balance sheet
reported financial liabilities at fair value, debt securities in
issue and subordinated liabilities. It does not include
participation in the central bank facilities reported within
repurchase agreements and other similar secured
borrowing.
|
|
3
|
Includes structured notes of £73.5bn, of which £21.8bn
matures within one year.
|
|
Capital ratios1,2
|
As at 31.12.25
|
As at 30.09.25
|
As at 31.12.24
|
|
CET1
|
14.3%
|
14.1%
|
13.6%
|
|
T1
|
17.9%
|
17.8%
|
16.9%
|
|
Total regulatory capital
|
20.4%
|
20.4%
|
19.6%
|
|
MREL ratio as a percentage of total RWAs
|
35.8%
|
35.8%
|
34.4%
|
|
|
|
|
|
|
Own funds and eligible liabilities
|
£m
|
£m
|
£m
|
|
Total equity excluding non-controlling interests per the balance
sheet
|
77,784
|
76,394
|
71,821
|
|
Less: other equity instruments (recognised as AT1
capital)
|
(12,725)
|
(13,243)
|
(12,075)
|
|
Adjustment to retained earnings for foreseeable ordinary share
dividends
|
(778)
|
(478)
|
(786)
|
|
Adjustment to retained earnings for foreseeable repurchase of
shares
|
(271)
|
(477)
|
—
|
|
Adjustment to retained earnings for foreseeable other equity
coupons
|
(36)
|
(44)
|
(35)
|
|
|
|
|
|
|
Other regulatory adjustments and deductions
|
|
|
|
|
Additional value adjustments (PVA)
|
(1,956)
|
(1,941)
|
(2,051)
|
|
Goodwill and intangible assets
|
(8,255)
|
(8,228)
|
(8,272)
|
|
Deferred tax assets that rely on future profitability excluding
temporary differences
|
(1,069)
|
(1,225)
|
(1,451)
|
|
Fair value reserves related to gains or losses on cash flow
hedges
|
666
|
1,312
|
2,930
|
|
Excess of expected losses over impairment
|
(436)
|
(423)
|
(403)
|
|
Gains or losses on liabilities at fair value resulting from own
credit
|
904
|
988
|
981
|
|
Defined benefit pension fund assets
|
(2,398)
|
(2,261)
|
(2,367)
|
|
Direct and indirect holdings by an institution of own CET1
instruments
|
(14)
|
(3)
|
(1)
|
|
Adjustment under IFRS 9 transitional arrangements
|
—
|
—
|
138
|
|
Other regulatory adjustments
|
(346)
|
(117)
|
129
|
|
CET1 capital
|
51,070
|
50,254
|
48,558
|
|
|
|
|
|
|
AT1 capital
|
|
|
|
|
Capital instruments and related share premium accounts
|
12,758
|
13,289
|
12,108
|
|
Other regulatory adjustments and deductions
|
(33)
|
(46)
|
(32)
|
|
AT1 capital
|
12,725
|
13,243
|
12,076
|
|
|
|
|
|
|
T1 capital
|
63,795
|
63,498
|
60,634
|
|
|
|
|
|
|
T2 capital
|
|
|
|
|
Capital instruments and related share premium accounts
|
8,835
|
9,528
|
9,150
|
|
Qualifying T2 capital (including minority interests) issued by
subsidiaries
|
55
|
65
|
367
|
|
Other regulatory adjustments and deductions
|
(71)
|
(118)
|
(33)
|
|
Total regulatory capital
|
72,614
|
72,974
|
70,118
|
|
|
|
|
|
|
Less : Ineligible T2 capital (including minority interests) issued
by subsidiaries
|
(55)
|
(65)
|
(367)
|
|
Eligible liabilities
|
55,106
|
55,142
|
53,547
|
|
Total own funds and eligible
liabilities3
|
127,665
|
128,050
|
123,298
|
|
|
|
|
|
|
Total RWAs
|
356,774
|
357,378
|
358,127
|
|
1
|
2024 comparatives for Capital and RWAs have been calculated
applying the IFRS 9 transitional arrangements in accordance with
the CRR. Effective from 1 January 2025, the IFRS 9 transitional
arrangements no longer applied.
|
|
2
|
2024 comparatives for total capital were calculated applying the
grandfathering of certain capital instruments within Tier 2
capital. Effective from 29 June 2025, the grandfathered instruments
no longer qualified as Tier 2 capital.
|
|
3
|
As at 31 December 2025, the Group's MREL requirement, excluding the
institution-specific confidential PRA buffer, was to hold
£108.9bn of own funds and eligible liabilities equating to
30.5% of RWAs. The Group remains above its MREL regulatory
requirement including the institution-specific confidential PRA
buffer.
|
|
Movement in CET1 capital
|
Three months ended 31.12.25
|
Twelve months ended 31.12.25
|
|
|
£m
|
£m
|
|
Opening CET1 capital
|
50,254
|
48,558
|
|
|
|
|
|
Profit for the period attributable to equity holders
|
1,453
|
7,172
|
|
Own credit relating to derivative liabilities
|
—
|
(15)
|
|
Ordinary share dividends paid and foreseen
|
(300)
|
(1,200)
|
|
Purchased and foreseeable share repurchase
|
(500)
|
(2,500)
|
|
Other equity coupons paid and foreseen
|
(250)
|
(998)
|
|
Increase in retained regulatory capital generated from
earnings
|
403
|
2,459
|
|
|
|
|
|
Net impact of share schemes
|
4
|
190
|
|
Fair value through other comprehensive income reserve
|
296
|
773
|
|
Currency translation reserve
|
5
|
(1,132)
|
|
Other reserves
|
5
|
(68)
|
|
Increase/(Decrease) in other qualifying reserves
|
310
|
(237)
|
|
|
|
|
|
Pension remeasurements within reserves
|
117
|
(14)
|
|
Defined benefit pension fund asset deduction
|
(137)
|
(31)
|
|
Net impact of pensions
|
(20)
|
(45)
|
|
|
|
|
|
Additional value adjustments (PVA)
|
(15)
|
95
|
|
Goodwill and intangible assets
|
(27)
|
17
|
|
Deferred tax assets that rely on future profitability excluding
those arising from temporary differences
|
156
|
382
|
|
Excess of expected loss over impairment
|
(13)
|
(33)
|
|
Direct and indirect holdings by an institution of own CET1
instruments
|
(11)
|
(13)
|
|
Adjustment under IFRS 9 transitional arrangements
|
—
|
(138)
|
|
Other regulatory adjustments
|
33
|
25
|
|
Increase in regulatory capital due to adjustments and
deductions
|
123
|
335
|
|
|
|
|
|
Closing CET1 capital
|
51,070
|
51,070
|
|
●
|
£7.2bn
of capital generated from profit partially offset by distributions
of £4.7bn comprising:
|
|
|
|
-
|
£2.5bn share buybacks including the now completed £1.0bn
announced with FY24 results and £1.0bn announced with H125
results and the ongoing £0.5bn share buyback announced with
Q325 results
|
|
|
-
|
£1.2bn of ordinary share dividends paid and foreseen
reflecting £0.4bn interim dividend paid in September 2025 and
a £0.8bn accrual towards the FY25 dividend
|
|
|
-
|
£1.0bn of equity coupons paid and foreseen
|
|
●
|
£0.2bn decrease in other qualifying reserves including a
£1.1bn reduction in the currency translation reserve primarily
as a result of the strengthening of spot GBP against USD, partially
offset by a £0.8bn gain in the fair value through other
comprehensive income reserve.
|
|
RWAs by risk type and business
|
|||||||||||||
|
|
Credit risk
|
|
Counterparty credit risk
|
|
Market Risk
|
|
Operational risk
|
Total RWAs
|
|||||
|
|
STD
|
IRB
|
|
STD
|
IRB
|
Settlement Risk
|
CVA
|
|
STD
|
IMA
|
|
|
|
|
As at 31.12.25
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
£m
|
£m
|
|
Barclays UK
|
16,731
|
55,037
|
|
132
|
8
|
—
|
43
|
|
177
|
—
|
|
13,697
|
85,825
|
|
Barclays UK Corporate Bank
|
3,878
|
18,341
|
|
89
|
312
|
1
|
4
|
|
31
|
343
|
|
3,510
|
26,509
|
|
Barclays Private Bank & Wealth Management
|
4,981
|
580
|
|
112
|
19
|
—
|
11
|
|
39
|
240
|
|
2,054
|
8,036
|
|
Barclays Investment Bank
|
44,961
|
49,750
|
|
21,986
|
19,442
|
165
|
3,030
|
|
12,018
|
20,111
|
|
25,238
|
196,701
|
|
Barclays US Consumer Bank
|
21,050
|
1,004
|
|
—
|
1
|
—
|
—
|
|
—
|
—
|
|
5,393
|
27,448
|
|
Head Office
|
5,405
|
5,439
|
|
1
|
5
|
—
|
—
|
|
219
|
59
|
|
1,127
|
12,255
|
|
Barclays Group
|
97,006
|
130,151
|
|
22,320
|
19,787
|
166
|
3,088
|
|
12,484
|
20,753
|
|
51,019
|
356,774
|
|
As at 30.09.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
16,142
|
56,992
|
|
138
|
7
|
—
|
50
|
|
224
|
—
|
|
13,196
|
86,749
|
|
Barclays UK Corporate Bank
|
3,983
|
17,023
|
|
92
|
323
|
—
|
8
|
|
16
|
425
|
|
3,282
|
25,152
|
|
Barclays Private Bank & Wealth Management
|
4,907
|
615
|
|
127
|
17
|
—
|
11
|
|
33
|
298
|
|
1,870
|
7,878
|
|
Barclays Investment Bank
|
42,790
|
48,162
|
|
24,129
|
21,714
|
82
|
2,613
|
|
14,922
|
20,430
|
|
24,293
|
199,135
|
|
Barclays US Consumer Bank
|
19,976
|
962
|
|
—
|
2
|
—
|
—
|
|
—
|
—
|
|
4,856
|
25,796
|
|
Head Office
|
5,923
|
5,415
|
|
1
|
4
|
—
|
1
|
|
27
|
74
|
|
1,223
|
12,668
|
|
Barclays Group
|
93,721
|
129,169
|
|
24,487
|
22,067
|
82
|
2,683
|
|
15,222
|
21,227
|
|
48,720
|
357,378
|
|
As at 31.12.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
15,516
|
55,301
|
|
146
|
11
|
—
|
74
|
|
228
|
—
|
|
13,181
|
84,457
|
|
Barclays UK Corporate Bank
|
3,932
|
15,680
|
|
106
|
336
|
—
|
12
|
|
16
|
548
|
|
3,282
|
23,912
|
|
Barclays Private Bank & Wealth Management
|
5,058
|
434
|
|
118
|
31
|
—
|
16
|
|
44
|
330
|
|
1,859
|
7,890
|
|
Barclays Investment Bank
|
40,957
|
49,231
|
|
21,889
|
24,094
|
70
|
2,913
|
|
12,442
|
23,023
|
|
24,164
|
198,783
|
|
Barclays US Consumer Bank
|
21,019
|
966
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
|
4,864
|
26,849
|
|
Head Office
|
6,580
|
8,162
|
|
1
|
20
|
—
|
4
|
|
—
|
212
|
|
1,257
|
16,236
|
|
Barclays Group
|
93,062
|
129,774
|
|
22,260
|
24,492
|
70
|
3,019
|
|
12,730
|
24,113
|
|
48,607
|
358,127
|
|
Movement analysis of RWAs
|
Credit risk
|
Counterparty credit risk
|
Market risk
|
Operational risk
|
Total RWAs
|
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
RWAs as at 31.12.24
|
222,836
|
49,841
|
36,843
|
48,607
|
358,127
|
|
Book size
|
13,766
|
(1,994)
|
(3,031)
|
2,412
|
11,153
|
|
Acquisitions and disposals
|
(3,322)
|
—
|
—
|
—
|
(3,322)
|
|
Book quality
|
(1,888)
|
(618)
|
—
|
—
|
(2,506)
|
|
Model updates
|
304
|
68
|
—
|
—
|
372
|
|
Methodology and policy
|
(305)
|
(229)
|
—
|
—
|
(534)
|
|
Foreign exchange movements1
|
(4,234)
|
(1,707)
|
(575)
|
—
|
(6,516)
|
|
Total RWA movements
|
4,321
|
(4,480)
|
(3,606)
|
2,412
|
(1,353)
|
|
RWAs as at 31.12.25
|
227,157
|
45,361
|
33,237
|
51,019
|
356,774
|
|
1
|
Foreign exchange movements does not include the impact of foreign
exchange for modelled market risk or operational risk.
|
|
●
|
A £13.8bn increase in book size primarily reflecting lending
growth in UK businesses and business activity within
IB
|
|
●
|
A £3.3bn decrease in acquisitions and disposals reflecting the
sale of the German Consumer Finance business and of Barclays' joint
venture interest in Entercard, partially offset by the acquisition
of the GM portfolio
|
|
●
|
A £1.9bn decrease in book quality RWAs primarily driven by
improvements in credit quality within the Barclays UK mortgages
portfolio
|
|
●
|
A £4.2bn decrease as a result of foreign exchange movements
primarily due to the strengthening of spot GBP against
USD
|
|
●
|
A
£4.5bn decrease in the RWAs primarily reflecting trading
activity and the impact of foreign exchange movements due to the
strengthening of spot GBP against USD
|
|
●
|
A
£3.0bn decrease in book size due to trading activity within
Global Markets
|
|
●
|
A £2.4bn increase in book size primarily driven by the
inclusion of higher 2025 income compared to 2022
|
|
Leverage ratios1
|
As at 31.12.25
|
As at 30.09.25
|
As at 31.12.24
|
|
£m
|
£m
|
£m
|
|
|
UK leverage ratio2
|
5.1%
|
4.9%
|
5.0%
|
|
T1 capital
|
63,795
|
63,498
|
60,634
|
|
UK leverage exposure
|
1,247,313
|
1,285,291
|
1,206,502
|
|
Average UK leverage ratio
|
4.7%
|
4.7%
|
4.6%
|
|
Average T1 capital
|
63,277
|
62,556
|
60,291
|
|
Average UK leverage exposure
|
1,358,364
|
1,339,336
|
1,308,335
|
|
1
|
2024 comparatives for UK leverage ratios have been calculated
applying the IFRS 9 transitional arrangements in accordance with
the CRR. Effective from 1 January 2025, the IFRS 9 transitional
arrangements no longer applied.
|
|
2
|
Although the leverage ratio is expressed in terms of T1 capital,
the leverage ratio buffers and 75% of the minimum requirement must
be covered solely with CET1 capital. The CET1 capital held against
the 0.53% G-SII ALRB was £6.6bn and against the 0.3% CCLB was
£3.7bn.
|
|
Condensed consolidated income statement
|
||
|
|
Year ended 31.12.25
|
Year ended 31.12.24
|
|
|
£m
|
£m
|
|
Interest and similar income
|
36,189
|
38,326
|
|
Interest and similar expense
|
(21,688)
|
(25,390)
|
|
Net interest income
|
14,501
|
12,936
|
|
Fee and commission income
|
11,282
|
10,847
|
|
Fee and commission expense
|
(3,784)
|
(3,600)
|
|
Net fee and commission income
|
7,498
|
7,247
|
|
Net trading income
|
7,042
|
5,768
|
|
Net investment income
|
10
|
216
|
|
Gain on acquisition
|
—
|
556
|
|
Other income
|
89
|
65
|
|
Total income
|
29,140
|
26,788
|
|
|
|
|
|
Staff costs
|
(10,607)
|
(9,876)
|
|
Infrastructure, administration and general expenses
|
(6,433)
|
(6,319)
|
|
UK regulatory levies
|
(313)
|
(320)
|
|
Litigation and conduct
|
(392)
|
(220)
|
|
Operating expenses
|
(17,745)
|
(16,735)
|
|
|
|
|
|
Share of post-tax results of associates and joint
ventures
|
66
|
37
|
|
Loss on disposal of subsidiaries, associates and joint
ventures
|
(43)
|
—
|
|
Profit before impairment
|
11,418
|
10,090
|
|
Credit impairment charges
|
(2,279)
|
(1,982)
|
|
Profit before tax
|
9,139
|
8,108
|
|
Tax charge
|
(1,926)
|
(1,752)
|
|
Profit after tax
|
7,213
|
6,356
|
|
|
|
|
|
Attributable to:
|
|
|
|
Shareholders of the parent
|
6,175
|
5,316
|
|
Other equity holders
|
997
|
991
|
|
Equity holders of the parent
|
7,172
|
6,307
|
|
Non-controlling interests
|
41
|
49
|
|
Profit after tax
|
7,213
|
6,356
|
|
|
|
|
|
Earnings per share
|
|
|
|
Basic earnings per ordinary share
|
43.8p
|
36.0p
|
|
Diluted earnings per ordinary share
|
42.3p
|
34.8p
|
|
Condensed consolidated statement of comprehensive
income
|
||
|
|
Year ended 31.12.25
|
Year ended 31.12.24
|
|
|
£m
|
£m
|
|
Profit after tax
|
7,213
|
6,356
|
|
|
|
|
|
Other comprehensive income/(loss) that may be recycled to profit or
loss:
|
|
|
|
Currency translation reserve
|
|
|
|
Currency translation differences1
|
(1,131)
|
(59)
|
|
Tax
|
(1)
|
13
|
|
Fair value through other comprehensive income reserve
|
|
|
|
Net gains/(losses) from changes in fair value
|
1,024
|
(863)
|
|
Net losses/(gains) transferred to net profit on
disposal
|
191
|
(164)
|
|
Net (gain)/losses relating to (releases of) impairment
|
(3)
|
1
|
|
Net (losses)/gains due to fair value hedging
|
(142)
|
325
|
|
Tax
|
(297)
|
194
|
|
Cash flow hedging reserve
|
|
|
|
Net gains/(losses) from changes in fair value
|
3,675
|
(784)
|
|
Net (gains)/losses transferred to net profit
|
(522)
|
1,842
|
|
Tax
|
(889)
|
(281)
|
|
Other comprehensive income that may be recycled to profit or
loss
|
1,905
|
224
|
|
|
|
|
|
Other comprehensive income/(loss) not recycled to profit or
loss:
|
|
|
|
Retirement benefit remeasurements
|
(10)
|
(427)
|
|
Own credit
|
89
|
(1,130)
|
|
Tax
|
(30)
|
432
|
|
Other comprehensive income/(loss) not recycled to profit or
loss
|
49
|
(1,125)
|
|
|
|
|
|
Other comprehensive income/(loss) for the year
|
1,954
|
(901)
|
|
|
|
|
|
Total comprehensive income for the period
|
9,167
|
5,455
|
|
|
|
|
|
Attributable to:
|
|
|
|
Equity holders of the parent
|
9,126
|
5,406
|
|
Non-controlling interests
|
41
|
49
|
|
Total comprehensive income for the period
|
9,167
|
5,455
|
|
1
|
Includes £44m loss (2024: £1m loss) on recycling of
currency translation differences to net profit.
|
|
Condensed consolidated balance sheet
|
||
|
|
As at 31.12.25
|
As at 31.12.24
|
|
Assets
|
£m
|
£m
|
|
Cash and balances at central banks
|
229,752
|
210,184
|
|
Cash collateral and settlement balances
|
130,532
|
119,843
|
|
Debt securities at amortised cost
|
68,475
|
68,210
|
|
Loans and advances at amortised cost to banks
|
8,638
|
8,327
|
|
Loans and advances at amortised cost to customers
|
352,885
|
337,946
|
|
Reverse repurchase agreements and other similar secured lending at
amortised cost
|
17,622
|
4,734
|
|
Trading portfolio assets
|
190,061
|
166,453
|
|
Financial assets at fair value through the income
statement
|
186,857
|
193,734
|
|
Derivative financial instruments
|
252,459
|
293,530
|
|
Financial assets at fair value through other comprehensive
income
|
74,394
|
78,059
|
|
Investments in associates and joint ventures
|
739
|
891
|
|
Goodwill and intangible assets
|
8,284
|
8,275
|
|
Current tax assets
|
276
|
155
|
|
Deferred tax assets
|
4,992
|
6,321
|
|
Assets included in a disposal group classified as held for
sale
|
5,932
|
9,854
|
|
Other assets
|
12,267
|
11,686
|
|
Total assets
|
1,544,165
|
1,518,202
|
|
|
|
|
|
Liabilities
|
|
|
|
Deposits at amortised cost from banks
|
20,413
|
13,203
|
|
Deposits at amortised cost from customers
|
565,200
|
547,460
|
|
Cash collateral and settlement balances
|
117,583
|
106,229
|
|
Repurchase agreements and other similar secured borrowings at
amortised cost
|
25,170
|
39,415
|
|
Debt securities in issue
|
119,033
|
92,402
|
|
Subordinated liabilities
|
12,954
|
11,921
|
|
Trading portfolio liabilities
|
57,737
|
56,908
|
|
Financial liabilities designated at fair value
|
294,108
|
282,224
|
|
Derivative financial instruments
|
240,808
|
279,415
|
|
Current tax liabilities
|
868
|
566
|
|
Deferred tax liabilities
|
13
|
18
|
|
Liabilities included in a disposal group classified as held for
sale
|
—
|
3,726
|
|
Other liabilities
|
12,042
|
12,234
|
|
Total liabilities
|
1,465,929
|
1,445,721
|
|
|
|
|
|
Equity
|
|
|
|
Called up share capital and share premium
|
4,178
|
4,186
|
|
Other reserves
|
1,628
|
(468)
|
|
Retained earnings
|
59,253
|
56,028
|
|
Shareholders' equity attributable to ordinary shareholders of the
parent
|
65,059
|
59,746
|
|
Other equity instruments
|
12,725
|
12,075
|
|
Total equity excluding non-controlling interests
|
77,784
|
71,821
|
|
Non-controlling interests
|
452
|
660
|
|
Total equity
|
78,236
|
72,481
|
|
|
|
|
|
Total liabilities and equity
|
1,544,165
|
1,518,202
|
|
Condensed consolidated statement of changes in equity
|
|||||||
|
Called up share capital and share
premium1,2
|
Other equity
instruments3
|
Other reserves4
|
Retained earnings
|
Total
|
Non-controlling interests
|
Total equity
|
|
|
Year ended 31.12.2025
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Balance as at 1 January 2025
|
4,186
|
12,075
|
(468)
|
56,028
|
71,821
|
660
|
72,481
|
|
Profit after tax
|
—
|
997
|
—
|
6,175
|
7,172
|
41
|
7,213
|
|
Currency translation movements
|
—
|
—
|
(1,132)
|
—
|
(1,132)
|
—
|
(1,132)
|
|
Fair value through other comprehensive income reserve
|
—
|
—
|
773
|
—
|
773
|
—
|
773
|
|
Cash flow hedges
|
—
|
—
|
2,264
|
—
|
2,264
|
—
|
2,264
|
|
Retirement benefit remeasurements
|
—
|
—
|
—
|
(14)
|
(14)
|
—
|
(14)
|
|
Own credit
|
—
|
—
|
63
|
—
|
63
|
—
|
63
|
|
Total comprehensive income for the period
|
—
|
997
|
1,968
|
6,161
|
9,126
|
41
|
9,167
|
|
Employee share schemes and hedging thereof
|
150
|
—
|
—
|
1,127
|
1,277
|
—
|
1,277
|
|
Issue and redemption of other equity instruments
|
—
|
651
|
—
|
(4)
|
647
|
—
|
647
|
|
Other equity instruments coupon paid
|
—
|
(997)
|
—
|
—
|
(997)
|
—
|
(997)
|
|
Redemption of preference shares
|
—
|
—
|
—
|
(59)
|
(59)
|
(211)
|
(270)
|
|
Vesting of employee share schemes net of purchases
|
|
|
(36)
|
(554)
|
(590)
|
|
(590)
|
|
Dividends paid
|
—
|
—
|
—
|
(1,213)
|
(1,213)
|
(41)
|
(1,254)
|
|
Repurchase of shares
|
(158)
|
—
|
158
|
(2,241)
|
(2,241)
|
—
|
(2,241)
|
|
Other movements
|
|
(1)
|
6
|
8
|
13
|
3
|
16
|
|
Balance as at 31 December 2025
|
4,178
|
12,725
|
1,628
|
59,253
|
77,784
|
452
|
78,236
|
|
Year ended 31.12.2024
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Balance as at 1 January 2024
|
4,288
|
13,259
|
(77)
|
53,734
|
71,204
|
660
|
71,864
|
|
Profit after tax
|
—
|
991
|
—
|
5,316
|
6,307
|
49
|
6,356
|
|
Currency translation movements
|
—
|
—
|
(46)
|
—
|
(46)
|
—
|
(46)
|
|
Fair value through other comprehensive income reserve
|
—
|
—
|
(507)
|
—
|
(507)
|
—
|
(507)
|
|
Cash flow hedges
|
—
|
—
|
777
|
—
|
777
|
—
|
777
|
|
Retirement benefit remeasurements
|
—
|
—
|
—
|
(303)
|
(303)
|
—
|
(303)
|
|
Own credit
|
—
|
—
|
(822)
|
—
|
(822)
|
—
|
(822)
|
|
Total comprehensive income for the period
|
—
|
991
|
(598)
|
5,013
|
5,406
|
49
|
5,455
|
|
Employee share schemes and hedging thereof
|
103
|
—
|
—
|
874
|
977
|
—
|
977
|
|
Issue and redemption of other equity instruments
|
—
|
(1,155)
|
—
|
(96)
|
(1,251)
|
—
|
(1,251)
|
|
Other equity instruments coupon paid
|
—
|
(991)
|
—
|
—
|
(991)
|
—
|
(991)
|
|
Vesting of employee shares scheme net of purchases
|
—
|
—
|
(1)
|
(508)
|
(509)
|
—
|
(509)
|
|
Dividends paid
|
—
|
—
|
—
|
(1,221)
|
(1,221)
|
(49)
|
(1,270)
|
|
Repurchase of shares
|
(205)
|
—
|
205
|
(1,760)
|
(1,760)
|
—
|
(1,760)
|
|
Other movements
|
—
|
(29)
|
3
|
(8)
|
(34)
|
—
|
(34)
|
|
Balance as at 31 December 2024
|
4,186
|
12,075
|
(468)
|
56,028
|
71,821
|
660
|
72,481
|
|
1
|
As at 31 December 2025, Called up share capital comprises 13,867m
(December 2024: 14,420m) ordinary shares of 25p each.
|
|
2
|
For the period ended 31 December 2025, Barclays PLC fully executed
two share buybacks and partially executed one share buyback
totalling £2,232m. Accordingly, it repurchased and cancelled
636m shares. The nominal value of £158m has been transferred
from Share capital to Capital redemption reserve within Other
reserves. For the year ended 31 December 2024, two share buybacks
were executed, totalling £1,750m. Accordingly, Barclays PLC
repurchased and cancelled 818m shares. The nominal value of
£205m was transferred from Share capital to Capital redemption
reserve within Other reserves.
|
|
3
|
Other equity instruments of £12,725m (December 2024:
£12,075m) comprise AT1 securities issued by Barclays PLC.
There were four issuances in the form of Fixed Rate Resetting
Perpetual Subordinated Contingent Convertible Securities for
£3,784m (net of £15m issuance costs) and three
redemptions of £3,133m (net of £13m issuance costs,
transferred to retained earnings on redemption) for the period
ended 31 December 2025. During the period ended 31 December 2024,
there were two issuances in the form of Fixed Rate Resetting
Perpetual Subordinated Contingent Convertible Securities, for
£1,598m, which includes issuance costs of £6m and two
redemptions totalling £2,753m.
|
|
4
|
See Note 8 Other reserves
|
|
Condensed consolidated cash flow statement
|
||
|
|
Year ended 31.12.25
|
Year ended 31.12.24
|
|
|
£m
|
£m
|
|
Profit before tax
|
9,139
|
8,108
|
|
Adjustment for non-cash and other items
|
11,054
|
6,620
|
|
Net (increase)/decrease in loans and advances at amortised
cost
|
(17,403)
|
284
|
|
Net increase in deposits at amortised cost
|
24,950
|
14,952
|
|
Net increase/(decrease) in debt securities in issue
|
20,925
|
(9,978)
|
|
Changes in other operating assets and liabilities
|
(28,533)
|
(11,590)
|
|
Corporate income tax paid
|
(1,393)
|
(1,283)
|
|
Net cash from operating activities
|
18,739
|
7,113
|
|
Net cash from investing activities
|
1,595
|
(17,886)
|
|
Net cash from financing
activities1
|
2,256
|
784
|
|
Effect of exchange rates on cash and cash equivalents
|
(1,738)
|
(2,407)
|
|
Net increase/(decrease) in cash and cash equivalents
|
20,852
|
(12,396)
|
|
Cash and cash equivalents at beginning of the period
|
235,611
|
248,007
|
|
Cash and cash equivalents at end of the period
|
256,463
|
235,611
|
|
1
|
Issuance and redemption of debt securities included in financing
activities relate to instruments that qualify as eligible
liabilities and satisfy regulatory requirements for MREL
instruments which came into effect during 2019.
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
Deferred tax assets and liabilities
|
£m
|
£m
|
|
UK
|
3,408
|
4,451
|
|
USA
|
1,260
|
1,432
|
|
Other territories
|
324
|
438
|
|
Deferred tax assets
|
4,992
|
6,321
|
|
Deferred tax liabilities
|
(13)
|
(18)
|
|
|
|
|
|
Analysis of deferred tax assets
|
|
|
|
Temporary differences
|
3,895
|
4,787
|
|
Tax losses
|
1,097
|
1,534
|
|
Deferred tax assets
|
4,992
|
6,321
|
|
|
Year ended 31.12.25
|
Year ended 31.12.24
|
|
|
£m
|
£m
|
|
Profit attributable to ordinary equity holders of the
parent
|
6,175
|
5,316
|
|
|
|
|
|
|
m
|
m
|
|
Basic weighted average number of shares in issue
|
14,112
|
14,755
|
|
Number of potential ordinary shares
|
492
|
516
|
|
Diluted weighted average number of shares
|
14,604
|
15,271
|
|
|
|
|
|
|
p
|
p
|
|
Basic earnings per ordinary share
|
43.8
|
36.0
|
|
Diluted earnings per ordinary share
|
42.3
|
34.8
|
|
|
Year ended 31.12.25
|
Year ended 31.12.24
|
||
|
|
Per share
|
Total
|
Per share
|
Total
|
|
Dividends paid during the period
|
p
|
£m
|
p
|
£m
|
|
Full year dividend paid during the period
|
5.50
|
791
|
5.30
|
796
|
|
Interim dividend paid during the period
|
3.00
|
422
|
2.90
|
425
|
|
Total Dividend
|
8.50
|
1,213
|
8.20
|
1,221
|
|
|
2025
|
2024
|
||||||
|
|
Valuation techniques used
|
Valuation techniques used
|
||||||
|
|
Quoted market price
|
Observable inputs
|
Significant unobservable inputs
|
|
Quoted market price
|
Observable inputs
|
Significant unobservable inputs
|
|
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
As at 31 December
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Trading portfolio assets
|
111,158
|
68,556
|
10,347
|
190,061
|
77,761
|
78,577
|
10,115
|
166,453
|
|
Financial assets at fair value through the income
statement
|
5,140
|
173,140
|
8,577
|
186,857
|
3,526
|
181,784
|
8,424
|
193,734
|
|
Derivative financial assets
|
108
|
250,639
|
1,712
|
252,459
|
101
|
291,352
|
2,077
|
293,530
|
|
Financial assets at fair value through other comprehensive
income
|
51,717
|
19,578
|
3,099
|
74,394
|
25,913
|
48,407
|
3,739
|
78,059
|
|
Investment property
|
—
|
—
|
43
|
43
|
—
|
—
|
9
|
9
|
|
Total assets
|
168,123
|
511,913
|
23,778
|
703,814
|
107,301
|
600,120
|
24,364
|
731,785
|
|
Trading portfolio liabilities
|
(42,917)
|
(14,733)
|
(87)
|
(57,737)
|
(27,694)
|
(28,819)
|
(395)
|
(56,908)
|
|
Financial liabilities designated at fair value
|
(1,702)
|
(287,532)
|
(4,874)
|
(294,108)
|
(181)
|
(278,785)
|
(3,258)
|
(282,224)
|
|
Derivative financial liabilities
|
(93)
|
(237,650)
|
(3,065)
|
(240,808)
|
(86)
|
(276,148)
|
(3,181)
|
(279,415)
|
|
Total liabilities
|
(44,712)
|
(539,915)
|
(8,026)
|
(592,653)
|
(27,961)
|
(583,752)
|
(6,834)
|
(618,547)
|
|
|
Year ended
31.12.25
|
Year ended
31.12.24
|
|
|
£m
|
£m
|
|
Opening balance as at 1 January
|
11,921
|
10,494
|
|
Issuances
|
1,772
|
1,870
|
|
Redemptions
|
(727)
|
(476)
|
|
Other
|
(12)
|
33
|
|
Closing balance
|
12,954
|
11,921
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
£m
|
£m
|
|
Customer redress
|
543
|
299
|
|
Legal, competition and regulatory matters
|
79
|
59
|
|
Redundancy and restructuring
|
190
|
213
|
|
Undrawn contractually committed facilities and
guarantees
|
416
|
439
|
|
Onerous contracts
|
41
|
14
|
|
Sundry provisions
|
395
|
359
|
|
Total
|
1,664
|
1,383
|
|
|
As at 31.12.25
|
As at 31.12.24
|
|
|
£m
|
£m
|
|
Currency translation reserve
|
2,493
|
3,625
|
|
Fair value through other comprehensive income reserve
|
(1,100)
|
(1,873)
|
|
Cash flow hedging reserve
|
(666)
|
(2,930)
|
|
Own credit reserve
|
(990)
|
(1,059)
|
|
Other reserves and treasury shares
|
1,891
|
1,769
|
|
Total
|
1,628
|
(468)
|
|
Measure
|
Definition
|
|
Loan: deposit ratio
|
Total loans and advances at amortised cost divided by total
deposits at amortised cost.
|
|
Period end tangible equity refers to:
|
|
|
Period end tangible shareholders' equity (for Barclays
Group)
|
Shareholders' equity attributable to ordinary shareholders of the
parent, adjusted for the deduction of goodwill and intangible
assets.
|
|
Period end allocated tangible equity (for businesses)
|
Allocated tangible equity is calculated as 13.5% (2024: 13.5%) of
RWAs for each business, adjusted for capital deductions, excluding
goodwill and intangible assets, reflecting the assumptions the
Barclays Group uses for capital planning purposes. Head Office
allocated tangible equity represents the difference between the
Barclays Group’s tangible shareholders’ equity and the
amounts allocated to businesses.
|
|
Average tangible equity refers to:
|
|
|
Average tangible shareholders’ equity (for Barclays
Group)
|
Calculated as the average of the previous month’s period end
tangible shareholders' equity and the current month’s period
end tangible shareholders' equity. The average tangible
shareholders’ equity for the period is the average of the
monthly averages within that period.
|
|
Average allocated tangible equity (for businesses)
|
Calculated as the average of the previous month’s period end
allocated tangible equity and the current month’s period end
allocated tangible equity. The average allocated tangible equity
for the period is the average of the monthly averages within that
period.
|
|
Return on tangible equity (RoTE) refers to:
|
|
|
Return on average tangible shareholders’ equity (for Barclays
Group)
|
Group attributable profit, as a proportion of average tangible
shareholders’ equity. The components of the calculation have
been included on page 71.
|
|
Return on average allocated tangible equity (for
businesses)
|
Business attributable profit, as a proportion of that business's
average allocated tangible equity. The components of the
calculation have been included on pages 73 to 74.
|
|
|
|
|
Operating costs
|
A measure of total operating expenses excluding litigation and
conduct charges and UK regulatory levies.
|
|
Cost: income ratio
|
Total operating expenses divided by total income.
|
|
Loan loss rate
|
Quoted in basis points and represents total impairment charges
divided by total gross loans and advances held at amortised cost
(including portfolios reclassified to assets held for sale) at the
balance sheet date. The components of the calculation have been
included on pages 75 to 77.
|
|
Net interest margin
|
Net interest income divided by the sum of average customer assets.
The components of the calculation have been included on page
26.
|
|
Tangible net asset value per share
|
Calculated by dividing shareholders’ equity, excluding
non-controlling interests and other equity instruments, less
goodwill and intangible assets, by the number of issued ordinary
shares. The components of the calculation have been included on
page 79.
|
|
Profit before impairment
|
Calculated by excluding credit impairment charges or releases from
profit before tax.
|
|
Structural cost actions
|
Cost actions taken to improve future financial
performance.
|
|
Net New Assets Under Management
|
The net inflows and outflows of client balances within
Discretionary Portfolio Management and Advisory mandates. Excludes
market performance and foreign exchange translation but includes
reinvested dividend payments.
|
|
Assets under Management (AUM)
|
Total market value of client investment balances managed within
investment mandates where Barclays provides discretionary portfolio
management or advisory services. Total Assets Under Management
excludes uninvested cash held under an investment
mandate.
|
|
Assets under Supervision (AUS)
|
Total market value of client investment balances where Barclays
provides custodian or transactional services.
|
|
Group net interest income excluding Barclays Investment Bank and
Head Office
|
A measure of Barclays Group net interest income, excluding the net
interest income reported in Barclays Investment Bank and Head
Office.
|
|
Income over average risk weighted assets
|
Represents total income as a proportion of average risk weighted
assets. Average risk weighted assets calculated as the average of
the previous month’s period end risk weighted assets and the
current month’s period end risk weighted assets. Average risk
weighted assets for the period is the average of the monthly
averages within that period.
|
|
|
Year ended 31.12.25
|
|
|||||
|
|
Barclays UK
|
Barclays UK
Corporate
Bank
|
Barclays
Private Bank
and Wealth
Management
|
Barclays
Investment
Bank
|
Barclays US
Consumer
Bank
|
Head Office
|
Barclays
Group
|
|
Return on average tangible equity
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Attributable profit/(loss)
|
2,443
|
648
|
291
|
3,092
|
390
|
(689)
|
6,175
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Average equity
|
15.8
|
3.4
|
1.2
|
29.1
|
4.1
|
9.3
|
62.9
|
|
Average goodwill and intangibles
|
(4.0)
|
—
|
(0.1)
|
—
|
(0.6)
|
(3.6)
|
(8.3)
|
|
Average tangible equity
|
11.8
|
3.4
|
1.1
|
29.1
|
3.5
|
5.7
|
54.6
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible equity
|
20.7%
|
18.9%
|
26.3%
|
10.6%
|
11.0%
|
n/m
|
11.3%
|
|
|
Year ended 31.12.24
|
|
|||||
|
|
Barclays UK
|
Barclays UK
Corporate
Bank
|
Barclays
Private Bank
and Wealth
Management
|
Barclays
Investment
Bank
|
Barclays US
Consumer
Bank
|
Head Office
|
Barclays
Group
|
|
Return on average tangible equity
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Attributable profit/(loss)
|
2,465
|
490
|
288
|
2,513
|
302
|
(742)
|
5,316
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Average equity
|
14.6
|
3.1
|
1.1
|
29.7
|
3.7
|
6.5
|
58.7
|
|
Average goodwill and intangibles
|
(3.9)
|
—
|
(0.1)
|
—
|
(0.4)
|
(3.6)
|
(8.0)
|
|
Average tangible equity
|
10.7
|
3.1
|
1.0
|
29.7
|
3.3
|
2.9
|
50.7
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible equity
|
23.1%
|
16.0%
|
28.1%
|
8.5%
|
9.1%
|
n/m
|
10.5%
|
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Attributable profit
|
1,195
|
1,457
|
1,659
|
1,864
|
|
965
|
1,564
|
1,237
|
1,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Average shareholders' equity
|
64.8
|
63.3
|
62.1
|
61.4
|
|
59.7
|
59.1
|
57.7
|
58.3
|
|
|
Average goodwill and intangibles
|
(8.3)
|
(8.2)
|
(8.2)
|
(8.3)
|
|
(8.2)
|
(8.1)
|
(7.9)
|
(7.8)
|
|
|
Average tangible shareholders' equity
|
56.5
|
55.1
|
53.9
|
53.1
|
|
51.5
|
51.0
|
49.8
|
50.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
8.5%
|
10.6%
|
12.3%
|
14.0%
|
|
7.5%
|
12.3%
|
9.9%
|
12.3%
|
|
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Attributable profit
|
706
|
647
|
580
|
510
|
|
781
|
621
|
584
|
479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Average allocated equity
|
15.9
|
15.9
|
15.8
|
15.7
|
|
15.1
|
14.5
|
14.4
|
14.3
|
|
|
Average goodwill and intangibles
|
(4.0)
|
(4.0)
|
(4.0)
|
(4.0)
|
|
(3.9)
|
(3.9)
|
(3.9)
|
(3.9)
|
|
|
Average allocated tangible equity
|
11.9
|
11.9
|
11.8
|
11.7
|
|
11.2
|
10.6
|
10.5
|
10.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
23.8%
|
21.8%
|
19.7%
|
17.4%
|
|
28.0%
|
23.4%
|
22.3%
|
18.5%
|
|
|
Barclays UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Attributable profit
|
168
|
196
|
142
|
142
|
|
98
|
144
|
135
|
113
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Average allocated equity
|
3.5
|
3.4
|
3.4
|
3.3
|
|
3.2
|
3.1
|
3.0
|
3.0
|
|
|
Average goodwill and intangibles
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
|
Average allocated tangible equity
|
3.5
|
3.4
|
3.4
|
3.3
|
|
3.2
|
3.1
|
3.0
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
19.1%
|
22.8%
|
16.6%
|
17.1%
|
|
12.3%
|
18.8%
|
18.0%
|
15.2%
|
|
|
Barclays Private Bank and Wealth Management
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Attributable profit
|
35
|
72
|
88
|
96
|
|
63
|
74
|
77
|
74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Average allocated equity
|
1.2
|
1.2
|
1.2
|
1.2
|
|
1.2
|
1.1
|
1.1
|
1.1
|
|
|
Average goodwill and intangibles
|
(0.1)
|
(0.1)
|
(0.1)
|
(0.1)
|
|
(0.1)
|
(0.1)
|
(0.1)
|
(0.1)
|
|
|
Average allocated tangible equity
|
1.1
|
1.1
|
1.1
|
1.1
|
|
1.1
|
1.0
|
1.0
|
1.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
12.6%
|
26.4%
|
31.9%
|
34.5%
|
|
23.9%
|
29.0%
|
30.8%
|
28.7%
|
|
|
Barclays Investment Bank
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Attributable profit
|
294
|
723
|
876
|
1,199
|
|
247
|
652
|
715
|
899
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Average allocated equity
|
29.6
|
28.6
|
28.7
|
29.6
|
|
29.3
|
29.5
|
29.9
|
30.0
|
|
|
Average goodwill and intangibles
|
—
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
|
Average allocated tangible equity
|
29.6
|
28.6
|
28.7
|
29.6
|
|
29.3
|
29.5
|
29.9
|
30.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
4.0%
|
10.1%
|
12.2%
|
16.2%
|
|
3.4%
|
8.8%
|
9.6%
|
12.0%
|
|
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Attributable profit
|
144
|
118
|
87
|
41
|
|
94
|
89
|
75
|
44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Average allocated equity
|
4.2
|
4.0
|
4.0
|
4.2
|
|
4.0
|
3.8
|
3.6
|
3.6
|
|
|
Average goodwill and intangibles
|
(0.6)
|
(0.5)
|
(0.6)
|
(0.6)
|
|
(0.6)
|
(0.5)
|
(0.3)
|
(0.3)
|
|
|
Average allocated tangible equity
|
3.6
|
3.5
|
3.4
|
3.6
|
|
3.4
|
3.3
|
3.3
|
3.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
15.8%
|
13.5%
|
10.2%
|
4.5%
|
|
11.2%
|
10.9%
|
9.2%
|
5.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended 31.12.25
|
|
|||||
|
|
Barclays UK
|
Barclays UK
Corporate
Bank
|
Barclays
Private Bank
and Wealth
Management
|
Barclays
Investment
Bank
|
Barclays US
Consumer
Bank
|
Head Office
|
Barclays
Group
|
|
Loan loss rate
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Credit impairment (charges)/ releases
|
(413)
|
(37)
|
8
|
(305)
|
(1,521)
|
(11)
|
(2,279)
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Gross
loans and advances held at amortised cost (including portfolios
reclassified as held for sale)1
|
231.9
|
30.2
|
15.1
|
131.0
|
30.6
|
2.5
|
441.3
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
18
|
12
|
(5)
|
23
|
496
|
n/m
|
52
|
|
|
Year ended 31.12.24
|
|
|||||
|
|
Barclays UK
|
Barclays UK
Corporate Bank
|
Barclays
Private Bank
and Wealth
Management
|
Barclays
Investment
Bank
|
Barclays US
Consumer
Bank
|
Head Office
|
Barclays Group
|
|
Loan loss rate
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Credit impairment charges
|
(365)
|
(76)
|
(6)
|
(123)
|
(1,293)
|
(119)
|
(1,982)
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Gross
loans and advances held at amortised cost (including portfolios
reclassified as held for sale)1
|
227.5
|
25.8
|
14.7
|
124.9
|
30.0
|
6.7
|
429.6
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
16
|
29
|
4
|
10
|
431
|
n/m
|
46
|
|
1
|
Includes gross loans and advances to customers and banks, in
addition to debt securities.
|
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Credit impairment charges
|
(535)
|
(632)
|
(469)
|
(643)
|
|
(711)
|
(374)
|
(384)
|
(513)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
441.3
|
437.5
|
428.4
|
430.4
|
|
429.6
|
408.3
|
409.1
|
407.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
48
|
57
|
44
|
61
|
|
66
|
37
|
38
|
51
|
|
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Credit impairment charges
|
(74)
|
(102)
|
(79)
|
(158)
|
|
(283)
|
(16)
|
(8)
|
(58)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
231.9
|
230.9
|
228.5
|
227.5
|
|
227.5
|
218.4
|
217.3
|
219.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
13
|
18
|
14
|
28
|
|
49
|
3
|
1
|
11
|
|
|
Barclays UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Credit impairment charges
|
(1)
|
(5)
|
(12)
|
(19)
|
|
(40)
|
(13)
|
(8)
|
(15)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
30.2
|
29.2
|
28.2
|
27.0
|
|
25.8
|
25.2
|
26.0
|
26.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
1
|
7
|
17
|
28
|
|
62
|
21
|
12
|
23
|
|
|
Barclays Private Bank and Wealth Management
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Credit impairment (charges)/releases
|
(2)
|
(1)
|
2
|
9
|
|
(2)
|
(7)
|
3
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
15.1
|
15.2
|
14.8
|
14.8
|
|
14.7
|
14.3
|
14.1
|
14.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
5
|
3
|
(5)
|
(25)
|
|
5
|
19
|
(9)
|
—
|
|
|
Barclays Investment Bank
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Credit impairment (charges)/releases
|
(22)
|
(144)
|
(67)
|
(72)
|
|
(46)
|
(43)
|
(44)
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
131.0
|
129.8
|
126.8
|
129.6
|
|
124.9
|
116.5
|
115.5
|
113.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
7
|
44
|
21
|
23
|
|
15
|
15
|
15
|
(4)
|
|
|
Barclays US Consumer Bank
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
|
Credit impairment charges
|
(431)
|
(379)
|
(312)
|
(399)
|
|
(298)
|
(276)
|
(309)
|
(410)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)
|
30.6
|
29.8
|
27.4
|
28.9
|
|
30.0
|
26.7
|
28.4
|
27.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
558
|
505
|
456
|
562
|
|
395
|
411
|
438
|
610
|
|
|
Barclays Investment Bank
|
Year ended 31.12.25
|
Year ended 31.12.24
|
|
£m
|
£m
|
|
|
Income
|
13,055
|
11,805
|
|
|
|
|
|
|
£bn
|
£bn
|
|
Average RWAs
|
198.6
|
202.7
|
|
|
|
|
|
Income over average RWAs
|
6.6%
|
5.8%
|
|
Barclays Investment Bank
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
Q324
|
Q224
|
Q124
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
|
Income
|
2,792
|
3,083
|
3,307
|
3,873
|
|
2,607
|
2,851
|
3,019
|
3,328
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Average RWAs
|
202.1
|
194.9
|
196.1
|
201.4
|
|
199.9
|
201.8
|
204.9
|
204.4
|
|
|
|
|
|
|
|
|
|
|
|
|
Income over average RWAs
|
5.5%
|
6.3%
|
6.7%
|
7.7%
|
|
5.2%
|
5.7%
|
5.9%
|
6.5%
|
|
Tangible net asset value per share
|
As at 31.12.25
|
As at 31.12.24
|
|
|
£m
|
£m
|
|
Total equity excluding non-controlling interests
|
77,784
|
71,821
|
|
Other equity instruments
|
(12,725)
|
(12,075)
|
|
Goodwill
and intangibles
|
(8,284)
|
(8,275)
|
|
Tangible shareholders' equity attributable to ordinary shareholders
of the parent
|
56,775
|
51,471
|
|
|
|
|
|
|
m
|
m
|
|
Shares in issue1
|
13,867
|
14,420
|
|
|
|
|
|
|
p
|
p
|
|
Tangible net asset value per share
|
409
|
357
|
|
1
|
The number of shares of 13,867m as at 31 December 2025 is different
from the 13,865m quoted in the 2 January 2026 announcement entitled
“Total Voting Rights” because the share buyback
transaction executed on 30 December 2025 did not settle until 2
January 2026.
|
|
Results timetable1
|
|
|
|
|
Date
|
|
|
Ex-dividend date
|
|
|
|
|
19 February 2026
|
|
|
Dividend record date
|
|
|
|
|
20 February 2026
|
|
|
DRIP last election date
|
|
|
|
|
10 March 2026
|
|
|
Dividend payment date
|
|
|
|
|
31 March 2026
|
|
|
Q1 2026 Results Announcement
|
|
|
|
|
28 April 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For qualifying ADR holders, the 2025 full year dividend of 5.6p per
ordinary share becomes 22.4p per ADS (representing four shares).
The ex-dividend date for ADR holders is 20 February 2026. The
dividend record and dividend payment dates for ADR holders are as
shown above.
|
||||||
|
A Dividend Re-Investment Plan (DRIP) is provided by Equiniti
Financial Services Limited. The DRIP enables the Company’s
shareholders to elect to have their cash dividend payments used to
purchase the Company’s shares.
More information can be found at shareview.co.uk/info/drip
|
||||||
|
DRIP participants will usually receive their additional ordinary
shares (in lieu of a cash dividend) three to four days after the
dividend payment date. Qualifying ADR holders should contact
Shareowner Services for further details regarding the
DRIP.
|
||||||
|
Barclays PLC ordinary shares ISIN code: GB0031348658
|
||||||
|
Barclays PLC ordinary shares TIDM Code: BARC
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
Exchange rates
|
31.12.25
|
31.12.24
|
Change2
|
|
|
|
|
Period end - USD/GBP
|
1.34
|
1.25
|
8%
|
|
|
|
|
YTD average - USD/GBP
|
1.32
|
1.28
|
3%
|
|
|
|
|
3 month average - USD/GBP
|
1.33
|
1.28
|
4%
|
|
|
|
|
Period end - EUR/GBP
|
1.15
|
1.21
|
(5)%
|
|
|
|
|
YTD average - EUR/GBP
|
1.17
|
1.18
|
(1)%
|
|
|
|
|
3 month average - EUR/GBP
|
1.14
|
1.20
|
(5)%
|
|
|
|
|
|
|
|
|
|
|
|
|
Share price data
|
|
|
|
|
|
|
|
Barclays PLC (p)
|
476
|
268
|
|
|
|
|
|
Barclays PLC number of shares (m)3
|
13,867
|
14,420
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For further information please contact
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor relations
|
Media relations
|
|||||
|
Marina Shchukina +44 (0) 20 7116 2526
|
Tom Hoskin +44 (0) 20 7116 4755
|
|||||
|
|
|
|||||
|
More information on Barclays can be found on our website:
home.barclays
|
||||||
|
|
|
|
|
|
|
|
|
Registered office
|
|
|
|
|
|
|
|
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20
7116 1000. Company number: 48839.
|
||||||
|
|
|
|
|
|
|
|
|
Registrar
|
|
|
|
|
|
|
|
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99
6DA, United Kingdom.
|
|
|
||||
|
Tel: +44 (0)371 384 2055 (UK and International telephone
number)4.
|
|
|
||||
|
|
|
|
|
|
|
|
|
American Depositary Receipts (ADRs)
|
|
|
|
|
|
|
|
Shareowner Services
|
||||||
|
P.O. Box 64504
|
||||||
|
St. Paul, MN 55164-0504
|
||||||
|
United States of America
|
||||||
|
shareowneronline.com
|
|
|
||||
|
Toll Free Number (US and Canada): +1 800-990-1135
|
|
|
||||
|
Outside the US and Canada: +1 651-453-2128
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
Delivery of ADR certificates and overnight mail
|
|
|
|
|
|
|
|
Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota
Heights, MN 55120-4100, USA.
|
||||||
|
1
|
Note that these dates are provisional and subject to
change.
|
|
2
|
The change is the impact to GBP reported information.
|
|
3
|
The number of shares of 13,867m as at 31 December 2025 is different
from the 13,865m quoted in the 2 January 2026 announcement entitled
“Total Voting Rights” because the share buyback
transaction executed on 30 December 2025 did not settle until 2
January 2026.
|
|
4
|
Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding
UK public holidays in England and Wales.
|